10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from                               to                             

Commission File Number: 001-37397

Rimini Street, Inc.

(Exact name of registrant as specified in its charter)

Delaware	36-4880301
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
3993 Howard Hughes Parkway, Suite 500, Las Vegas, NV	89169
(Address of principal executive offices)	(Zip Code)
Registrant's telephone number, including area code:	(702) 839-9671

Not Applicable

(Former name, former address and former fiscal year, if changed since last report) 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:	Trading Symbol(s)	Name of each exchange on which registered:
Common Stock, par value $0.0001 per share	RMNI	The Nasdaq Global Market
Public Units, each consisting of one share of Common Stock, $0.0001 par value, and one-half of one Warrant	RMNIU	OTC Pink Current Information Marketplace
Warrants, exercisable for one share of Common Stock, $0.0001 par value	RMNIW	OTC Pink Current Information Marketplace

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.         Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨ Accelerated filer þ Non-accelerated filer ¨

Smaller reporting company ☑ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).        

Yes ☐ No þ

The registrant had approximately 86,790,000 shares of its $0.0001 par value common stock outstanding as of November 1, 2021. 

RIMINI STREET, INC.

TABLE OF CONTENTS

		Page
PART I. FINANCIAL INFORMATION		2
ITEM 1.	Financial Statements	2
	Unaudited Condensed Consolidated Balance Sheets	2
	Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income	3
	Unaudited Condensed Consolidated Statements of Stockholders' Deficit	4
	Unaudited Condensed Consolidated Statements of Cash Flows	5
	Notes to Unaudited Condensed Consolidated Financial Statements	7
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	39
ITEM 4.	Controls and Procedures	39
PART II. OTHER INFORMATION		40
ITEM 1.	Legal Proceedings	40
ITEM 1A.	Risk Factors	41
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	63
ITEM 3.	Defaults Upon Senior Securities	63
ITEM 4.	Mine Safety Disclosures	63
ITEM 5.	Other Information	63
ITEM 6.	Exhibits	64
SIGNATURES		65

1

PART I - FINANCIAL INFORMATION

ITEM 1. Financial Statements. 

RIMINI STREET, INC. 

Unaudited Condensed Consolidated Balance Sheets

(In thousands, except per share amounts)

	September 30,		December 31,
	2021		2020
ASSETS
Current assets:
Cash and cash equivalents	$	103,015	$	87,575
Restricted cash	425		334
Accounts receivable, net of allowance of $566 and $723, respectively	76,258		117,937
Deferred contract costs, current	15,008		13,918
Prepaid expenses and other	17,041		13,456
Total current assets	211,747		233,220
Long-term assets:
Property and equipment, net of accumulated depreciation and amortization of $12,664 and $10,985, respectively	4,547		4,820
Operating lease right-of-use assets	15,023		17,521
Deferred contract costs, noncurrent	21,716		21,027
Deposits and other	1,940		1,476
Deferred income taxes, net	1,756		1,871
Total assets	$	256,729	$	279,935
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Current maturities of long-term debt	$	3,670	$	—
Accounts payable	9,051		3,241
Accrued compensation, benefits and commissions	38,115		38,026
Other accrued liabilities	17,118		21,154
Operating lease liabilities, current	4,226		3,940
Deferred revenue, current	203,806		228,967
Total current liabilities	275,986		295,328
Long-term liabilities:
Long-term debt, net of current maturities	80,556		—
Deferred revenue, noncurrent	39,876		27,966
Operating lease liabilities, noncurrent	13,574		15,993
Accrued PIK dividends payable	—		1,193
Liability for redeemable warrants	5,145		2,122
Other long-term liabilities	1,756		2,539
Total liabilities	416,893		345,141
Commitments and contingencies (Note 9)
Redeemable Series A Preferred Stock:
Authorized 180 shares; issued and outstanding — shares and 155 shares, respectively. Liquidation preference of $0, net of discount of $0 and $154,911, net of discount of $17,057, respectively.	—		137,854
Stockholders’ deficit:
Preferred stock; $0.0001 par value. Authorized 99,820 shares (excluding 180 shares of Series A Preferred Stock); no other series has been designated	—		—
Common stock; $0.0001 par value. Authorized 1,000,000 shares; issued and outstanding 86,658 and 76,406 shares, respectively	9		8
Additional paid-in capital	139,505		98,258
Accumulated other comprehensive loss	(2,716)		(318)
Accumulated deficit	(295,846)		(301,008)
Treasury stock, at cost	(1,116)		—
Total stockholders' deficit	(160,164)		(203,060)
Total liabilities, redeemable preferred stock and stockholders' deficit	$	256,729	$	279,935

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2

RIMINI STREET, INC. 

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income

(In thousands, except per share amounts)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Revenue	$	95,642	$	82,518	$	275,151	$	238,952
Cost of revenue	33,376		31,991		101,807		92,627
Gross profit	62,266		50,527		173,344		146,325
Operating expenses:
Sales and marketing	32,527		29,195		96,067		84,443
General and administrative	15,631		13,025		48,728		38,159
Impairment charge related to operating right of use assets	—		—		393		—
Litigation costs and related recoveries:
Professional fees and other costs of litigation	6,581		3,773		14,130		9,247
Insurance costs and recoveries, net	—		—		—		1,062
Litigation costs and related recoveries, net	6,581		3,773		14,130		10,309
Total operating expenses	54,739		45,993		159,318		132,911
Operating income	7,527		4,534		14,026		13,414
Non-operating income and (expenses):
Interest expense	(653)		(10)		(738)		(35)
Gain (loss) on change in fair value of redeemable warrants	(2,053)		303		(3,023)		(243)
Other income (expenses), net	(1,161)		54		(885)		(731)
Income before income taxes	3,660		4,881		9,380		12,405
Income tax expense	(1,729)		(1,272)		(4,218)		(3,327)
Net income	1,931		3,609		5,162		9,078
Other comprehensive income:
Foreign currency translation gain (loss)	(454)		520		(2,398)		109
Comprehensive income	$	1,477	$	4,129	$	2,764	$	9,187
Net loss attributable to common stockholders	$	(6,691)	$	(3,136)	$	(21,382)	$	(10,986)
Net loss per share attributable to common stockholders:
Basic and diluted	$	(0.08)	$	(0.04)	$	(0.26)	$	(0.16)
Weighted average number of shares of Common Stock outstanding:
Basic and diluted	86,189		72,377		83,449		69,521

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

RIMINI STREET, INC.

Unaudited Condensed Consolidated Statements of Stockholders' Deficit

(In thousands) 

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Common Stock, Shares
Beginning of period	85,704		68,530		76,406		67,503
Exercise of stock options for cash	383		976		1,183		1,540
Restricted stock units vested	708		601		1,456		1,064
Issuance of Common Stock in March 2021 and August 2020 Offerings	—		6,100		7,750		6,100
Treasury shares	(137)		—		(137)		—
End of period	86,658		76,207		86,658		76,207
Total Stockholders' Deficit, beginning of period	$	(156,299)	$	(227,788)	$	(203,060)	$	(223,321)
Common Stock, Amount
Beginning of period	9		7		8		7
Exercise of stock options for cash	—		—		—		—
Restricted stock units vested	—		—		—		—
Issuance of Common Stock in March 2021 and August 2020 Offerings, net	—		1		1		1
End of period	9		8		9		8
Additional Paid-in Capital
Beginning of period	143,801		81,170		98,258		90,695
Stock based compensation expense	2,393		2,189		7,104		5,425
Exercise of stock options for cash	1,933		1,081		5,046		1,639
Restricted stock units vested	—		—		—		—
Issuance of Common Stock in March 2021 and August 2020 Offerings, net	—		25,103		55,641		25,103
Share redemption of Series A Preferred Stock in July 2021 and April 2021:
Accretion related to redemption of Series A Preferred Stock	(8,020)		—		(13,693)		—
Make-whole dividends related to redemption of Series A Preferred Stock	(602)		—		(2,945)		—
Return on repurchase of Series A Preferred Stock shares in January 2021	—		—		(38)		—
Accretion of discount on Series A Preferred Stock	—		(1,587)		(2,277)		(4,702)
Accrued dividends on Series A Preferred Stock:
Payable in cash	—		(3,968)		(5,839)		(11,817)
Payable in kind	—		(1,190)		(1,752)		(3,545)
End of period	139,505		102,798		139,505		102,798
Accumulated Other Comprehensive Loss
Beginning of period	(2,262)		(1,840)		(318)		(1,429)
Foreign currency translation gain (loss)	(454)		520		(2,398)		109
End of period	(2,716)		(1,320)		(2,716)		(1,320)
Accumulated Deficit
Beginning of period	(297,777)		(307,125)		(301,008)		(312,594)
Net income	1,931		3,609		5,162		9,078
End of period	(295,846)		(303,516)		(295,846)		(303,516)
Treasury Stock	(1,116)		—		(1,116)		—
Total Stockholders' Deficit, end of period	$	(160,164)	$	(202,030)	$	(160,164)	$	(202,030)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

RIMINI STREET, INC.

Unaudited Condensed Consolidated Statements of Cash Flows

(In thousands)

	Nine Months Ended September 30,
	2021		2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	5,162	$	9,078
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on change in fair value of redeemable warrants	3,023		243
Stock-based compensation expense	7,104		5,425
Depreciation and amortization	1,772		1,321
Accretion and amortization of debt discount and issuance costs	196		—
Deferred income taxes	1		(275)
Impairment charge related to operating right of use assets	393		—
Amortization and accretion related to operating right of use assets	4,625		4,628
Other	—		8
Changes in operating assets and liabilities:
Accounts receivable	41,021		42,367
Prepaid expenses, deposits and other	(4,289)		4,656
Deferred contract costs	(1,780)		(4,872)
Accounts payable	5,605		1,712
Accrued compensation, benefits, commissions and other liabilities	(3,940)		(3,632)
Deferred revenue	(11,079)		(28,826)
Net cash provided by operating activities	47,814		31,833
CASH FLOWS USED IN INVESTING ACTIVITIES:
Capital expenditures	(1,455)		(1,159)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds related to Common Stock issuances in March 2021 and August 2020 Offerings	56,965		25,657
Payments of professional fees related to Common Stock issuances in March 2021 and August 2020 Offerings	(1,296)		(253)
Proceeds from issuance of Credit Facility	89,313		—
Debt issuance costs paid	(4,013)		—
Principal payments on the Credit Facility	(1,125)		—
Payments to repurchase shares of Series A Preferred Stock	(156,753)		—
Payments of cash dividends on Series A Preferred Stock	(12,679)		(11,750)
Payments for treasury stock	(1,116)		—
Principal payments on capital leases	(330)		(170)
Proceeds from exercise of employee stock options	5,044		1,639
Net cash used in financing activities	(25,990)		15,123
Effect of foreign currency translation changes	(4,838)		(442)
Net change in cash, cash equivalents and restricted cash	15,531		45,355
Cash, cash equivalents and restricted cash at beginning of period	87,909		38,388
Cash, cash equivalents and restricted cash at end of period	$	103,440	$	83,743

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

RIMINI STREET, INC. 

Unaudited Condensed Consolidated Statements of Cash Flows, Continued

(In thousands)

	Nine Months Ended September 30,
	2021		2020
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	$	524	$	37
Cash paid for income taxes	3,053		2,165
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Discount on shares of Common Stock issued in March 2021 and August 2020 Public Offerings:
Underwriter discounts and commissions	$	2,948	$	1,650
Underwriter expenses	1,050		143
Accrued professional fees related to the issuance of Common Stock	27		300
Redeemable Series A Preferred Stock Dividends and Accretion:
Accrued cash dividends	$	—	$	3,977
Accrued PIK dividends	—		1,182
Accretion of discount on Series A Preferred Stock	2,277		4,702
Issuance of Series A Preferred Stock for PIK dividends	2,891		3,498
Increase in payables for debt issuance costs	$	145	$	—
Increase in principal related to the Credit Facility discount	28		—
Purchase of equipment under capital lease obligations	—		1,641
Increase in payables for capital expenditures	—		2

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 — NATURE OF BUSINESS AND BASIS OF PRESENTATION

Nature of Business

Rimini Street, Inc. (the “Company”) is a global provider of enterprise software support services. The Company’s subscription-based software support products and services offer enterprise software licensees a choice of solutions that replace or supplement the support products and services offered by enterprise software vendors. 

Basis of Presentation and Consolidation

The unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly-owned subsidiaries, are prepared in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”). All significant intercompany balances and transactions have been eliminated. The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, certain information and footnote disclosures required by U.S. GAAP for complete financial statements have been condensed or omitted in accordance with such rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the unaudited condensed consolidated financial statements have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2020, included in the Company’s 2020 Annual Report on Form 10-K as filed with the SEC on March 3, 2021 and as subsequently amended on May 10, 2021 (as amended, the “2020 Form 10-K/A”).

The accompanying condensed consolidated balance sheet and related disclosures as of December 31, 2020 have been derived from the Company’s audited financial statements. The Company’s financial condition as of September 30, 2021, and operating results for the three months ended September 30, 2021, are not necessarily indicative of the financial condition and results of operations that may be expected for any future interim period or for the year ending December 31, 2021.

NOTE 2 — LIQUIDITY AND SIGNIFICANT ACCOUNTING POLICIES

Liquidity

As of September 30, 2021, the Company’s current liabilities exceeded its current assets by $64.2 million, and the Company recorded net income of $1.9 million for the three months ended September 30, 2021. As of September 30, 2021, the Company had available cash, cash equivalents and restricted cash of $103.4 million. As of September 30, 2021, the Company’s current liabilities included $203.8 million of deferred revenue whereby the historical costs of fulfilling the Company's commitments to provide services to its clients was approximately 35% of the related deferred revenue for the three months ended September 30, 2021.

On July 20, 2021, the Company redeemed the remaining 87,802 shares of its 13.00% Series A Preferred Stock at an aggregate total redemption price of $88.4 million. The total redemption price consisted of $87.8 million related to the outstanding shares of Series A Preferred Stock with a face value of $1,000 per share and $0.6 million or $6.86 per share of Series A Preferred Stock related to the dividends earned for the period from July 1, 2021 through July 19, 2021. The redeemed shares of the Series A Preferred Stock, along with the dividends, were recorded on the redemption date of July 20, 2021.

The Company funded the July 20, 2021 redemption with borrowings from a five year term loan of $90 million, which was entered into on July 20, 2021 (the “Credit Facility”). Annual minimum principal payments over the five year term for the Credit Facility will be 5%, 5%, 7.5%, 7.5% and 10%, respectively, with the remaining balance due at the end of the term. See Note 5 for further information regarding the Company's Credit Facility.

7

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

As discussed in Note 7, the Company completed a firm commitment underwritten public offering on March 11, 2021 (the “March 2021 Offering”) of 7.8 million shares of its common stock, par value $0.0001 per share (“Common Stock”), at a price of $7.75 per share for total gross proceeds of $57.0 million. Underwriter discounts and commissions were $2.9 million and the underwriter expenses were $0.2 million. The Company also incurred additional professional fees and expenses of $1.3 million as part of the transaction, resulting in net proceeds from the March 2021 Offering of approximately $55.6 million. The Company had previously completed a firm commitment underwritten public offering on August 18, 2020 (the “August 2020 Offering”) of 6.1 million shares of its Common Stock at a price of $4.50 per share for total gross proceeds of $27.5 million. Underwriter discounts and commissions were $1.7 million and the underwriter expenses were $0.1 million. The Company also incurred additional professional fees of $0.6 million as part of the transaction, resulting in net proceeds from the August 2020 Offering of approximately $25.1 million.

Additionally, the Company is obligated to make operating and financing lease payments that are due within the next 12 months in the aggregate amount of $6.3 million. In March 2020, the World Health Organization declared the outbreak of a novel strain of the coronavirus (“COVID-19”) to be a pandemic. After the issuance date of these financial statements, the Company’s ability to operate continues not to be significantly adversely impacted by the COVID-19 pandemic, the Company believes that current cash, cash equivalents, restricted cash, and future cash flow from operating activities will be sufficient to meet the Company’s anticipated cash needs, including Credit Facility repayments, working capital needs, capital expenditures and other contractual obligations for at least 12 months from the issuance date of these financial statements.

Revision of Previously Issued Financial Statements

The Company has revised certain prior period amounts on the unaudited condensed consolidated financial statements to correct a misstatement with respect to improperly classifying certain warrants to purchase approximately 6.1 million shares of the Company’s Common Stock, at $11.50 per share (the “GP Sponsor Private Placement Warrants”) as equity instead of as a warrant liability that is adjusted through charges or credits to the income statement each quarter to reflect changes in the fair value of the warrants, under the guidance of Accounting Standards Codification (“ASC”) 815-40, Contracts in Entity’s Own Equity. The Company recorded a liability for the warrants of $2.1 million as of December 31, 2020 and adjusted its additional paid-in capital and accumulated deficit accordingly. The impact to the statement of operations and statement of cash flows for both the three and nine months ended September 30, 2020 was a gain of $0.3 million and a loss of $0.2 million, respectively. There was no income tax impact associated with this revision. Total stockholders’ deficit increased by $1.0 million and $0.7 million as of September 30, 2020 and December 31, 2019, respectively.

The Company has assessed the impact of improperly classifying the GP Sponsor Private Placement Warrants as equity rather than as a warranty liability that is adjusted through charges or credits to the income statement each quarter to reflect changes in the fair value of the warrants and determined the impact is not material, quantitatively or qualitatively, to the periods presented. Accordingly, the Company will adjust prior periods as those financial statements are presented for comparative purposes in future filings.

See Note 12 for additional information regarding the assumptions made to determine the fair value of the GP Sponsor Private Placement Warrants as of September 30, 2021 and December 31, 2020.

Use of Estimates

The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the amounts reported in its consolidated financial statements and accompanying notes. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes are reasonable under the circumstances to determine the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s significant accounting estimates include, but are not necessarily limited to, accounts receivable, valuation assumptions for stock options and leases, deferred income taxes and the related valuation allowances, and the evaluation and measurement of contingencies. To the extent there are material differences between the Company’s estimates and actual results, the Company’s future consolidated results of operation may be affected.

Recent Accounting Pronouncements

Recently Adopted Standards. The following accounting standards were adopted during the fiscal year 2021:

In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The guidance removes certain exceptions to the general income tax

8

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

accounting principles, and clarifies and amends existing guidance to facilitate consistent application of the accounting principles. The new guidance was effective for the Company as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU 2020-1, Investments—Equity Securities (Topic 321), Investments - Equity and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The guidance clarifies interactions between current accounting standards on equity securities, equity method and joint ventures, and derivatives and hedging. The new guidance addresses accounting for the transition into and out of the equity method and measuring certain purchased options and forward contracts to acquire investments. The new guidance was effective for the Company as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.

NOTE 3 - DEFERRED CONTRACT COSTS AND DEFERRED REVENUE

Activity for deferred contract costs for the three and nine months ended September 30, 2021 and 2020 is shown below (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Deferred contract costs, current and noncurrent, as of the beginning of period	$	36,561	$	29,384	$	34,945	$	28,049
Capitalized commissions during the period	4,295		7,123		13,437		15,165
Amortized deferred contract costs during the period	(4,132)		(3,585)		(11,658)		(10,292)
Deferred contract costs, current and noncurrent, as of the end of period	$	36,724	$	32,922	$	36,724	$	32,922

Deferred revenue activity for the three and nine months ended September 30, 2021 and 2020 is shown below (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Deferred revenue, current and noncurrent, as of the beginning of period	$	265,638	$	218,506	$	256,933	$	235,498
Billings, net	73,686		68,309		261,900		207,751
Revenue recognized	(95,642)		(82,518)		(275,151)		(238,952)
Deferred revenue, current and noncurrent, as of the end of period	$	243,682	$	204,297	$	243,682	$	204,297

The transaction price allocated to the remaining performance obligations represents contracted revenue that has not yet been recognized. As of September 30, 2021, the remaining transaction price included in deferred revenue was $203.8 million in current and $39.9 million in noncurrent.

NOTE 4 — OTHER FINANCIAL INFORMATION

Other Accrued Liabilities

As of September 30, 2021 and December 31, 2020, other accrued liabilities consist of the following (in thousands): 

	2021		2020
Accrued sales and other taxes	$	4,238	$	5,213
Accrued professional fees	6,997		5,912
Accrued dividends on Redeemable Series A Preferred Stock	—		3,842
Current maturities of capital lease obligations	334		429
Income taxes payable	721		2,245
Other accrued expenses	4,828		3,513
Total other accrued liabilities	$	17,118	$	21,154

9

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 5 — DEBT

Debt is presented net of debt discounts and issuance costs in the Company's balance sheets. As of September 30, 2021 and December 31, 2020, debt consisted of the following (in thousands):

	2021		2020
Credit Facility	$	84,226	$	—
Less current maturities	3,670		—
Long-term debt, net of current maturities	$	80,556	$	—

Effective July 20, 2021, the Company received $89.3 million of net proceeds related to the Credit Facility. The borrowings under the Credit Facility were discounted at 0.375%.. As part of the transaction, the Company incurred issuance costs of $4.2 million, which were capitalized and will be amortized over the term of the Credit Facility.

The Credit Facility bears interest at the London Interbank Offered Rate (“LIBOR”), plus a margin ranging from 1.75% to 2.50%. For the three months ended September 30, 2021, the interest rate on the Credit Facility was 2.4%. The LIBOR rate as of September 30, 2021 was not materially different from the interest rate for the three months ended September 30, 2021. Hence the fair value of the Credit Facility approximated the book value as of September 30, 2021.

The Credit Facility contains certain financial covenants, including a minimum fixed charge coverage ratio greater than 1.25, a total leverage ratio less than 3.75, and a minimum liquidity of $20 million in U.S. cash. Annual minimum principal payments over the five year term for the Credit Facility will be 5%, 5%, 7.5%, 7.5%,and 10%, respectively, with the remaining balance due at the end of the term. On September 30, 2021, the Company made a principal payment of $1.1 million.

Pursuant to a Guaranty and Security Agreement, dated July 2, 2021 (the “Guaranty and Security Agreement”), among the Credit Parties and Capital One, National Association, as agent, the obligations under the Credit Agreement are guaranteed by certain of the Company’s subsidiaries (the Company and the guarantors, collectively, the “Credit Parties”) and are secured, subject to customary permitted liens and exceptions, by a lien on substantially all assets of the Credit Parties.

The components of interest expense for the three and nine months ended September 30, 2021 and 2020 are presented below (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Credit Facility:
Interest expense	$	435	$	—	$	435	$	—
Accretion expense related to discount and issuance costs	196		—		196		—
Interest on finance leases	22		10		107		35
	$	653	$	10	$	738	$	35

NOTE 6 — REDEEMABLE SERIES A PREFERRED STOCK

2018 Securities Purchase Agreement

On July 19, 2018, the Company closed a Securities Purchase Agreement (the “2018 SPA”) with several accredited investors (the “Purchasers”) for a private placement (the “Initial Private Placement”) of (i) 140,000 shares of Series A Preferred Stock, (ii) approximately 2.9 million shares of Common Stock, and (iii) convertible secured promissory notes (the “Convertible Notes”), with no principal amount outstanding at issuance that solely collateralize amounts, if any, that may become payable by the Company pursuant to certain redemption provisions of the Series A Preferred Stock.

10

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Pursuant to the 2018 SPA, the Purchasers acquired an aggregate of 140,000 shares of Series A Preferred Stock, 2.9 million shares of Common Stock, and Convertible Notes with no principal amount outstanding as of the issuance date, for an aggregate purchase price equal to $133.0 million in cash (after taking into account a discount of $7.0 million, but before the incremental and direct transaction costs associated with the Private Placement of $4.6 million). The allocation of the net proceeds as of the closing date, along with changes in the net carrying value of the Series A Preferred Stock through September 30, 2021, are set forth below (dollars in thousands):

	Series A Preferred Stock				Common			Convertible
	Shares	Amount			Stock			Notes		Total
Fair value on July 19, 2018:
Series A Preferred Stock	140,000	$	126,763	(1)	$	—		$	—	$	126,763
Common Stock	—	—			20,131		(2)	—		20,131
Convertible Notes	—	—			—			—		—
Total	140,000	$	126,763		$	20,131		$	—	$	146,894
Relative fair value allocation on July 19, 2018
Aggregate cash proceeds on July 19, 2018	140,000	$	114,773	(3)	$	18,227	(3)	$	—	$	133,000
Incremental and direct costs	—	(3,994)		(4)	(634)		(4)	—		(4,628)
Net carrying value on July 19, 2018	140,000	$	110,779		$	17,593		$	—	$	128,372

_________________

(1)The liquidation preference for each share of Series A Preferred Stock on the closing date for the Initial Private Placement was $1,000 per share for an aggregate liquidation preference of $140.0 million. The estimated fair value of the Series A Preferred Stock was approximately $126.8 million on July 19, 2018, which is the basis for allocation of the net proceeds. Please refer to Note 12 for further discussion of the valuation methodology employed.

(2)The fair value of the issuance of approximately 2.9 million shares of Common Stock was based on the last closing price of $6.95 per share on the date prior to closing the transaction.

(3)The aggregate cash proceeds of $133.0 million on July 19, 2018 were allocated pro rata based on the fair value of all consideration issued.

(4)Incremental and direct costs of the Initial Private Placement were allocated pro rata based on the fair value of all consideration issued. Such costs include financial advisory and professional fees of $2.7 million that were incurred by the Company, and due diligence and professional fees incurred by the investors of $1.9 million.

At the closing, the Company used the $133.0 million of proceeds from the Initial Private Placement plus cash and cash equivalents of $2.7 million to (i) repay all outstanding indebtedness and various operating and financing fees and expenses under its former credit facility in the aggregate amount of $132.8 million, (ii) pay incremental and direct transaction costs of $2.7 million, and (iii) pay a professional services retainer of $0.2 million.

March 2019 Securities Purchase Agreement

On March 7, 2019, the Company entered into a securities purchase agreement (the “March 2019 SPA”) with an accredited investor for a private placement (the “March 2019 Private Placement”) of (i) 6,500 shares of Series A Preferred Stock, (ii) 134,483 shares of Common Stock, and (iii) a Convertible Note with no principal balance outstanding. The shares of Series A Preferred Stock were authorized pursuant to the CoD and are subject to the provisions set forth in an amended Security Agreement, a Convertible Note and a registration rights agreement that is substantially similar in all material respects to the Registration Rights Agreement entered into in connection with the 2018 SPA discussed above. The accredited investor in the March 2019 Private Placement is affiliated with one of the accredited investors in the Initial Private Placement.

The aggregate cash proceeds from the March 2019 Private Placement were $5.8 million in cash (after an 11.0% discount or $0.7 million). The net proceeds were approximately $5.0 million after estimated transaction costs payable by the Company of $0.8 million. The transaction costs consisted of 85,000 shares of Common Stock issued to the existing holders of the Series A Preferred Stock for their consent at a cost of approximately $0.5 million and direct transaction costs of approximately $0.3 million related to due diligence and professional fees. The net proceeds were allocated based on their relative fair values at issuance of the Series A Preferred Stock and the Common Stock. The allocation of the net proceeds from the March 2019

11

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Private Placement are set forth below (dollars in thousands):

	Series A Preferred Stock				Common			Convertible
	Shares	Amount			Stock			Notes		Total
Fair value on March 7, 2019:
Series A Preferred Stock	6,500	$	5,313	(1)	$	—		$	—	$	5,313
Common Stock	—	—			722		(2)	—		722
Convertible Notes	—	—			—			—		—
Total	6,500	$	5,313		$	722		$	—	$	6,035
Relative fair value allocation on March 7, 2019:
Aggregate cash proceeds on March 7, 2019	6,500	$	5,093	(3)	$	692	(3)	$	—	$	5,785
Incremental and direct costs	—	(661)		(4)	(90)		(4)	—		(751)
Net carrying value on March 7, 2019	6,500	$	4,432		$	602		$	—	$	5,034

(1)The liquidation preference for each share of Series A Preferred Stock on the closing date for the March 2019 Private Placement was $1,000 per share for an aggregate liquidation preference of $6.5 million. The estimated fair value of the Series A Preferred Stock was approximately $5.3 million on March 7, 2019, which is the basis for allocation of the net proceeds. Please refer to Note 12 for further discussion of the valuation methodology employed.

(2)The fair value of the issuance of approximately 134,483 shares of Common Stock was based on the closing price of $5.37 per share on the date prior to closing of the transaction.

(3)The aggregate cash proceeds of $5.8 million on March 7, 2019 were allocated pro rata based on the fair value of all consideration issued.

(4)Incremental and direct costs related to the March 2019 Private Placement were allocated pro rata based on the fair value of all consideration issued. Such costs included the issuance of 85,000 shares of Common Stock to the Initial Private Placement investors in the Series A Preferred Stock for their consent of approximately $0.5 million and financial advisory and professional fees that were incurred of approximately $0.3 million that were either paid or accrued directly by the Company as of March 31, 2019.

June 2019 Securities Purchase Agreement

On June 20, 2019, the Company entered into a securities purchase agreement (the “June 2019 SPA”) with accredited investors for a private placement (the “June 2019 Private Placement”) of (i) 3,500 shares of Series A Preferred Stock, (ii) 72,414 shares of Common Stock, and (iii) a Convertible Note with no principal balance outstanding. The shares of the Series A Preferred Stock were authorized pursuant to the CoD and are subject to the provisions set forth in an amended Security Agreement, a Convertible Note and a registration rights agreement that is substantially similar in all material respects to the Registration Rights Agreement entered into in connection with the 2018 SPA discussed above. The accredited investors in the June 2019 Private Placement are not affiliated with the accredited investors in the March 2019 Private Placement or the Initial Private Placement.

The aggregate cash proceeds from the June 2019 Private Placement were $3.3 million in cash (after a 5.0% discount or $0.2 million). The net proceeds were approximately $3.0 million after estimated transaction costs payable by the Company of $0.3 million. The transaction costs consisted of 35,000 shares of Common Stock issued to the existing holders of the Series A Preferred Stock for their consent at a cost of approximately $0.2 million and direct transaction costs of approximately $0.2 million related to professional fees of the investors, existing holders of Series A Preferred Stock and the Company. The net proceeds were allocated based on their relative fair values at issuance of the Series A Preferred Stock and the Common Stock.

12

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The allocation of the net proceeds from the June 2019 Private Placement are set forth below (dollars in thousands):

	Series A Preferred Stock				Common			Convertible
	Shares	Amount			Stock			Notes		Total
Fair value on June 20, 2019:
Series A Preferred Stock	3,500	$	2,997	(1)	$	—		$	—	$	2,997
Common Stock	—	—			376		(2)	—		376
Convertible Notes	—	—			—			—		—
Total	3,500	$	2,997		$	376		$	—	$	3,373
Relative fair value allocation on June 20, 2019:
Aggregate cash proceeds on June 20, 2019	3,500	$	2,954	(3)	$	371	(3)	$	—	$	3,325
Incremental and direct costs	—	(301)		(4)	(38)		(4)	—		(339)
Net carrying value on June 20, 2019	3,500	$	2,653		$	333		$	—	$	2,986

(1)The liquidation preference for each share of Series A Preferred Stock on the closing date for the June 2019 Private Placement was $1,000 per share for an aggregate liquidation preference of $3.5 million. The estimated fair value of the Series A Preferred Stock was approximately $3.0 million on June 20, 2019, which is the basis for allocation of the net proceeds. Please refer to Note 12 for further discussion of the valuation methodology employed.

(2)The fair value of the issuance of approximately 72,414 shares of Common Stock was based on the closing price of $5.19 per share on the date prior to closing of the transaction.

(3)The aggregate cash proceeds of $3.3 million on June 20, 2019 were allocated pro rata based on the fair value of all consideration issued.

(4)Incremental and direct costs related to the June 2019 Private Placement were allocated pro rata based on the fair value of all consideration issued. Such costs included the issuance of 35,000 shares of Common Stock to the Initial Private Placement investors in the Series A Preferred Stock for their consent of approximately $0.2 million and financial advisory and professional fees that were incurred of approximately $0.2 million that were either paid or accrued directly by the Company as of June 30, 2019.

On July 20, 2021, the Company redeemed the remaining 87,802 shares of its 13.00% Series A Preferred Stock at an aggregate total redemption price of $88.4 million. The total price consisted of $87.8 million related to the outstanding shares of Series A Preferred Stock with a face value of $1,000 per share and $0.6 million or $6.86 per share of Series A Preferred Stock related to the dividends earned for the period from July 1, 2021 through July 19, 2021. The redeemed shares of the Series A Preferred Stock, along with the dividends, were recorded on the redemption date of July 20, 2021.

The Company funded the July 20, 2021 redemption with borrowings under the Credit Facility. See Note 5 for further information regarding the Company's Credit Facility.

On April 16, 2021, the Company redeemed 60,000 shares of its 13.00% Series A Preferred Stock at an aggregate total redemption price of $62.3 million. The total price consisted of $60.0 million related to the face value of $1,000 per share of Series A Preferred Stock and $2.3 million or $39.05 per share of Series A Preferred Stock related to the dividends to be earned for the period from April 1, 2021 through July 18, 2021. The redeemed shares of Series A Preferred Stock, along with the dividends were recorded when the Series A Preferred Stock became mandatorily redeemable on April 16, 2021.

The Company funded the April 16, 2021 redemption with a portion of the proceeds from the March 2021 Offering and the August 2020 Offering, which raised aggregate net proceeds of approximately $80.7 million.

On January 5, 2021, the Company entered into an agreement with certain of the holders of its Series A Preferred Stock (the “January 2021 Stock Repurchase Agreement”) to repurchase 10,000 shares of Series A Preferred Stock and the associated obligations pursuant to the Company’s Convertible Secured Promissory Notes outstanding in respect thereof (the “Note Obligations”) for an aggregate purchase price of approximately $8.95 million representing a discount to the face value of such shares of Series A Preferred Stock and no make-whole payments were required. The January 2021 Stock Repurchase Agreement contains customary representations, warranties and covenants of the parties and waivers relating to the purchased shares of Series A Preferred Stock.

Upon the closing of the transactions contemplated by the January 2021 Stock Repurchase Agreement, the shares of Series A Preferred Stock purchased by the Company were retired (and the underlying Note Obligations cancelled) and are not eligible for re-issuance by the Company in accordance with the terms of the CoD.

13

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The changes in the net carrying value of Series A Preferred Stock from December 31, 2020 to September 30, 2021 are set forth below (dollars in thousands):

	Series A Preferred Stock
	Shares	Amount
Net carrying value as of December 31, 2020	154,911	$	137,854
Issuance of shares to settle PIK Dividends on January 4, 2021	1,193	1,193
Repurchase of 10,000 shares on January 5, 2021	(10,000)	(8,913)
Accretion of discount for the three months ended March 31, 2021	—	1,473
Net carrying value as of March 31, 2021	146,104	131,607
Issuance of shares to settle PIK Dividends on April 1, 2021	1,051	1,051
Redemption of 60,000 shares on April 16, 2021	(60,000)	(54,327)
Accretion of discount for the three months ended June 30, 2021	—	804
Net carrying value as of June 30, 2021	87,155	79,135
Issuance of shares to settle PIK Dividends on July 1, 2021	647	647
Redemption of 87,802 shares on July 20, 2021	(87,802)	(79,782)
Net carrying value as of September 30, 2021	—	$	—

Certificate of Designations of the Series A Preferred Stock and Dividends

The CoD authorized the issuance of up to 180,000 shares of Series A Preferred Stock. The holders of Series A Preferred Stock were entitled to, from the respective issuance date, a cash dividend of 10.0% per annum (the “Cash Dividends”) and a payment-in-kind dividend of 3.0% per annum (the “PIK Dividends” and, together with the Cash Dividends, the “Dividends”) for the first five years following the initial June 2018 closing and thereafter all dividends accruing on such Series A Preferred Stock would be payable in cash at a rate of 13.0% per annum. The Series A Preferred Stock was classified as mezzanine equity in the Company’s consolidated balance sheet as of December 31, 2020 since the holders had redemption rights beginning on July 19, 2023 (and earlier under certain circumstances).

Presented below is a summary of total and per share dividends declared through September 30, 2021 (dollars in thousands, except per share amounts):

	Dividends Payable in:				Total		Dividends
	Cash		PIK		Dividends		Per Share
Dividends payable as of December 31, 2020	$	3,842	$	1,193	$	5,035	$	32.50
Cash Dividends @ 10% per annum	3,660		—		3,660		23.40
PIK Dividends @ 3% per annum	—		1,098		1,098		7.02
Fractional PIK shares settled for cash	47		(47)		—		—
Less dividends settled January 4, 2021	(4,009)		(1,193)		(5,202)		(33.26)
Dividends payable as of March 31, 2021	3,540		1,051		4,591		32.14
Cash Dividends @ 10% per annum	2,179		—		2,179		25.00
PIK Dividends @ 3% per annum	—		654		654		7.50
Fractional PIK shares settled for cash	7		(7)		—		—
Less dividends settled April 1, 2021	(3,540)		(1,051)		(4,591)		(52.68)
Dividends payable as of June 30, 2021	2,186		647		2,833		32.51
Less dividends settled on July 1, 2021	(2,186)		(647)		(2,833)		(32.27)
Dividends payable as of September 30, 2021	$	—	$	—	$	—	$	—

NOTE 7 — COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS

14

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Common Stock Offerings

On March 11, 2021, the Company completed the March 2021 Offering of 7.8 million shares of its Common Stock at a price of $7.75 per share for total gross proceeds of $57.0 million. Underwriter discounts and commissions were $2.9 million and the underwriter expenses were $0.2 million. The Company also incurred additional professional fees and expenses of $1.3 million as part of the transaction, resulting in net proceeds from the March 2021 Offering of approximately $55.6 million. The Company used the net proceeds from the March 2021 Offering to redeem 60,000 shares of Series A Preferred Stock in April 2021.

On August 18, 2020, the Company completed the August 2020 Offering of 6.1 million shares of its Common Stock at a price of $4.50 per share for total gross proceeds of $27.5 million. Underwriter discounts and commissions were $1.7 million and the underwriter expenses were $0.1 million. The Company also incurred additional professional fees of $0.6 million as part of the transaction, resulting in net proceeds from the August 2020 Offering of approximately $25.1 million. The Company used the net proceeds from the August 2020 Offering to redeem 60,000 shares of Series A Preferred Stock and for working capital and other general corporate purposes.

Acquisition of Common Stock upon Vesting of Restricted Stock Units

On August 6, 2021, the Company reacquired 0.1 million shares of common stock for $1.1 million related to restricted stock units (“RSUs”) that vested on that date.

Stock Plans

The Company’s stock plans consist of the 2007 Stock Plan (the “2007 Plan”) and the 2013 Equity Incentive Plan, as amended and restated in July 2017 (the “2013 Plan”). The 2007 Plan and the 2013 Plan are collectively referred to as the “Stock Plans”. On February 23, 2021, the Board of Directors authorized an increase of approximately 3.1 million shares available for grant under the 2013 Plan. For additional information about the Stock Plans, please refer to Note 8 to the Company’s consolidated financial statements for the year ended December 31, 2020, included in the 2020 Form 10-K/A. The information presented below provides an update for activity under the Stock Plans for both the three and nine months ended September 30, 2021.

Restricted Stock Units

For the nine months ended September 30, 2021, the Board of Directors granted RSUs under the 2013 Plan for an aggregate of approximately 1.4 million shares of Common Stock to employees and to non-employee directors of the Company. RSU grants vest over periods generally ranging from 12 to 36 months from the respective grant dates and the awards are subject to forfeiture upon termination of employment or service on the Board of Directors, as applicable. Based on the weighted average fair market value of the Common Stock on the date of grant of $7.57 per share, the aggregate fair value for the shares underlying the RSUs amounted to $10.6 million as of the grant date that will be recognized as compensation cost over the vesting period. Accordingly, compensation expense related to RSUs of approximately $2.1 million and $1.8 million was recognized for the three months ended September 30, 2021 and 2020, respectively. Compensation expense related to RSUs of approximately $6.2 million and $4.3 million was recognized for the nine months ended September 30, 2021 and 2020, respectively. As of September 30, 2021, the unrecognized expense of $12.2 million net of forfeitures is expected to be charged to expense on a straight-line basis as the RSUs vest over a weighted-average period of approximately 1.8 years.

Stock Options

For the nine months ended September 30, 2021, the Board of Directors granted stock options for the purchase of an aggregate of approximately 0.9 million shares of Common Stock at exercise prices that were equal to the fair market value of the Common Stock on the date of grant. These stock options generally vest annually for one-third of the awards and expire ten years after the grant date.

The following table sets forth a summary of stock option activity under the Stock Plans for the nine months ended September 30, 2021 (shares in

15

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

thousands): 

	Shares	Price (1)		Term (2)
Outstanding, December 31, 2020	7,007	$	5.24	5.0
Granted	928	7.77
Forfeited	(170)	6.21
Expired	(113)	6.63
Exercised	(1,184)	4.26
Outstanding, September 30, 2021 (3)(4)	6,468	5.73		5.1
Vested, September 30, 2021 (3)	5,056	5.53		4.0

(1)Represents the weighted average exercise price.

(2)Represents the weighted average remaining contractual term until the stock options expire.

(3)As of September 30, 2021, the aggregate intrinsic value of all stock options outstanding was $25.4 million. As of September 30, 2021, the aggregate intrinsic value of vested stock options was $20.9 million.

(4)The number of outstanding stock options that are not expected to ultimately vest due to forfeiture amounted to 0.2 million shares as of September 30, 2021.

The following table presents activity affecting the total number of shares available for grant under the Stock Plans for the nine months ended September 30, 2021 (in thousands):

 

Available, December 31, 2020	4,037
Newly authorized by Board of Directors	3,056
Stock options granted	(928)
Restricted stock units granted	(1,394)
Expired options under Stock Plans	113
Forfeited options under Stock Plans	170
Forfeited restricted stock units under Stock Plans	348
Shares repurchased	137
Available, September 30, 2021	5,539

The aggregate fair value of approximately 0.9 million stock options granted for the nine months ended September 30, 2021 amounted to $3.0 million, or $3.20 per stock option as of the grant date utilizing the Black-Scholes-Merton (“BSM”) method. The fair valued derived under the BSM method will result in the recognition of compensation cost over the vesting period of the stock options. For the nine months ended September 30, 2021, the fair value of each stock option grant under the Stock Plans was estimated on the date of grant using the BSM option-pricing model, with the following weighted-average assumptions:

 

Expected life (in years)	6.0
Volatility	42%
Dividend yield	0%
Risk-free interest rate	0.87%
Fair value per common share on date of grant	$7.77

As of September 30, 2021 and December 31, 2020, total unrecognized compensation costs related to unvested stock options, net of estimated forfeitures, was $2.4 million and $1.2 million, respectively. As of September 30, 2021, the unrecognized costs are expected to be charged to expense on a straight-line basis over a weighted-average vesting period of approximately 2.1 years.

Stock-Based Compensation Expense

16

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Stock-based compensation expense attributable to RSUs and stock options is classified as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Cost of revenues	$	376	$	303	$	1,067	$	866
Sales and marketing	752		734		2,353		1,994
General and administrative	1,265		1,152		3,684		2,565
Total	$	2,393	$	2,189	$	7,104	$	5,425

Warrants

On April 12, 2021, the SEC issued a Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (the “SEC Staff Statement”). Upon review of the SEC Staff Statement which addressed certain accounting and reporting considerations related to warrants similar to the Company’s GP Sponsor Private Placement Warrants and upon review of ASC 815-40, Contracts in Entity’s Own Equity, the Company determined that its GP Sponsor Private Placement Warrants should have been classified as a liability instead of equity. See Note 2 for further information regarding this revision to the Company’s consolidated financial statements. See Note 12 for information regarding the fair value of the GP Sponsor Private Placement Warrants as of September 30, 2021 and December 31, 2020.

As of September 30, 2021, warrants were outstanding for an aggregate of 18.1 million shares of Common Stock, including 3.4 million shares of Common Stock exercisable at $5.64 per share, and an aggregate of 14.7 million shares of Common Stock exercisable at $11.50 per share. For additional information about these warrants, please refer to Note 8 to the Company’s consolidated financial statements for the year ended December 31, 2020, included in the 2020 Form 10-K/A.

NOTE 8 — INCOME TAXES

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was passed into law, amending portions of relevant U.S. tax laws. The CARES Act contains changes to corporate taxation, including among other things, adjusting net operating loss (NOL) limitations and carryback rules, refundable AMT credits, bonus depreciation and interest expense limitations. The CARES Act also provides for an Employee Retention Credit, a fully refundable payroll tax credit for certain eligible employers and the ability for all eligible employers to defer payment of the employer share of payroll taxes owed on wages paid for the period ending December 31, 2020 (such deferred payroll taxes are due in two installments: 50% by December 31, 2021 and 50% by December 31, 2022). The Company has elected to defer payroll tax payments which totaled $3.2 million as of September 30, 2021.

For the three months ended September 30, 2021 and 2020, the Company’s effective tax rate was 47.2% and 26.1%, respectively. For the nine months ended September 30, 2021 and 2020, the Company’s effective tax rate was 45.0% and 26.8%, respectively. The Company’s income tax expense was primarily attributable to earnings in foreign jurisdictions subject to income taxes and foreign withholding taxes. In addition, there was no tax impact associated with the loss on change in fair value of redeemable warrants for three months ended September 30, 2021. The Company did not have any material changes to its conclusions regarding valuation allowances for deferred income tax assets or uncertain tax positions for the three months ended September 30, 2021 and 2020.

NOTE 9 — COMMITMENTS AND CONTINGENCIES

Retirement Plan

The Company has defined contribution plans for both its U.S. and foreign employees. For certain of these plans, employees may contribute up to the statutory maximum, which is set by law each year. The plans also provide for employer contributions. The Company’s matching contributions to these plans totaled $0.8 million and $0.7 million for the three months ended September 30, 2021 and 2020, respectively. The Company’s matching contributions to these plans totaled $2.5 million and $2.0 million for the nine months ended September 30, 2021 and 2020, respectively.

17

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Rimini I Litigation

In January 2010, certain subsidiaries of Oracle Corporation (together with its subsidiaries individually and collectively, “Oracle”) filed a lawsuit, Oracle USA, Inc. et al. v. Rimini Street, Inc. et al. (United States District Court for the District of Nevada) (the “District Court”) (“Rimini I”), against the Company and its Chief Executive Officer, Seth Ravin, alleging that certain of the Company’s processes (Process 1.0) violated Oracle’s license agreements with its customers and that the Company committed acts of copyright infringement and violated other federal and state laws. The litigation involved the Company’s business processes and the manner in which the Company provided services to its clients.

After completion of a jury trial in 2015 and subsequent appeals, the final outcome of Rimini I was that Mr. Ravin was found not liable for any claims and the Company was found liable for only one claim: “innocent infringement,” a jury finding that the Company did not know and had no reason to know that its former support processes were infringing. The jury also found that the infringement did not cause Oracle to suffer lost profits. The Company was ordered to pay a judgment of $124.4 million in 2016, which the Company promptly paid and then pursued appeals. With interest, attorneys’ fees and costs, the total judgment paid by the Company to Oracle after the completion of all appeals was approximately $89.9 million. A portion of such judgment was paid by the Company’s insurance carriers.

Injunction Proceedings

In October 2016, the District Court entered a permanent injunction prohibiting the Company from using certain processes. In August 2019, the United States Court of Appeals for the Ninth Circuit (the “Court of Appeals”) affirmed the permanent injunction issued by the District Court, while also correcting certain legal errors that narrowed the scope of the injunction. The injunction prohibits the Company from using support processes that had been found in Rimini I to “innocently” infringe certain Oracle copyrights, which the Company ceased using no later than July 31, 2014. The injunction does not prohibit the Company’s provision of support services for any Oracle product lines, but rather defines the manner in which the Company can provide support services for certain Oracle product lines.

On July 10, 2020, Oracle filed a motion to show cause contending that the Company is in violation of the injunction, and the Company opposed this motion, disputing Oracle’s claims. On March 31, 2021, the District Court issued an order resolving many outstanding disputes between the parties relating to the injunction. The District Court found that the Company violated the injunction in four certain narrow instances. The District Court refused to consider Oracle’s claims about certain processes that were not litigated in Rimini I, and that are being litigated in the separately filed Rimini Street Inc. v. Oracle Int’l Corp. litigation (described below under the heading “Rimini II Litigation”). In April 2021, the Company filed a motion for reconsideration for two of the four injunction violations identified by the District Court (since they occurred before the injunction became effective). The District Court granted the Company’s motion for reconsideration on June 10, 2021, striking from its March 31, 2021 order its holding regarding those two violations. During an evidentiary hearing in September 2021, the District Court heard evidence and argument regarding whether the Company (i) violated the injunction for certain accused conduct for which the District Court requested additional information and (ii) should be held in contempt in the two instances where the District Court found a violation of the injunction, and what sanctions, if any, are appropriate. As of the date of filing of this Report, the District Court has not rendered a decision regarding the issues presented in the September 2021 evidentiary hearing.

At this time, the Company does not have sufficient information regarding the likelihood of any possible damages for any violations of the injunction or the contempt claim asserted by Oracle. As a result, an estimate of any range of potential loss cannot be reasonably determined at this time. The Company believes that it has substantially complied with the injunction, that Oracle did not meet the burden to establish contempt of the injunction for the two certain narrow instances for which the District Court found violations, that Oracle was unable to establish additional violations of the injunction at the September 2021 hearing, and that an award for sanctions is not probable. Accordingly, no accrual has been made as of September 30, 2021. If the District Court orders any penalties for violations of the injunction and/or the Company is found to be in contempt of the injunction, Oracle may seek and the District Court may order equitable, punitive, and compensatory relief, the outcome of which could have a material adverse effect on the Company’s business and financial condition. The Company reserves all rights, including appellate rights, with respect to the District Court rulings and findings.

Rimini II Litigation

In October 2014, the Company filed a separate lawsuit, Rimini Street Inc. v. Oracle Int’l Corp., in the District Court against Oracle seeking a declaratory judgment that the Company’s revised “Process 2.0” support practices, in use since at least July 2014, do not infringe certain Oracle copyrights (“Rimini II”). The Company’s operative complaint asserts declaratory

18

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

judgment, tort, and statutory claims. Oracle’s operative counterclaim asserts declaratory judgment and copyright infringement claims and Lanham Act, breach of contract, and business tort violations.

On September 15, 2020, the District Court issued an order resolving the parties’ motions for summary judgment. It found infringement of 17 Oracle PeopleSoft copyrights for work the Company performed for a set of “gap customers” that were supported by processes litigated in Rimini I, and that became the Company’s customers after Rimini I was filed. The District Court also found infringement of four Oracle PeopleSoft copyrights involving support of two specific Company clients, described by the District Court as “limited cases” and involving “limited circumstance[s].” There was no finding of infringement on any other Oracle copyrights at issue.

The order also resolved several of the non-copyright claims asserted by the parties: (i) allowing the Company’s claim for injunctive relief against Oracle for unfair competition in violation of the California Business & Professions Code §17200 et seq. to proceed to trial; (ii) granting summary judgment for Oracle on the Company’s affirmative claims for damages under the Nevada and California unfair and deceptive trade practices statutes; and (iii) holding that Oracle had the right to revoke the Company’s access to its websites. The Court also reiterated that the Company has the legal right to provide aftermarket support for Oracle’s enterprise software.

The parties filed their joint pretrial order in Rimini II in December 2020. On September 3, 2021, the District Court granted Oracle’s motion to realign the parties with Oracle now designated as plaintiff and the Company and Mr. Ravin now designated as the defendants in the case caption and at trial. The District Court also granted Oracle’s motion to bifurcate the trial – the jury trial will proceed first and will be followed by a separate bench trial on the parties’ equitable claims for unfair competition and Oracle’s claim for an accounting.

On September 30, 2021, the District Court approved the Pretrial Order and indicated that it had “ordered counsel to meet and confer on possible trial dates in mid-2022 and the potential trial length for a trial.” Presently, there is no specific trial date approved or ordered by the District Court.

As of this date, no damages of any kind have been awarded by the District Court in Rimini II. Damages, if any, will be a decision for the Rimini II jury. The Company reserves all rights, including appellate rights, with respect to the District Court and jury rulings and findings in Rimini II.

At this time, the Company does not have sufficient information regarding possible damages exposure for the counterclaims asserted by Oracle. The Company maintains that zero damages should be awarded in Rimini II. A jury will ultimately determine what amount, if any, of damages to award. Both parties have sought injunctive relief in addition to monetary damages in this matter, and the Company has reserved its rights to appeal regarding the possible recovery of damages by the Company in connection with the Company’s claims against Oracle. As a result, an estimate of the range of loss, if any, cannot be reasonably determined. The Company also believes that an award for damages payable to Oracle is not probable, so no accrual has been made as of September 30, 2021. However, as with any jury trial, the ultimate outcome may be different from our best estimates and could have a material adverse impact on our financial results and our business.

Other Litigation

From time to time, the Company may be a party to litigation and subject to claims incident to the ordinary course of business. Although the results of litigation and claims cannot be predicted with certainty, the Company currently believes that the final outcome of these ordinary course matters will not have a material adverse effect on its business. Regardless of the outcome, litigation can have an adverse impact on the Company because of judgment, defense and settlement costs, diversion of management resources and other factors. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, Contingencies. Legal fees are expensed as incurred.

Liquidated Damages

The Company enters into agreements with clients that contain provisions related to liquidated damages that would be triggered in the event that the Company is no longer able to provide services to these clients. The maximum cash payments related to these liquidated damages is approximately $10.9 million and $13.8 million as of September 30, 2021 and December 31, 2020, respectively. To date, the Company has not incurred any costs as a result of such provisions and has not accrued any liabilities related to such provisions in these unaudited condensed consolidated financial statements.

19

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 10 — RELATED PARTY TRANSACTIONS

Rimini Street, Inc. (“RSI”) was incorporated in the state of Nevada in September 2005. RSI provides enterprise software support services. In May 2017, RSI entered into an Agreement and Plan of Merger (the “Merger Agreement”) with GP Investments Acquisition Corp. (“GPIA”), a publicly-held special purpose acquisition company (“SPAC”) incorporated in the Cayman Islands and formed for the purpose of effecting a business combination with one or more businesses. The Merger Agreement was approved by the respective shareholders of RSI and GPIA in October 2017, and closing occurred on October 10, 2017, resulting in (i) the merger of a wholly-owned subsidiary of GPIA with and into RSI, with RSI as the surviving corporation, after which (ii) RSI merged with and into GPIA, with GPIA as the surviving corporation and renamed “Rimini Street, Inc.” (referred to herein as “RMNI”, as distinguished from RSI, which is defined as the predecessor entity with the same legal name) immediately after consummation of the second merger. Prior to the consummation of the mergers, the ultimate parent entity of GPIA was GP Investments, Ltd. (“GP Investments”), a global private equity firm and an affiliate of the Company. An affiliate of GP Investments (Mr. Antonio Bonchristiano) was a member of our Board of Directors until May 5, 2020.

In addition, an affiliate of Adams Street Partners and its affiliates (collectively referred to as “ASP”) is also a member of the Company’s Board of Directors. As of September 30, 2021, ASP owned approximately 27.2% of the Company’s issued and outstanding shares of Common Stock. In July 2018, ASP acquired 19,209 shares of Series A Preferred Stock and approximately 0.4 million shares of Common Stock issued in the Initial Private Placement for total consideration of approximately $19.2 million, which shares of Series A Preferred Stock were all redeemed by the Company in 2021 on the same terms as the redemption applicable to other holders of Series A Preferred Stock.

NOTE 11 —EARNINGS (LOSS) PER SHARE

The Company computes earnings per share in accordance with ASC Topic 260, Earnings per Share, which requires earnings per share for each class of stock to be calculated using the two-class method. The holders of Series A Preferred Stock were entitled to participate in Common Stock dividends, if and when declared, on a one-to-one per-share basis. Accordingly, in periods in which the Company has net income, earnings per share will be computed using the two-class method whereby the pro rata dividends on Common Stock that are also distributable to the holders of Series A Preferred Stock would have been deducted from earnings applicable to common stockholders, regardless of whether a dividend is declared for such undistributed earnings. Under the two-class method, earnings for the reporting period were allocated between the holders of the Company’s Common Stock and the Series A Preferred Stock based on their respective participation rights in undistributed earnings.

Basic earnings per share of Common Stock is computed by dividing net income attributable to common stockholders by the weighted average number of shares of basic Common Stock outstanding. Net income allocated to the holders of the Company’s Series A Preferred Stock is calculated based on the shareholders’ proportionate share of the weighted average shares of Common Stock outstanding on an if-converted basis. Diluted earnings per share of Common Stock is calculated by adjusting the basic earnings per share of Common Stock for the effects of potential dilutive Common Stock shares outstanding such as stock options, restricted stock units and warrants.

For the three and nine months ended September 30, 2021 and 2020, basic and diluted net earnings per share of Common Stock were computed by dividing the net income attributable to common stockholders by the weighted average number of common shares outstanding during the respective periods. The following tables set forth the computation of basic and diluted net loss attributable to common stockholders for the three and nine months ended September 30, 2021 and 2020 (in thousands, except per share amounts):

20

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Income attributable to common stockholders:
Net income	$	1,931		$	3,609		$	5,162		$	9,078
Return on repurchase of Series A Preferred Stock shares	—			—			(38)			—
Accretion related to redemption of Series A Preferred Stock	(8,020)			—			(13,693)			—
Make-whole dividends related to redemption of Series A Preferred Stock	(602)			—			(2,945)			—
Dividends and accretion related to Series A Preferred Stock:
Cash dividends declared	—			(3,968)			(5,839)			(11,817)
PIK dividends declared	—			(1,190)			(1,752)			(3,545)
Accretion of discount	—			(1,587)			(2,277)			(4,702)
	(6,691)			(3,136)			(21,382)			(10,986)
Undistributed earnings allocated using the two-class method	—			—			—			—
Net loss attributable to common stockholders	$	(6,691)		$	(3,136)		$	(21,382)		$	(10,986)
	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Weighted average number of shares of Common Stock outstanding	86,189			72,377			83,449			69,521
Additional shares outstanding if Series A Preferred Stock is converted to Common Stock	1,813			15,873			8,698			15,756
Total shares outstanding if Series A Preferred Stock is converted to Common Stock	88,002			88,250			92,147			85,277
Percentage of shares allocable to Series A Preferred Stock	2.1		%	18.0		%	9.4		%	18.5		%
Weighted average number of shares of Common Stock outstanding:
Basic and diluted	86,189			72,377			83,449			69,521
Net loss per share attributable to common stockholders:
Basic and diluted	$	(0.08)		$	(0.04)		$	(0.26)		$	(0.16)

For both the three months and nine months ended September 30, 2021 and 2020, basic and diluted loss per share attributable to common stockholders were the same because all Common Stock equivalents were anti-dilutive. If the Company had recorded net income attributable to common stockholders, the diluted shares would have been as follows (in thousands):

	Three Months Ended September 30,		Nine Months Ended September 30,
	2021	2020	2021	2020
Restricted stock units	1,673	685	1,815	598
Stock options	2,136	1,243	2,964	1,640
Warrants	1,203	—	988	—
Total	5,012	1,928	5,767	2,238

As of September 30, 2021 and December 31, 2020, the following potential Common Stock equivalents were excluded from the computation of diluted net loss per share for the respective periods ending on these dates since the impact of inclusion was anti-dilutive (in thousands): 

21

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

	2021	2020
Series A Preferred Stock	—	15,491
Restricted stock units	2,913	3,322
Stock options	6,468	7,007
Warrants	18,128	18,128
Total	27,509	43,948

NOTE 12 — FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS

Fair Value Measurements

Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which it transacts, and considers assumptions that market participants would use when pricing the asset or liability. Additional information on fair value measurements is included in Note 13 to the Company’s consolidated financial statements for the year ended December 31, 2020, included in the 2020 Form 10-K/A. The Company’s policy is to recognize asset or liability transfers among Level 1, Level 2 and Level 3 as of the actual date of the events or change in circumstances that caused the transfer.

As of September 30, 2021 and December 31, 2020, the Company has determined that its GP Sponsor Private Placement Warrants are subject to treatment as a liability. The GP Sponsor Private Placement Warrants may not be redeemed by the Company so long as these warrants are held by the initial purchasers or such purchasers’ permitted transferees. If these warrants are held by someone other than the initial purchasers or such purchasers’ permitted transferees, these warrants are redeemable by the Company and exercisable on the same basis as certain warrants to purchase approximately 8.6 million shares of the Company’s Common Stock, at $11.50 per share (the “Public Warrants”). As a result, the GP Sponsor Private Placement Warrants were reclassified as a liability. The fair value of these instruments as of September 30, 2021 and December 31, 2020 was $5.1 million and $2.1 million, respectively, utilizing the BSM method. The GP Sponsor Private Placement Warrants are classified as Level 2 financial instruments. The key assumptions used to determine the fair value was the term period of the warrants, the risk free rate and volatility. As of September 30, 2021, the term to expiration was 1.03 years, the risk free rate of 0.10% and the implied volatility of 37.9%.

As discussed in Note 6, the fair value for the Company’s Series A Preferred Stock issuances on June 20, 2019, March 7, 2019 and July 19, 2018 was determined to be $3.0 million, $5.3 million and $126.8 million, respectively, which were utilized to determine the basis for allocating the net proceeds. The fair value was determined by utilizing a combination of a discounted cash flow methodology related to funds generated by the Series A Preferred Stock, along with the BSM option-pricing model in relation to the conversion feature. Key assumptions applied for the discounted cash flow and BSM analysis included (i) three different scenarios whereby the Series A Preferred Stock would remain outstanding between 4 and 5 years along with a probability weighting assigned to each scenario, (ii) an implied yield of the Series A Preferred Stock ranging from 20.9% to 22.9% calibrated to the transaction values as of June 20, 2019, March 7, 2019 and July 19, 2018, respectively, (iii) risk-free interest rates of 1.72%, 2.44% and 2.8% and (iv) historical volatility of 30.0%.

The carrying amounts of the Company’s financial instruments including cash and cash equivalents, restricted cash, accounts receivable, accounts payable, and accrued liabilities approximate fair values due to their short-term maturities. Based on borrowing rates currently available to the Company for debt with similar terms, the carrying value of capital lease obligations approximate fair value as of the respective balance sheet dates. The liability for redeemable warrants are also considered financial instruments and valued utilizing the BSM method and assumptions noted above.

Significant Concentrations

The Company attributes revenues to geographic regions based on the location of its clients’ contracting entity. The following table shows revenues by geographic region (in thousands):

22

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
United States of America	$	50,479	$	48,160	$	147,600	$	142,982
International	45,163		34,358		127,551		95,970
Total	$	95,642	$	82,518	$	275,151	$	238,952

No clients represented more than 10% of revenue for both the three months and nine months ended September 30, 2021 or 2020. As of September 30, 2021 and 2020, no clients accounted for more than 10% of total net accounts receivable. The Company tracks its assets by physical location. As of September 30, 2021 and December 31, 2020, the net carrying value of the Company’s property and equipment located outside of the United States amounted to approximately $1.5 million and $1.3 million, respectively. As of September 30, 2021, the Company had operating lease right-of-use assets of $9.5 million, $5.0 million and $0.5 million in the United States, India and the rest of the world, respectively. As of December 31, 2020, the Company had operating lease right-of-use assets of $11.0 million, $5.8 million and $0.8 million in the United States, India and the rest of the world, respectively.

Financial instruments that subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. The Company maintains its cash, cash equivalents and restricted cash at high-quality financial institutions, primarily in the United States. Deposits, including those held in foreign branches of global banks, may exceed the amount of insurance provided on such deposits. As of September 30, 2021 and December 31, 2020, the Company had cash, cash equivalents and restricted cash with a single financial institution for an aggregate of $73.3 million and $50.2 million, respectively. As of September 30, 2021 and December 31, 2020, the Company had restricted cash of $0.4 million and $0.3 million, respectively. The Company has never experienced any losses related to these balances.

Generally, credit risk with respect to accounts receivable is diversified due to the number of entities comprising the Company’s client base and their dispersion across different geographies and industries. The Company performs ongoing credit evaluations on certain clients and generally does not require collateral on accounts receivable. The Company maintains reserves for potential bad debts and historically such losses are generally not significant.

NOTE 13 - LEASES

Effective at the start of fiscal 2020, the Company adopted the provisions and expanded disclosure requirements described in Accounting Standards Codification (ASC) Topic 842, Leases. The Company adopted the standard using the prospective method. The Company has operating leases for real estate and equipment with an option to renew the leases for up to one month to five years. Some of the leases include the option to terminate the leases upon 30-days notice with a penalty. The Company’s leases have various remaining lease terms ranging from July 2021 to January 2027. The Company’s lease agreements may include renewal or termination options for varying periods that are generally at the Company's discretion. The Company’s lease terms only include those periods related to renewal options the Company believes are reasonably certain to exercise. The Company generally does not include these renewal options as it is not reasonably certain to renew at the lease commencement date. This determination is based on consideration of certain economic, strategic and other factors that the Company evaluates at lease commencement date and reevaluates throughout the lease term. Some leases also include options to terminate the leases and the Company only includes those periods beyond the termination date if it is reasonably certain not to exercise the termination option.

The Company uses a discount rate to calculate the right of use (“ROU”) asset and lease liability. When the implicit rate is known or provided in the lease documents, the Company is required to use this rate. In cases in which the implicit rate is not known, the Company uses an estimated incremental borrowing rate.

Some leasing arrangements require variable payments that are dependent on usage or may vary for other reasons, such as payments for insurance and tax payments. The variable portion of lease payments is not included in the Company’s ROU assets or lease liabilities. Rather, variable payments, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred and are included in lease expenses recorded in selling and administrative expenses on the Consolidated Statements of Operations and Comprehensive Income.

23

RIMINI STREET, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The Company has lease agreements with both lease and non-lease components that are treated as a single lease component for all underlying asset classes. Accordingly, all expenses associated with a lease contract are accounted for as lease expenses.

The Company has elected to apply the short-term lease exception for all underlying asset classes. That is, leases with a term of 12 months or less are not recognized on the balance sheet, but rather expensed on a straight-line basis over the lease term. The Company’s leases do not include significant restrictions or covenants, and residual value guarantees are generally not included within its operating leases. As of September 30, 2021, the Company did not have any material additional operating leases that have not yet commenced.

The components of lease expense and supplemental balance sheet information were as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Operating lease expense related to ROU assets and liabilities	$	1,526	$	1,581	$	4,626	$	4,628
Other lease expense	204		231		496		846
Total lease expense	$	1,730	$	1,812	$	5,122	$	5,474

Other information related to leases was as follows (in thousands):

Supplemental Balance Sheet Information	September 30, 2021		December 31, 2020
Operating lease right-of-use assets, noncurrent	$	15,023	$	17,521
	September 30, 2021		December 31, 2020
Operating lease liabilities, current	$	4,226	$	3,940
Operating lease liabilities, noncurrent	13,574		15,993
Total operating lease liabilities	$	17,800	$	19,933

Weighted Average Remaining Lease Term	Years
Operating leases	4.18
Weighted Average Discount Rate
Operating leases	10.5	%

Maturities of operating lease liabilities as of September 30, 2021 were as follows (in thousands):

Year ending September 30:
2022	$	5,831
2023	5,046
2024	4,409
2025	3,544
2026	2,422
Thereafter	832
Total future undiscounted lease payments	22,084
Less imputed interest	(4,284)
Total	$	17,800

For the three months ended September 30, 2021 and 2020, the Company paid $1.5 million and $1.6 million, respectively, for operating lease liabilities. For both the nine months ended September 30, 2021 and 2020, the Company paid $4.6 million for operating lease liabilities.

24

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

CAUTIONARY NOTE ABOUT FORWARD-LOOKING STATEMENTS

    This Quarterly Report on Form 10-Q (this “Report”) includes forward-looking statements. All statements other than statements of historical facts contained in this Report, including statements regarding our future results of operations and financial position, business strategy and plans, and our objectives for future operations, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would” and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements include, but are not limited to, information concerning:

•the duration of and economic, operational and financial impacts on our business of the COVID-19 pandemic, as well as the actions taken by governmental authorities, clients or others in response to the COVID-19 pandemic;

•the evolution of the enterprise software management and support landscape facing our clients and prospects;

•our ability to educate the market regarding the advantages of our enterprise software management and support services and products;

•estimates of our total addressable market;

•projections of client savings;

•the occurrence of catastrophic events that may disrupt our business or that of our current and prospective clients;

•our ability to maintain an adequate rate of revenue growth;

•our expectations about future financial, operating and cash flow results;

•the sufficiency of future cash and cash equivalents to meet our liquidity requirements;

•our ability to service the indebtedness under our Credit Facility;

•our business plan and our ability to effectively manage our growth and associated investments;

•beliefs and objectives for future operations;

•our ability to expand our leadership position in independent enterprise software support and sell our new application managed services;

•our ability to attract and retain clients;

•our ability to further penetrate our existing client base;

•our ability to maintain our competitive technological advantages against new entrants in our industry;

•our ability to timely and effectively scale and adapt our existing technology;

•our ability to innovate new products and bring them to market in a timely manner, including our announced salesforce and our announced application management services offerings;

•our ability to maintain, protect, and enhance our brand and intellectual property;

•our ability to capitalize on changing market conditions including a market shift to hybrid and cloud/SaaS offerings for information technology environments and retirement of certain software releases by software vendors;

•our ability to develop strategic partnerships;

•benefits associated with the use of our services;

•our ability to expand internationally;

•our ability to raise equity or debt financing and other transactions to simplify our capital structure in the future;

•the effects of increased competition in our market and our ability to compete effectively;

•our intentions with respect to our pricing model;

•cost of revenues, including changes in costs associated with production, manufacturing, and client support;

•operating expenses, including changes in sales and marketing, and general administrative expenses;

•anticipated income tax rates;

•our ability to maintain our good standing with the United States and international governments and capture new contracts;

•costs associated with defending intellectual property infringement and other claims, such as those claims discussed under the section titled “Business—Legal Proceedings” in our 2020 Annual Report on Form 10-K, as filed with the SEC on March 3, 2021 and as subsequently amended on May 10, 2021 (as amended the “2020 Form 10-K/A”);

•our expectations concerning relationships with third parties, including channel partners and logistics providers;

•economic and industry trends or trend analysis;

•the attraction and retention of qualified employees and key personnel;

•future acquisitions of or investments in complementary companies, products, subscriptions or technologies;

•uncertainty from the discontinuance of LIBOR and transition to other interest rate benchmarks;

•the impact of the reclassification of certain of our warrants as liabilities;

25

•the effects of seasonal trends on our results of operations, including the contract renewal cycles for vendor-supplied software services; and

•other risks and uncertainties, including those discussed under “Risk Factors” in Part II, Item 1A of this Report.

    We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those referred to Part II, Item 1A of this Report. Moreover, we operate in very competitive and rapidly changing markets. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this Report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

    You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. The forward-looking statements in this Report are made as of the date of the filing, and except as required by law, we disclaim and do not undertake any obligation to update or revise publicly any forward-looking statements in this Report. You should read this Report and the documents that we reference in this Report and have filed with the SEC as exhibits with the understanding that our actual future results, levels of activity and performance, as well as other events and circumstances, may be materially different from what we expect.

Overview

    The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the related notes to those statements included in Part I, Item 1 of this Report, and our audited consolidated financial statements for the year ended December 31, 2020, included in our 2020 Form 10-K/A.

    Certain figures, such as interest rates and other percentages included in this section have been rounded for ease of presentation. Percentage figures included in this section have not in all cases been calculated based on such rounded figures but on the basis of such amounts prior to rounding. For this reason, percentage amounts in this section may vary slightly from those obtained by performing the same calculations using the figures in our unaudited condensed consolidated financial statements or in the associated text. Certain other amounts that appear in this section may similarly not sum due to rounding.

We were incorporated as Rimini Street, Inc. (“RSI”) in the state of Nevada in September 2005. In May 2017, RSI entered into an Agreement and Plan of Merger (the “Merger Agreement”) with GP Investments Acquisition Corp. (“GPIA”), a publicly-held special purpose acquisition company incorporated in the Cayman Islands and formed for the purpose of effecting a business combination with one or more businesses. Substantially all of GPIA’s assets consisted of cash and cash equivalents. The Merger Agreement was approved by the respective shareholders of RSI and GPIA in October 2017, and closing occurred on October 10, 2017, resulting in (i) the merger of a wholly-owned subsidiary of GPIA with and into RSI, with RSI as the surviving corporation, after which (ii) RSI merged with and into GPIA, with GPIA as the surviving corporation. Prior to consummation of the mergers, GPIA domesticated as a Delaware corporation (the “Delaware Domestication”). Immediately after the Delaware Domestication and the consummation of the second merger, GPIA was renamed “Rimini Street, Inc.” (referred to herein as the Company, as distinguished from RSI with the same legal name).

    We are a global provider of enterprise software management and support products and services, and the leading independent software support provider for Oracle and SAP products, based on both the number of active clients supported and recognition by industry analyst firms.

In November 2019, we announced the global availability of our Application Management Services (“AMS”) for Oracle, which includes coverage for Oracle Database, Middleware and a wide range of Oracle applications including E-Business Suite, JD Edwards, PeopleSoft and Siebel. In addition to leveraging our support services for Oracle that replaces expensive and less robust software vendor annual support with a more responsive and comprehensive support offering, our clients can now have us manage their Oracle systems day-to-day with an integrated application management and support service provided by a single trusted vendor. As an integrated service, we believe we can provide clients a better model, better

26

service providers, and better outcomes with higher satisfaction and significant savings of time, labor and money. The AMS for Oracle includes system administration, operational support, health monitoring and enhancement support.

In August 2019, we announced plans to globally offer AMS for SAP enterprise software, expanding the scope of support services we will offer clients globally. This AMS service is in addition to our traditional enterprise Support Services. We are already providing this new SAP AMS service to clients in North and South America. The service includes system administration and SAP Basis support, system health monitoring with proactive analysis, preventative system recommendations and event detection; and enhancement support for complex SAP software landscapes.

    In 2018, we announced plans to support Software as a Service (”SaaS”) solutions beginning with Salesforce products. As a partner of Salesforce, we provide our award-winning service and support for custom code, release updates and application integrations in addition to ongoing administrative, configuration and enhancement of Salesforce’s industry leading cloud solutions.

    We founded our company to disrupt and redefine the enterprise software support market by developing and delivering innovative new products and services that fill a then unmet need in the market. We believe we have achieved our leadership position in independent enterprise software support by recruiting and hiring experienced, skilled and proven staff; delivering outcomes-based, value-driven and award-winning enterprise software support products and services; seeking to provide an exceptional client-service, satisfaction and success experience; and continuously innovating our unique products and services by leveraging our proprietary knowledge, tools, technology and processes.

    Enterprise software support products and services is one of the largest categories of overall global information technology (“IT”) spending. We believe core enterprise resource planning (ERP), client relationship management (CRM), product lifecycle management (PLM) and technology software platforms have become increasingly important in the operation of mission-critical business processes over the last 30 years, and also that the costs associated with failure, downtime, security exposure and maintaining the tax, legal and regulatory compliance of these core software systems have also increased. As a result, we believe that licensees often view software support as a mandatory cost of doing business, resulting in recurring and highly profitable revenue streams for enterprise software vendors. For example, for fiscal year 2020, SAP reported that support revenue represented approximately 42% of its total revenue. For fiscal year 2021, Oracle reported a margin of 85% for cloud services and license support.

    We believe that software vendor support is an increasingly costly model that has not evolved to offer licensees the responsiveness, quality, breadth of capabilities or value needed to meet the needs of licensees. Organizations are under increasing pressure to reduce their IT costs while also delivering improved business performance through the adoption and integration of emerging technologies, such as mobile, virtualization, internet of things (IoT) and cloud computing. Today, however, the majority of IT budgets are spent operating, maintaining and supporting existing infrastructure and systems. As a result, we believe organizations are increasingly seeking ways to redirect budgets from maintenance to new technology investments that provide greater strategic value, and our software management and support products and services help clients achieve these objectives by reducing the total cost of support.

    As of September 30, 2021, we employed over 1,590 professionals and supported over 2,790 active clients globally, including 72 Fortune 500 companies and 17 Fortune Global 100 companies across a broad range of industries. We define an active client as a distinct entity, such as a company, an educational or government institution, or a business unit of a company that purchases our services to support a specific product. For example, we count as two separate active client instances in circumstances where we provide support for two different products to the same entity.

    Our subscription-based revenue provides a strong foundation for, and visibility into, future period results. For the three months ended September 30, 2021 and 2020, we generated revenue of $95.6 million and $82.5 million, respectively, representing an increase of 16%. During the three months ended September 30, 2021, we had net income of $1.9 million, and as of September 30, 2021, we had an accumulated deficit of $295.8 million. Approximately 53% and 58% of our revenue was generated in the United States for the three months ended September 30, 2021 and 2020, respectively. Approximately 47% and 42% of our revenue was generated in foreign jurisdictions for the three months ended September 30, 2021 and 2020, respectively.

    Since our inception, we have financed our operations through cash collected from clients and net proceeds from equity financings and borrowings.

27

Impact of COVID-19

Near the end of the first quarter of 2020, the emergence of the COVID-19 pandemic took hold and had widespread, rapidly evolving and unpredictable impacts on global society, economies, financial markets and business practices. These rapidly evolving and unpredictable impacts continue as virus variants have resulted in additional outbreaks during fiscal year 2021 to date. In response to the COVID-19 pandemic, federal and state governments have implemented multiple measures aiming to contain the spread of the virus, including social distancing, travel restrictions, border closures, quarantine guidance following travel to certain jurisdictions, limitations on public gatherings and continued closures of certain non-essential businesses, vaccination mandates or requirements for businesses to confirm employees’ vaccination status, and other restrictions. As a result, to protect the health and well-being of our employees, clients and the communities in which we operate, we transitioned as many of our employees as possible to a work-at-home model, temporarily closed our offices worldwide, placed restrictions on non-essential business travel, transitioned to a no in-person event marketing strategy and implemented a fully remote sales model. We believe these measures have been successful and have not significantly affected our financial results for the nine months ended September 30, 2021. We have implemented business continuity measures and will continue to respond to the COVID-19 pandemic as circumstances dictate.

As a result of the measures that we have taken in response to the COVID-19 pandemic described above, we have realized reduced costs of travel, reductions in costs resulting from cancelling certain in-person marketing events, reductions in office operating costs and potential rent abatement related to office closures around the world. While some of our offices have partially re-opened with limited staffing, our offices will not fully re-open until local authorities permit us to, and our own criteria and conditions to ensure employee health and safety are satisfied. We continue to expect to offset some of these reduced costs with accelerated investments including implementing virtual sales and other marketing programs, special compensation bonuses for lower-paid employees and special compensation bonuses for employees who have tested positive for COVID-19. For example, during the COVID-19 pandemic, we paid COVID-19 special bonuses to certain of our employees to help with pandemic-related special costs and for the few of our employees who have tested positive for COVID-19. We have authorized COVID-19 special bonuses during pandemic that have been paid throughout 2020 and the nine months ended September 30, 2021. The cost of these special bonuses were more than offset by the cost reductions relating to travel and in-person marketing event fees and expenses described above.

The COVID-19 pandemic had no significant net impact on our revenue or results of operations during the three months ended September 30, 2021, and we continued to deliver uninterrupted and critical support services to our clients during this period. Our ability to utilize our secure remote-connectivity global infrastructure promotes the safety of our employees while abiding by the restrictions currently in place where they are located throughout the world. While we did implement discounted or extended payment terms for certain of our clients in 2020, in most cases it was in exchange for contractual concessions favorable to us, for example, extended contract terms or marketing support for references, and the collective impact of such changes was not material to our results. However, the COVID-19 pandemic has impacted business markets worldwide, primarily due to the uncertainty relating to the continued effects of the pandemic. As a result, we have experienced some clients not renewing our services as their businesses have been adversely impacted during the pandemic. Despite this, we expect to continue to be able to market, sell and provide our current and future products and services to clients globally. We also expect to continue investing in the development and improvement of new and existing products and services to address client needs.

The extent to which the COVID-19 pandemic impacts our business going forward will depend on numerous evolving factors we cannot reliably predict, including the duration and scope of the pandemic; governmental and business actions in response to the pandemic; and the impact on economic activity, including the possibility of recession or financial market instability. These factors may adversely impact consumer, business, and government spending on technology as well as our clients’ ability to pay for our services on an ongoing basis. This uncertainty also affects management’s accounting estimates and assumptions, which could result in greater variability in a variety of areas that depend on these estimates and assumptions, including receivables and forward-looking guidance. As such, the effects of the COVID-19 pandemic may not be fully reflected in our financial results until future periods. Refer to “Risk Factors” (Part II, Item 1A of this Report) for a discussion of these factors and other risks.

On March 27, 2020, CARES Act was signed into law in the United States to address the economic impact of the COVID-19 pandemic. We have elected to defer payroll tax payments which totaled $3.2 million as of September 30, 2021 as permitted by the CARES Act (such deferred payroll taxes are due in two installments: 50% by December 31, 2021 and 50% by December 31, 2022). We continue to monitor any effects that may result from the CARES Act and other similar legislation or actions in geographies in which our business operates.

28

Recent Developments

On July 20, 2021, we redeemed the remaining 87,802 shares of its 13.00% Series A Preferred Stock at an aggregate total redemption price of $88.4 million. The total redemption price consisted of $87.8 million related to the outstanding shares of Series A Preferred Stock with a face value of $1,000 per share and $0.6 million or $6.86 per share of Series A Preferred Stock related to the dividends earned for the period from July 1, 2021 through July 19, 2021. The redeemed shares of the Series A Preferred Stock, along with the dividends, were recorded on the redemption date of July 20, 2021.

We funded the July 20, 2021 redemption with borrowings from a five year secured term loan of $90 million, which was entered into on July 20, 2021 (the “Credit Facility”). Annual minimum principal payments over the five year term for the Credit Facility will be 5%, 5%, 7.5%, 7.5% and 10%, respectively, with the remaining balance due at the end of the term. See Note 5 to our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report for further information regarding our Credit Facility.

On April 16, 2021, we redeemed 60,000 shares of our 13.00% Series A Preferred Stock at an aggregate total redemption price of $62.3 million. The total price consists of $60.0 million related to the face value of $1,000 per share of Series A Preferred Stock and $2.3 million or $39.05 per share of Series A Preferred Stock related to the dividends to be earned for the period from April 1, 2021 through July 18, 2021. The redeemed shares of Series A Preferred Stock, along with the dividends to be earned, were recorded when the Series A Preferred Stock became mandatorily redeemable on April 16, 2021.

Additionally, reference is made to Note 6 to our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report for a discussion of developments related to our Series A Preferred Stock, Common Stock and Convertible Notes.

On March 11, 2021, we completed the March 2021 Offering of 7.8 million shares of our Common Stock at a price of $7.75 per share for total gross proceeds of $57.0 million. Underwriter discounts and commissions were $2.9 million and the underwriter expenses were $0.2 million. We also incurred additional professional fees and expenses of $1.3 million as part of the transaction, resulting in net proceeds from the March 2021 Offering of approximately $55.6 million. We used the net proceeds from the March 2021 Offering to redeem 60,000 shares of Series A Preferred Stock. Reference is made to Note 6 to our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report for information about the March 2021 Offering.

    Also, reference is made to Note 9 to our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report for a discussion of developments in our litigation with Oracle.

Key Business Metrics

Number of clients

    Since we founded our company, we have made the expansion of our client base a priority. We believe that our ability to expand our client base is an indicator of the growth of our business, the success of our sales and marketing activities, and the value that our services bring to our clients. We define an active client as a distinct entity, such as a company, an educational or government institution, or a business unit of a company that purchases our services to support a specific product. For example, we count as two separate active clients when support for two different products is being provided to the same entity. As of September 30, 2021 and 2020, we had over 2,790 and 2,360 active clients, respectively.

    We define a unique client as a distinct entity, such as a company, an educational or government institution or a subsidiary, division or business unit of a company that purchases one or more of our products or services. We count as two separate unique clients when two separate subsidiaries, divisions or business units of an entity purchase our products or services. As of September 30, 2021 and 2020, we had over 1,450 and 1,280 unique clients, respectively.

    The increases in both our active and unique client counts have been almost exclusively from new unique clients and not from sales of new products and services to existing unique clients. However, as noted previously, we intend to focus future growth on both new and existing clients. We believe that the growth in our number of clients is an indication of the increased adoption of our enterprise software products and services.

Annualized recurring revenue

29

    We recognize subscription revenue on a daily basis. We define annualized recurring revenue as the amount of subscription revenue recognized during a quarter and multiplied by four. This gives us an indication of the revenue that can be earned in the following 12-month period from our existing client base assuming no cancellations or price changes occur during that period. Subscription revenue excludes any non-recurring revenue, which has been insignificant to date. 

    Our annualized recurring revenue was $377 million and $327 million as of September 30, 2021 and 2020, respectively. We believe the sequential increase in annualized recurring revenue demonstrates a growing client base, which is an indicator of stability in future subscription revenue.

Revenue retention rate

    A key part of our business model is the recurring nature of our revenue. As a result, it is important that we retain clients after the completion of the non-cancellable portion of the support period. We believe that our revenue retention rate provides insight into the quality of our products and services and the value that our products and services provide our clients.

    We define revenue retention rate as the actual subscription revenue (dollar-based) recognized in a 12-month period from clients that existed on the day prior to the start of the 12-month period divided by our annualized recurring revenue as of the day prior to the start of the 12-month period. Our revenue retention rate was 93% and 92% for the 12 months ended September 30, 2021 and 2020, respectively.

Gross profit margin

    We derive revenue through the provision of our enterprise software products and services. All the costs incurred in providing these products and services are recognized as part of the cost of revenue. The cost of revenue includes all direct product line expenses, as well as the expenses incurred by our shared services organization which supports all product lines.

    We define gross profit as the difference between revenue and the costs incurred in providing the software products and services. Gross profit margin is the ratio of gross profit divided by revenue. Our gross profit margin was approximately 65.1% and 61.2% for the three months ended September 30, 2021 and 2020, respectively. We believe the gross profit margin provides an indication of how efficiently and effectively we are operating our business and serving our clients.

30

Results of Operations

Comparison of Three Months Ended September 30, 2021 and 2020

    Our consolidated statements of operations for the three months ended September 30, 2021 and 2020, are presented below (in thousands): 

	Three Months Ended September 30,						Variance
	2021			2020			Amount		Percent
Revenue	$	95,642		$	82,518		$	13,124	15.9%
Cost of revenue:
Employee compensation and benefits	23,174			20,996			2,178		10.4%
Engineering consulting costs	4,648			5,656			(1,008)		(17.8)%
Administrative allocations (1)	3,574			3,544			30		0.8%
All other costs	1,980			1,795			185		10.3%
Total cost of revenue	33,376			31,991			1,385		4.3%
Gross profit	62,266			50,527			11,739		23.2%
Gross margin	65.1		%	61.2		%
Operating expenses:
Sales and marketing	32,527			29,195			3,332		11.4%
General and administrative	15,631			13,025			2,606		20.0%
Litigation costs and related recoveries, net	6,581			3,773			2,808		74.4%
Total operating expenses	54,739			45,993			8,746		19.0%
Operating income	7,527			4,534			2,993		66.0%
Non-operating income and (expenses):
Interest expense	(653)			(10)			(643)		6,430.0%
Gain (loss) on change in fair value of redeemable warrants	(2,053)			303			(2,356)		(777.6)%
Other income (expenses), net	(1,161)			54			(1,215)		(2,250.0)%
Income before income taxes	3,660			4,881			(1,221)		(25.0)%
Income tax expense	(1,729)			(1,272)			(457)		35.9%
Net income	$	1,931		$	3,609		$	(1,678)	(46.5)%

(1)Includes the portion of costs for IT, security services and facilities costs that are allocated to cost of revenue. In our unaudited condensed consolidated financial statements, the total of such costs is allocated between cost of revenue, sales and marketing, and general and administrative expenses, based primarily on relative headcount, except for facilities which is based on occupancy.

    Revenue. Revenue increased from $82.5 million for the three months ended September 30, 2020 to $95.6 million for the three months ended September 30, 2021, an increase of $13.1 million or 16%. The increase was driven by a 14% increase in the average number of unique clients from 1,246 for the three months ended September 30, 2020 to 1,420 for the three months ended September 30, 2021. On a geographic basis, United States revenue grew from $48.2 million for the three months ended September 30, 2020 to $50.5 million for the three months ended September 30, 2021, an increase of $2.3 million or 5%. Our international revenue grew from $34.4 million for the three months ended September 30, 2020 to $45.2 million for the three months ended September 30, 2021, an increase of $10.8 million or 31%. Our international revenue growth was led primarily by strong results from our Asia-Pacific region.

    Cost of revenue. Cost of revenue increased from $32.0 million for the three months ended September 30, 2020 to $33.4 million for the three months ended September 30, 2021, an increase of $1.4 million or 4%. The key drivers related to the cost of revenue increase were a $2.2 million increase in compensation costs and a $0.2 million increase in administrative allocations and all other costs, which was offset by a decrease of $1.0 million in engineering consulting costs. The compensation cost increase was attributable to an increase of 15% in the average number of employees required to support the revenue growth.

31

As discussed in Note 9 to our consolidated financial statements included in Part 1, Item 1 of this Report, following post-trial motions, the District Court entered a permanent injunction prohibiting us from using certain processes, including processes adjudicated as infringing at trial, that we ceased using no later than July 2014, which we subsequently appealed to the Court of Appeals. In August 2019, the Court of Appeals affirmed the permanent injunction issued by the District Court, while also correcting certain legal errors that narrowed the scope of the injunction. A copy of the injunction is publicly available in the case docket. As a result of the injunction, we expect to incur additional expenses in the range of 1% to 2% of revenue for additional labor costs because, as drafted, the injunction contains language that could be read to cover some current support practices (Process 2.0) that are being litigated in the “Rimini II” lawsuit and that have not been found to be infringing. On July 10, 2020, Oracle filed a motion to show cause contending that we are in contempt of the injunction. On March 31, 2021, the District Court issued an order resolving many outstanding disputes between the parties relating to the injunction and found that we violated the injunction in four certain narrow instances. The District Court refused to consider Oracle’s claims about certain processes that were not litigated in Rimini I, and that are being litigated in the separately filed “Rimini II" litigation. In April 2021, the Company filed a motion for reconsideration for two of the four injunction violations identified by the District Court (since they occurred before the injunction became effective). The District Court granted the Company’s motion for reconsideration on June 10, 2021, striking from its March 31, 2021 order its holding regarding those two violations. During an evidentiary hearing in September 2021, the District Court heard evidence and argument regarding (i) whether we violated the injunction for certain accused conduct for which the District Court requested additional information; and (ii) whether we should be held in contempt in the two instances where the District Court found a violation of the injunction, and what sanctions, if any, are appropriate.

    Gross profit. Gross profit increased from $50.5 million for the three months ended September 30, 2020 compared to $62.3 million for the three months ended September 30, 2021, an increase of $11.7 million or 23%. Gross profit margin for the three months ended September 30, 2020 was 61.2% compared to 65.1% for three months ended September 30, 2021. For the three months ended September 30, 2021, total cost of revenue increased by 4% compared to an increase in revenue of 16% for the three months ended September 30, 2021. As a result, our gross profit margin improved by 4% period over period.

    Sales and marketing expenses. As a percentage of our revenue, sales and marketing expenses decreased from 35% for the three months ended September 30, 2020 to 34% for the three months ended September 30, 2021. In dollar terms, sales and marketing expenses increased from $29.2 million for the three months ended September 30, 2020 to $32.5 million for the three months ended September 30, 2021, an increase of $3.3 million or 11%. This increase was primarily due to (i) an increase in employee compensation and benefits of $3.6 million, (ii) an increase in recruitment costs of $0.4 million, and (iii) an increase in administrative allocations and other costs of $0.5 million. These increases were offset, in part, by a decrease in marketing promotional expenses and trade show expenses of $1.2 million. We will continue to accelerate our future revenue growth by investing in more resources.

    The $3.6 million increase in sales and marketing expense attributable to employee compensation and benefits for the three months ended September 30, 2021, was primarily due to an increase in salaries, wages and benefit costs of $3.4 million due to a 21% increase in the average number of employees devoted to sales and marketing functions, pay increases, and higher bonus payouts and commissions of $0.2 million.

    General and administrative expenses. General and administrative expenses increased from $13.0 million for the three months ended September 30, 2020 to $15.6 million for the three months ended September 30, 2021, an increase of $2.6 million or 20%. This increase was comprised of several items, which included (i) increased costs in salaries, wages and benefits of $2.1 million as the average number of employees increased by 12%, (ii) an increase in sales taxes and other taxes of $0.4 million, (iii) an increase of our computer software and license costs of $0.4 million, and (iv) an increase in travel and entertainment expenses of $0.3 million for the three months ended September 30, 2021. These unfavorable variances were offset, in part, by favorable variances including (i) an increase in administrative allocations of $0.4 million and (ii) a decrease in all other costs of $0.2 million, which included a reduction in bad debt expense.

Looking forward on a quarter-over-quarter basis, we are monitoring the demand for our services in light of the COVID-19 pandemic related environment and will adjust our spend accordingly. However, we expect to incur higher expenses associated with supporting the growth of our business, both in terms of size and geographical diversity, and to meet the increased compliance requirements associated with no longer being classified as an “emerging growth company” or “smaller reporting company” for purposes of SEC reporting. Public company costs that are expected to increase in the future include costs relating to continuing compliance with the auditor attestation requirements under Section 404 of the Sarbanes-Oxley Act, additional information systems costs, costs for additional personnel in our accounting, human resources, IT and legal functions, SEC and Nasdaq fees, and incremental professional, legal, audit and insurance costs. As a result, not taking into account temporary reductions in certain expenses resulting from the COVID-19 pandemic, we expect our general and administrative expenses related to public company costs will continue to increase in future periods.

32

    Litigation costs, net of related insurance recoveries. Litigation costs, net of related insurance recoveries for the three months ended September 30, 2021 and 2020, consist of the following (in thousands):

 

	2021		2020		Change
Professional fees and other costs of litigation	$	6,581	$	3,773	$	2,808
Insurance costs and recoveries, net	—		—		—
Litigation costs and related recoveries, net	$	6,581	$	3,773	$	2,808

    Professional fees and other costs associated with litigation increased from $3.8 million for the three months ended September 30, 2020 to $6.6 million for the three months ended September 30, 2021, an increase of $2.8 million. This increase was primarily due to timing of the costs associated with the September 2021 hearing related to determining if we had been in contempt of the permanent injunction.

    Interest expense. Interest expense increased from $10 thousand for the three months ended September 30, 2020 to $0.7 million for the three months ended September 30, 2021, an increase of $0.6 million. Interest expense increased primarily due to entering into a five-year Credit Facility for $90 million on July 20, 2021.

Gain (loss) on change in fair value of redeemable warrants. Gain (loss) on change in fair value of redeemable warrants amounted to a loss of $2.1 million for the three months ended September 30, 2021 as the fair value per warrant changed from $0.51 per warrant as of June 30, 2021 to $0.85 per warrant as of September 30, 2021. Gain (loss) on change in fair value of redeemable warrants amounted to a gain of $0.3 million for the three months ended September 30, 2020 as the fair value per warrant changed from $0.21 per warrant as of June 30, 2020 to $0.16 per warrant as of September 30, 2020.

    Other income (expenses), net. Other income (expenses), net is primarily comprised of interest income, foreign exchange gains and losses, and other non-operating income and expenses. For the three months ended September 30, 2021, net other expense of approximately $1.2 million was comprised primarily of foreign exchange losses of approximately $1.1 million. For the three months ended September 30, 2020, net other income of $0.1 million was also comprised primarily of foreign exchange gains of approximately $0.1 million.

    Income tax expense. We had income tax expense of $1.3 million for the three months ended September 30, 2020 compared to $1.7 million for the three months ended September 30, 2021. For both periods, our income taxes were primarily attributable to income taxes on our foreign operations and foreign withholding taxes.

Comparison of Nine Months Ended September 30, 2021 and 2020

33

Our consolidated statements of operations for the nine months ended September 30, 2021 and 2020, are presented below (in thousands): 

	Nine Months Ended September 30,						Variance
	2021			2020			Amount		Percent
Revenue	$	275,151		$	238,952		$	36,199	15.1%
Cost of revenue:
Employee compensation and benefits	71,522			61,842			9,680		15.7%
Engineering consulting costs	13,663			15,526			(1,863)		(12.0)%
Administrative allocations (1)	10,883			10,637			246		2.3%
All other costs	5,739			4,622			1,117		24.2%
Total cost of revenue	101,807			92,627			9,180		9.9%
Gross profit	173,344			146,325			27,019		18.5%
Gross margin	63.0		%	61.2		%
Operating expenses:
Sales and marketing	96,067			84,443			11,624		13.8%
General and administrative	48,728			38,159			10,569		27.7%
Impairment charge related to operating right of use assets	393			—			393		100.0%
Litigation costs and related recoveries, net	14,130			10,309			3,821		37.1%
Total operating expenses	159,318			132,911			26,407		19.9%
Operating income	14,026			13,414			612		4.6%
Non-operating income and (expenses):
Interest expense	(738)			(35)			(703)		2,008.6%
Loss on change in fair value of redeemable warrants	(3,023)			(243)			(2,780)		1,144.0%
Other income (expenses), net	(885)			(731)			(154)		21.1%
Income before income taxes	9,380			12,405			(3,025)		(24.4)%
Income tax expense	(4,218)			(3,327)			(891)		26.8%
Net income	$	5,162		$	9,078		$	(3,916)	(43.1)%

(1)Includes the portion of costs for IT, security services and facilities costs that are allocated to cost of revenue. In our unaudited condensed consolidated financial statements, the total of such costs is allocated between cost of revenue, sales and marketing, and general and administrative expenses, based primarily on relative headcount, except for facilities which is based on occupancy.

Revenue. Revenue increased from $239.0 million for the nine months ended September 30, 2020 to $275.2 million for the nine months ended September 30, 2021, an increase of $36.2 million or 15%. The increase was driven by a 14% increase in the average number of unique clients from 1,204 for the nine months ended September 30, 2020 to 1,377 for the nine months ended September 30, 2021. On a geographic basis, United States revenue grew slightly from $143.0 million for the nine months ended September 30, 2020 to $147.6 million for the nine months ended September 30, 2021, an increase of $4.6 million or 3%. Our international revenue grew from $96.0 million for the nine months ended September 30, 2020 to $127.6 million for the nine months ended September 30, 2021, an increase of $31.6 million or 33%. Our international revenue growth was led primarily by strong results from our Asia-Pacific region.

    Cost of revenue. Cost of revenue increased from $92.6 million for the nine months ended September 30, 2020 to $101.8 million for the nine months ended September 30, 2021, an increase of $9.2 million or 10%. The key drivers related to the cost of revenue increase were a $9.7 million increase in compensation costs and a $1.1 million increase in all other costs, which were offset by a decrease of $1.9 million in engineering consulting costs. The compensation cost increase was attributable to an increase of 16% in the average number of employees required to support the revenue growth.

Gross profit. Gross profit increased from $146.3 million for the nine months ended September 30, 2020 compared to $173.3 million for the nine months ended September 30, 2021, an increase of $27.0 million or 18%. Gross profit margin for the nine months ended September 30, 2020 was 61.2% compared to 63.0% for the nine months ended September 30, 2021. For the

34

nine months ended September 30, 2021, total cost of revenue increased by 10%, compared to an increase in revenue of 15% for the nine months ended September 30, 2021. As a result, our gross profit margin improved by 2% period over period.

    Sales and marketing expenses. As a percentage of our revenue, sales and marketing expenses were flat at 35% .for both the nine months ended September 30, 2020 and 2021. In dollar terms, sales and marketing expenses increased from $84.4 million for the nine months ended September 30, 2020 to $96.1 million for the nine months ended September 30, 2021, an increase of $11.6 million or 14%. This increase was primarily due to (i) an increase in employee compensation and benefits of $12.2 million, (ii) an increase in recruitment costs of $1.2 million (iii) an increase in marketing promotional expenses and trade show expenses of $0.3 million, (iv) an increase of administrative allocations of $0.2 million and (iv) an increase in all other costs of $0.2 million. These increases were offset, in part, by a decrease in travel expenses of $2.5 million. We will continue to accelerate our future revenue growth by investing in more sales and marketing resources.

    The $12.2 million increase in sales and marketing expense attributable to employee compensation and benefits for the nine months ended September 30, 2021 was primarily due to an increase in salaries, wages and benefit costs of $9.7 million due to a 16% increase in the average number of employees devoted to sales and marketing functions, pay increases, and higher bonus payouts and commissions of $2.4 million.

    General and administrative expenses. General and administrative expenses increased from $38.2 million for the nine months ended September 30, 2020 to $48.7 million for the nine months ended September 30, 2021, an increase of $10.6 million or 28%. This increase was comprised of several items, which included (i) increased costs in salaries, wages and benefits of $8.8 million as the average number of employees increased by 11%, (ii) an increase in sales taxes and other taxes of $1.2 million, (iii) an increase of our computer software and license costs of $0.8 million (iv) an increase in all other costs of $0.7 million, (v) an increase in professional services of $0.4 million and (vi) an increase of travel expense of $0.2 million for the nine months ended September 30, 2021. These unfavorable variances were offset, in part, by favorable variances including (i) a decrease in contract labor of $1.0 million, (ii) an increase of administrative allocations of $0.5 million, (iii) a decrease of rent and facility costs of $0.4 million, and (iv) a decrease in recruitment costs of $0.1 million.

Impairment charge related to operating right of use assets. We recognized an impairment charge of $0.4 million for the nine months ended September 30, 2021 related to one of our offices as we ceased use of a portion of the office space during the period due to the increased use of remote work which has occurred during the COVID-19 pandemic.

    Litigation costs, net of related insurance recoveries. Litigation costs, net of related insurance recoveries for the nine months ended September 30, 2021 and 2020, consist of the following (in thousands):

 

	2021		2020		Change
Professional fees and other costs of litigation	$	14,130	$	9,247	$	4,883
Insurance costs and recoveries, net	—		1,062		(1,062)
Litigation costs and related recoveries, net	$	14,130	$	10,309	$	3,821

    Professional fees and other costs associated with litigation increased from $9.2 million for the nine months ended September 30, 2020 to $14.1 million for the nine months ended September 30, 2021, an increase of $4.9 million. This increase was primarily due to the timing of costs associated with discovery work on the Rimini II litigation and the Rimini I appeal during the nine months ended September 30, 2021.

    Insurance costs and related recoveries, net changed from an expense of $1.1 million for the nine months ended September 30, 2020 to no costs for the nine months ended September 30, 2021. We recognized costs of $1.1 million in the prior year period to revise our estimated liability owed to an insurance company related to a pro rata sharing agreement for any recoveries associated with the Court of Appeals and U.S. Supreme Court awards. The liability was paid in September 2020. We are self-insured for any costs related to any current or future intellectual property litigation. We currently believe our cash on hand, accounts receivable and contractually committed backlog provides us with sufficient liquidity to cover costs related to our litigation with Oracle.

    Interest expense. Interest expense increased from $35 thousand for the nine months ended September 30, 2020 to $0.7 million for the nine months ended September 30, 2021, an increase of $0.7 million. Interest expense increased primarily due to entering into a five-year Credit Facility for $90 million on July 20, 2021.

Loss on change in fair value of redeemable warrants. Loss on change in fair value of redeemable warrants amounted to a loss of $0.2 million for the nine months ended September 30, 2020 compared to a loss of $3.0 million for the nine months

35

ended September 30, 2021. The fair value per warrant changed from $0.35 per warrant as of December 31, 2020 to $0.85 per warrant as of September 30, 2021. The fair value per warrant changed from $0.12 per warrant as of December 31, 2019 to $0.16 per warrant as of September 30, 2020.

    Other expenses, net. Other expenses, net is primarily comprised of interest income, foreign exchange gains and losses, and other non-operating income and expenses. For the nine months ended September 30, 2021, net other income of approximately $0.9 million was comprised primarily of foreign exchange losses of approximately $0.7 million. For the nine months ended September 30, 2020, net other expense of $0.7 million was also comprised primarily of foreign exchange losses of approximately $0.6 million.

    Income tax expense. We had an income tax expense of $3.3 million for the nine months ended September 30, 2020 compared to $4.2 million for the nine months ended September 30, 2021. For both periods, our income taxes were primarily attributable to income tax on our foreign operations and foreign withholding taxes.

Liquidity and Capital Resources

Overview

    As of September 30, 2021, we had a working capital deficit of $64.2 million and an accumulated deficit of $295.8 million. For the three months ended September 30, 2021, we had net income of $1.9 million. As of September 30, 2021, we had available cash, cash equivalents and restricted cash of $103.4 million.

On July 20, 2021, we redeemed the remaining 87,802 shares of its 13.00% Series A Preferred Stock at an aggregate total redemption price of $88.4 million. The total redemption price consisted of $87.8 million related to the outstanding shares of Series A Preferred Stock with a face value of $1,000 per share and $0.6 million or $6.86 per share of Series A Preferred Stock related to the dividends earned for the period from July 1, 2021 through July 19, 2021. The redeemed shares of the Series A Preferred Stock, along with the dividends, were recorded on the redemption date of July 20, 2021.

We funded the July 20, 2021 redemption with borrowings from our Credit Facility. The Credit Facility will bear interest at LIBOR plus a margin ranging from 1.75% to 2.50% and contains certain financial covenants, including a minimum fixed charge coverage ratio, a total leverage ratio, and a minimum liquidity of $20 million in U.S. cash. Annual minimum principal payments over the five year term for the Credit Facility will be 5%, 5%, 7.5%, 7.5%, and 10%, respectively, with the remaining balance due at the end of the term.

On March 11, 2021, we completed the March 2021 Offering of 7.8 million shares of our Common Stock at a price of $7.75 per share for total gross proceeds of $56.9 million. Net proceeds from the March 2021 Offering were $55.6 million after underwriter and offering expenses. We used the net proceeds from the March 2021 Offering to redeem 60,000 shares of Series A Preferred Stock.

Please refer to Notes 5 through 7 to the unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report for information regarding our Credit Facility, our Series A Preferred Stock and our Common Stock Offerings.

    A key component of our business model requires that substantially all clients prepay us annually for the services we will provide over the following year or longer. As a result, we typically collect cash from our clients in advance of when the related service costs are incurred, which resulted in deferred revenue of $203.8 million that is included in current liabilities as of September 30, 2021. Therefore, we believe that working capital deficit is not as meaningful in evaluating our liquidity since the historical costs of fulfilling our commitments to provide services to clients are currently limited to approximately 35% of the related deferred revenue based on our gross profit percentage of 65% for the three months ended September 30, 2021.

    For the next year, assuming that the Company’s operations are not significantly impacted by the COVID-19 pandemic, we believe that cash, cash equivalents and restricted cash of $103.4 million as of September 30, 2021, plus future cash flows from operating activities will be sufficient to meet our anticipated cash needs including working capital requirements, planned capital expenditures and our contractual obligations.

    For the nine months ended September 30, 2021, we generated cash flows from our operating activities of approximately $47.8 million, which was derived from our cash earnings of approximately $22.3 million and by favorable changes in operating assets and liabilities of approximately $25.5 million. We believe that our operating cash flows for the year

36

ending December 31, 2021 will be sufficient to fund the portion of our contractual obligations that is not funded with existing capital resources.

Cash Flows Summary

    Presented below is a summary of our operating, investing and financing cash flows for the nine months ended September 30, 2021 and 2020 (in thousands): 

	2021		2020
Net cash provided by (used in):
Operating activities	$	47,814	$	31,833
Investing activities	(1,455)		(1,159)
Financing activities	(25,990)		15,123

The effect of foreign currency translation was unfavorable for $0.4 million for the nine months ended September 30, 2020 compared to an unfavorable change of $4.8 million for the nine months ended September 30, 2021.

Cash Flows Provided by Operating Activities

    A key component of our business model requires that clients typically prepay us annually for the services which we will provide over the following year or longer. As a result, we typically collect cash in advance of the date when the vast majority of the related services are provided. The key components in the calculation of our cash provided by operating activities for the nine months ended September 30, 2021 and 2020, are as follows (in thousands):

	2021		2020
Net income	$	5,162	$	9,078
Non-cash expenses, net	17,114		11,350
Changes in operating assets and liabilities, net	25,538		11,405
Net cash provided by operating activities	$	47,814	$	31,833

    For the nine months ended September 30, 2021, cash flows provided by operating activities amounted to approximately $47.8 million. The key drivers resulting in our cash provided by operating activities for the nine months ended September 30, 2021, included net income of $5.2 million, as adjusted for non-cash and non-operating expenses totaling $17.1 million and favorable changes in operating assets and liabilities of $25.5 million, resulting in net cash provided by operating activities of $47.8 million.

For the nine months ended September 30, 2021, the non-cash expenses, net consisted primarily of a loss on change in fair value of redeemable warrants of $3.0 million, stock-based compensation expense of $7.1 million, amortization and accretion related to operating lease ROU assets of $4.6 million, depreciation and amortization expense of $1.8 million, and an impairment charge related to operating ROU assets of $0.4 million. For the nine months ended September 30, 2021, the changes in operating assets and liabilities, net consisted of favorable changes to accounts receivable of $41.0 million and accounts payable of $5.6 million. These favorable cash sources were offset by unfavorable changes to deferred revenue of $11.1 million, prepaid expenses, deposits and other of $4.3 million, accrued liabilities of $3.9 million and deferred contract costs of $1.8 million.

For the nine months ended September 30, 2020, cash flows provided by operating activities amounted to approximately $31.8 million. The key drivers resulting in our cash provided by operating activities for the nine months ended September 30, 2020, included our net income of $9.1 million, as adjusted for non-cash and non-operating expenses totaling $11.3 million and favorable changes in operating assets and liabilities of $11.4 million, resulting in net cash provided by operating activities of $31.8 million.

For the nine months ended September 30, 2020, the non-cash expenses, net consisted primarily of loss on change in fair value of redeemable warrants of $0.2 million, stock-based compensation expense of $5.4 million, amortization and accretion related to operating lease ROU assets of $4.6 million and depreciation and amortization expense of $1.3 million. For the nine months ended September 30, 2020, the changes in operating assets and liabilities, net consisted of favorable changes to accounts receivable of $42.4 million, accounts payable of $1.7 million and prepaid expenses and other assets of $4.7 million. These favorable cash sources were offset by unfavorable changes to deferred revenue of $28.8 million, deferred contract costs of $4.9 million and accrued liabilities of $3.6 million.

37

Cash Flows Used in Investing Activities

    Cash used in investing activities was primarily driven by capital expenditures for leasehold improvements and computer equipment as we continued to invest in our business infrastructure and advance our geographic expansion. Capital expenditures totaled $1.5 million and $1.2 million for the nine months ended September 30, 2021 and 2020, respectively.

    For the nine months ended September 30, 2021, capital expenditures of $1.5 million consisted of $0.6 million primarily for new computer equipment in our U.S. facilities and $0.9 million for computer equipment at our foreign locations, primarily in India $0.4 million.

For the nine months ended September 30, 2020, capital expenditures of approximately $1.2 million consisted primarily of $0.7 million for leasehold improvements, furniture and fixtures, and new computer equipment related to our U.S. facilities and $0.5 million for computer equipment at our foreign locations, primarily in India.

Cash Flows from Financing Activities

    For the nine months ended September 30, 2021, cash utilized in financing activities of $26.0 million was attributable to payments to repurchase shares of Series A Preferred Stock totaling $156.8 million, which included $87.8 million in July 2021, $60.0 million in April 2021 and $9.0 million in January 2021; recurring dividend payments $9.7 million and a make-whole dividend payments of $2.9 million; payments related to debt issuance costs of $4.0 million; payments for professional fees associated with our March 2021 Offering of $1.3 million; principal payment related to the Credit Facility of $1.1 million; payments of $1.1 million related to treasury stock and capital lease payments of $0.3 million. These cash uses were offset by proceeds of $89.3 million from the new Credit Facility, proceeds of $57.0 million generated from the March 2021 Offering and proceeds of $5.0 million received from stock option exercises.

For the nine months ended September 30, 2020, cash provided by financing activities of $15.1 million was attributable to net proceeds of $25.7 million generated from our August 2020 Offering and proceeds of $1.6 million received from our stock option exercises. These cash proceeds were offset, in part, by dividend payments of $11.8 million, payments for professional fees associated with our August 2020 Offering of $0.3 million and capital lease payments of $0.2 million.

Foreign Subsidiaries

    Our foreign subsidiaries and branches are dependent on our U.S.-based parent for continued funding. We currently do not intend to repatriate any amounts that have been invested overseas back to the U.S.-based parent. However, we may still be liable for withholding taxes, state taxes, or other income taxes that might be incurred upon the repatriation of foreign earnings. We have not made any provision for additional income taxes on undistributed earnings of our foreign subsidiaries. As of September 30, 2021, we had cash and cash equivalents of $30.7 million in our foreign subsidiaries.

Critical Accounting Policies and Significant Judgments and Estimates

    Our management’s discussion and analysis of financial condition and results of operations is based on our unaudited condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported revenue and expenses during the reporting periods. These items are monitored and analyzed for changes in facts and circumstances, and material changes in these estimates could occur in the future. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Changes in estimates are reflected in reported results for the period in which they become known. Actual results may differ from these estimates under different assumptions or conditions.

    For the three months ended September 30, 2021, see Note 2 to our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report for changes to the critical accounting policies.

Recent Accounting Pronouncements

    From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by us as of the specified effective date. For additional information on recently issued accounting standards and our

38

plans for adoption of those standards, please refer to the section titled Recent Accounting Pronouncements under Note 2 to our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report.

Recently Issued Accounting Standards

In August 2020, the FASB issued ASU 2020-6, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40). The guidance eliminates the beneficial conversion and cash conversion accounting for convertible instruments. The new guidance also modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. The new guidance is effective for us as of January 1, 2022. We are assessing the impact of the adoption of this guidance on our Consolidated Financial Statements.

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk.

Foreign Currency Exchange Risk

    We have foreign currency risks related to our revenue and operating expenses denominated in currencies other than the U.S. Dollar, primarily the Euro, British Pound Sterling, Brazilian Real, Australian Dollar, Indian Rupee and Japanese Yen. For the three months ended September 30, 2021 and 2020, we generated approximately 47% and 42% of our revenue from our international business, respectively. Increases in the relative value of the U.S. Dollar to other currencies may negatively affect our revenue, partially offset by a positive impact to operating expenses in other currencies as expressed in U.S. Dollars. We have experienced and will continue to experience fluctuations in our net income (loss) as a result of transaction gains or losses related to revaluing certain current asset and current liability balances, including intercompany receivables and payables, which are denominated in currencies other than the functional currency of the entities in which they are recorded. While we have not engaged in the hedging of our foreign currency transactions to date, we are evaluating the costs and benefits of initiating such a program and we may in the future hedge selected significant transactions denominated in currencies other than the U.S. Dollar.

During the three months ended September 30, 2021 and 2020, the effect of a hypothetical 10% change in foreign currency exchange rates applicable to our business would not have had a material impact on our consolidated financial statements.

Interest Rate Risk

Risk with Respect to Investments

    We hold cash and cash equivalents for working capital purposes. We do not have material exposure to market risk with respect to investments, as any investments we enter into are primarily highly liquid investments.

Variable Rate Debt

In July 2021, we entered into the Credit Facility, which will bear interest at LIBOR plus a margin. ranging from 1.75% to 2.50%. Accordingly, we are exposed to market risk due to variable interest rates based on LIBOR. As of September 30, 2021, we had $84.2 million outstanding debt under the Credit Facility. As of this date, a reasonably possible hypothetical adverse change of 100 basis points in would have resulted in an increase of approximately $0.1 million in annual interest expense. While we have not engaged in the hedging of variable interest rates under our Credit Facility, we are evaluating the costs and benefits of initiating such a program and we may in the future hedge all or a portion of our variable interest rate debt. See the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part I, Item 2 and Note 5 of our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report for more information related to the Credit Facility.

ITEM 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

    We maintain a system of disclosure controls and procedures that are designed to reasonably ensure that information required to be disclosed in our SEC reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and to reasonably ensure that such information is accumulated and communicated to our

39

management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure.

    Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) (“Disclosure Controls”) will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. We monitor our Disclosure Controls and make modifications as necessary; our intent in this regard is that the Disclosure Controls will be modified as systems change and conditions warrant.

    In connection with the preparation of this Report, as of September 30, 2021, an evaluation of the effectiveness of the design and operation of our Disclosure Controls was performed. This evaluation was performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer. Based on this evaluation, we concluded that our disclosure controls and procedures were effective to provide reasonable assurance that

information required to be disclosed in our SEC reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and to reasonably ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure.

Previously Identified Material Weaknesses in our Internal Control over Financial Reporting

In connection with the preparation of our Quarterly Report on Form 10-Q as of March 31, 2021, an evaluation of the effectiveness of the design and operation of our Disclosure Controls was performed. Based on this evaluation, we concluded that our disclosure controls and procedures were not effective, and as a result of the material weakness in our internal control over financial reporting relating to improperly applying the accounting guidance for our GP Sponsor Private Placement Warrants, recognizing them as equity instead of a warrant liability, under the guidance of Accounting Standards Codification (ASC) 815-40, Contracts in Entity’s Own Equity. As a result, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective at a reasonable assurance level as of March 31, 2021 to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act was recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC.

Changes in Internal Control over Financial Reporting

    During the nine months ended September 30, 2021, we have implemented internal controls to ensure that we have adequately evaluated the accounting guidance for our GP Sponsor Private Placement Warrants recognizing them as a warrant liability, under the guidance of Accounting Standards Codification (ASC) 815-40, Contracts in Entity’s Own Equity. We improved our processes to ensure that we have properly identified and evaluated the appropriate accounting technical pronouncements. These processes included enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding the application of complex accounting transactions.

There were no changes in our internal control over financial reporting during the latest fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting other than the item noted above.

PART II - OTHER INFORMATION

ITEM 1. Legal Proceedings.

40

    The legal proceedings described in Note 9 of our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report are incorporated herein by reference. In addition, from time to time, we may be a party to litigation and subject to claims incident to the ordinary course of business. Although the results of litigation and claims cannot be predicted with certainty, we currently believe that the final outcome of these ordinary course matters will not have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us because of judgment, defense and settlement costs, diversion of management resources and other factors.

ITEM 1A. Risk Factors.

    Factors that could cause our actual results to differ materially from those in this Report are any of the risks described in this Item 1A. Any of these factors could result in a significant or material adverse effect on our business, financial condition, results of operations and cash flows. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. In addition, risk factors relating to economic uncertainties, downturns in the general economy or the industries in which our clients operate should be interpreted as heightened risks as a result of the COVID-19 pandemic.

    Our business operations are subject to a number of risk factors that may adversely affect our business, financial condition, results of operations or cash flows. If any significant adverse developments resulting from these risk factors should occur, the trading price of our securities could decline, and moreover, investors in our securities could lose all or part of their investment in our securities.

    You should refer to the explanation of the qualifications and limitations on forward-looking statements under “Cautionary Note About Forward-Looking Statements” set forth in Part I, Item 2 of this Report. All forward-looking statements made by us are qualified by the risk factors described below.

Risks Related to Our Business, Operations and Industry

Risks Related to Litigation

•We are involved in continuing litigation with Oracle since 2010. An adverse outcome in the litigation could result in the payment of substantial damages and/or an injunction against certain of our business practices.

•The Oracle software products that are part of our litigation represent a significant portion of our revenue.

•Our ongoing litigation with Oracle presents challenges for growing our business.

•Oracle has a history of litigation against companies offering alternative support programs for Oracle products.

Other Risks Related to Our Business, Operations and Industry

•The duration of and impacts on our business of the COVID-19 pandemic, as well as the responsive actions taken by governments or clients may have a material adverse effect on our business.

•The market for independent software support services is relatively undeveloped and may not grow.

•We have had a history of losses and may not achieve or sustain profitability in the future.

•If we are unable to attract new clients or retain and sell additional products or services to existing clients, our revenue growth will be adversely affected.

•If our retention rates decrease our future revenue and results of operations may be harmed.

•We face significant competition.

•Our past growth is not indicative of future growth, and we may not be able to manage our growth effectively.

•Our failure to generate significant capital or raise additional capital necessary to fund our operations and invest in new services and products could reduce our ability to compete and could harm our business.

•Our business may suffer if it is alleged or determined that our technology infringes others’ intellectual property rights.

•The loss of one or more key employees could harm our business.

•The failure to attract and retain additional qualified personnel, including sales personnel, could prevent us from executing our business strategy.

•Because we recognize revenue from subscriptions over the term of the relevant contract, downturns or upturns in sales are not immediately reflected in full in our results of operations.

•Failure to effectively develop and expand our marketing and sales capabilities could harm our ability to increase our client base and achieve broader market acceptance of our products and services.

•Interruptions to or degraded performance of our service could result in client dissatisfaction, damage to our reputation, loss of clients, limited growth and reduction in revenue.

•We may experience fluctuations in our results of operations due to a number of factors, which makes our future results difficult to predict and could cause our results of operations to fall below expectations or our guidance.

41

•Our future liquidity and results of operations may be adversely affected by the timing of new orders, the level of client renewals and cash receipts from clients.

•We may be subject to additional obligations to collect and remit sales tax and other taxes, and we may be subject to tax liability, interest and/or penalties for past sales, which could adversely harm our business.

•We may need to change our pricing models to compete successfully.

•If we are not able to scale our business quickly and grow efficiently, our results of operations could be harmed.

•We have experienced significant growth resulting in changes to our organization and structure, which if not effectively managed, could have a negative impact on our business.

•Our business will be susceptible to risks associated with global operations.

•If we fail to forecast our revenue accurately, or if we fail to match our expenditures with corresponding revenue, our results of operations and liquidity could be adversely affected.

•Consolidation in our target sales markets is continuing at a rapid pace, which could harm our business.

•If there is a widespread shift by clients or potential clients to enterprise software vendors, products and releases for which we do not provide software products or services, our business would be adversely impacted.

•Delayed or unsuccessful investment in new technology, products, services and markets may harm our financial condition and results of operations.

•If our data security measures are compromised, our services may be perceived as not being secure, clients may curtail or cease their use of our services, our reputation may be harmed, and we may incur significant liabilities.

•If our products and services fail due to defects or similar problems, we could lose clients, become subject to service performance or warranty claims or incur significant costs.

•If we take advantage of certain exemptions from reporting and disclosure requirements available to smaller reporting companies that are also accelerated filers, this could make our common stock less attractive to investors.

•If we are not able to maintain an effective system of internal control over financial reporting, investors could lose confidence in our financial reporting, which could harm our business and have an adverse effect on our stock price.

•Economic uncertainties or downturns in the general economy or the industries in which our clients operate could disproportionately affect the demand for our products and services and negatively impact our results of operations.

•Catastrophic events may disrupt our business.

•If we fail to enhance our brand, our ability to expand our client base will be impaired.

•If we fail to adequately protect our proprietary rights, our competitive position could be impaired and we may lose valuable assets, experience reduced revenue and incur costly litigation to protect our rights.

•We may not be able to use a portion of our net operating loss carryforwards, which could adversely affect profitability.

•We are a multinational organization, and we could be obligated to pay additional taxes in various jurisdictions.

•Future strategic transactions could be difficult to identify and integrate, divert the attention of management, disrupt our business, dilute stockholder value and adversely affect our financial condition and results of operations.

•Failure to comply with laws and regulations could harm our business.

•Changes in financial accounting standards or practices may cause adverse, unexpected financial reporting fluctuations and affect our reported results of operations.

•Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our Common Stock.

Risks Related to Capitalization Matters and Corporate Governance

Risks Related to our Indebtedness and Securities

•Our level of indebtedness and any future indebtedness we may incur may limit our operational and financing flexibility and negatively impact our business.

•The terms of our Credit Facility impose operating and financial restrictions on us.

•Our variable rate indebtedness subjects us to interest rate risk, which could cause our indebtedness service obligations to increase significantly.

•The price of our Common Stock, warrants and units may be volatile.

•Certain of our common stockholders can exercise significant control, which could limit our stockholders’ ability to influence the outcome of key transactions, including a change of control.

•Future resales of our Common Stock held by significant stockholders may cause the market price of our Common Stock to drop significantly.

•Any issuance of Common Stock upon the exercise of warrants will cause dilution to existing stockholders and may depress the market price of our Common Stock.

•We do not currently intend to pay dividends on our Common Stock.

42

Risks Related to our Corporate Governance

•The DGCL and our organizational documents contain provisions that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable.

•Our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, stockholders or employees could be limited by our choice of forum in our bylaws.

Risks Related to Our Business, Operations and Industry

Risks Related to Litigation

We and our Chief Executive Officer are involved in continuing litigation with Oracle since 2010. An adverse outcome in the ongoing litigation could result in the payment of substantial damages and/or an injunction against certain of our business practices, either of which could have a material adverse effect on our business and financial results.

In January 2010, certain subsidiaries of Oracle Corporation (together with its subsidiaries individually and collectively, “Oracle”) filed a lawsuit, Oracle USA, Inc. et al v. Rimini Street, Inc. et al (United States District Court for the District of Nevada) (“District Court”), against us and our Chief Executive Officer, Seth Ravin, alleging that certain of our processes (Process 1.0) violated Oracle’s license agreements with its customers and that we committed acts of copyright infringement and violated other federal and state laws (“Rimini I”). The litigation involved our business processes and the manner in which we provided our services to our clients.

After completion of jury trial in 2015 and subsequent appeals, the final outcome of Rimini I was that Mr. Ravin was found not liable for any claims and we were found liable for only one claim: “innocent infringement,” a jury finding that we did not know and had no reason to know that our former support processes were infringing. The jury also found that the infringement did not cause Oracle to suffer lost profits. We were ordered to pay a judgment of $124.4 million in 2016, which we promptly paid and then pursued appeals. With interest, attorneys’ fees and costs, the total judgment paid by us to Oracle after the completion of all appeals was approximately $89.9 million. A portion of such judgment was paid by our insurance carriers (for additional information on this topic, see Note 9 to our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report).

The total judgment paid by us and our insurance carriers reflects a reduction of approximately $12.8 million that we had previously paid to Oracle (plus interest of $0.2 million), representing an award of non-taxable expenses to Oracle that was eventually overturned by unanimous decision of the U.S. Supreme Court in March 2019. As mandated by the U.S. Supreme Court, $13.0 million (the principal amount plus post-judgment interest) was refunded to us by Oracle in April 2019.

Following post-trial motions, the District Court entered a permanent injunction prohibiting us from using certain processes. In August 2019, the Court of Appeals affirmed the permanent injunction issued by the District Court, while also correcting certain legal errors that narrowed the scope of the injunction. The injunction prohibits us from using support processes that had been found in Rimini I to “innocently” infringe certain Oracle copyrights, which we ceased using no later than July 31, 2014.

On July 10, 2020, Oracle filed a motion to show cause contending that we are in contempt of the injunction, which we opposed. On March 31, 2021, the District Court issued an order resolving many outstanding disputes between the parties relating to the injunction and found that we violated the injunction in four certain narrow instances. In April 2021, we filed a motion for reconsideration for two of the four violations identified by the District Court (since they occurred before the injunction became effective). The District Court granted our motion for reconsideration on June 10, 2021, striking from its March 31, 2021 order its holding regarding those two violations. During an evidentiary hearing in September 2021, the District Court heard evidence and argument regarding whether we (i) violated the injunction for certain accused conduct for which the District Court requested additional information; and (ii) should be held in contempt in the four instances where the District Court found a violation of the injunction, and what sanctions, if any, are appropriate.

At this time, we do not have sufficient information regarding the likelihood of any possible damages for any violations of the injunction or for the contempt claim asserted by Oracle. As a result, an estimate of any range of potential loss cannot be reasonably determined at this time. We believe that we have substantially complied with the injunction, that Oracle did not meet the burden to establish contempt of the injunction for the two certain narrow instances for which the District Court found violations, that Oracle was unable to establish additional violations of the injunction at the September 2021 hearing, and that an award for sanctions is not probable. Accordingly, no accrual has been made as of September 30, 2021. If the District Court orders any penalties for violations of the injunction and/or we are found to be in contempt of the injunction, Oracle may seek

43

and the District Court may order equitable, punitive, and compensatory relief, the outcome of which could have a material adverse effect on our business and financial condition. We reserve all rights, including appellate rights, with respect to the District Court rulings and findings.

Oracle may file additional contempt motions against us at any time to attempt to enforce its interpretation of the injunction or if it has reason to believe we are not in compliance with the express terms of the injunction. Such contempt proceedings or any judicial finding of contempt could result in a material adverse effect on our business and financial condition. In addition, the pendency of the injunction, alone, or the District Court’s March 31, 2021 order relating to the injunction described above, could dissuade clients from purchasing or continuing to purchase our services. If we are obligated to pay substantial civil assessments arising from any finding of contempt, this could reduce the amount of cash flows available to pay principal, interest, fees and other amounts due under our Credit Facility, which could result in an event of default, in which case the lenders could demand accelerated payment of principal, accrued and unpaid interest, and other fees. We cannot assure you that we will have sufficient assets which would allow us to repay such indebtedness in full at such time. As a result, we could be forced into bankruptcy or liquidation.

In October 2014, we filed a separate lawsuit, Rimini Street Inc. v. Oracle Int’l Corp., in the District Court against Oracle seeking a declaratory judgment that our support practices, in use since at least July 2014, do not infringe certain Oracle copyrights (“Rimini II”). Our operative complaint asserts declaratory judgment, tort, and statutory claims. Oracle’s operative counterclaim asserts declaratory judgment and copyright infringement claims and Lanham Act, breach of contract, and business tort violations.

On September 15, 2020, the District Court issued an order resolving the parties’ motions for summary judgment. It found infringement of 17 Oracle PeopleSoft copyrights for work we performed for a set of “gap customers” that were supported by processes litigated in Rimini I, and that became our customers after Rimini I was filed. The District Court also found infringement of four Oracle PeopleSoft copyrights involving support of two specific clients, described by the District Court as “limited cases” and involving “limited circumstance[s].” There was no finding of infringement on any other Oracle copyrights at issue.

We could be required to pay substantial damages for our current or past business activities and/or be enjoined from certain business practices. Any of these outcomes could result in a material adverse effect on our business and financial condition, and the pendency of the litigation alone could dissuade clients from purchasing or continuing to purchase our services. If we are obligated to pay substantial damages to Oracle or are enjoined from certain business practices, this could reduce the amount of cash flows available to pay principal, interest, fees and other amounts due under our Credit Facility, which could result in an event of default, in which case the lenders could demand accelerated payment of principal, accrued and unpaid interest, and other fees. If we default in our payment obligations under the Credit Facility and the indebtedness under the Credit Facility were to be accelerated, there can be no assurance that our assets would be sufficient to repay such indebtedness in full, and we could be forced into bankruptcy or liquidation.

Our business has been and may continue to be materially harmed by this litigation and Oracle’s conduct. During the course of these cases, we anticipate there will be rulings by the District Court in Rimini II, the District Court in Rimini I, and possibly the Court of Appeals in both Rimini I and Rimini II in connection with hearings, motions, decisions, and other matters, as well as other interim developments related to the litigations. If securities analysts or investors regard these rulings as negative, the market price of our Common Stock may decline. If current or prospective clients regard these rulings as negative, it could negatively impact our new client sales or renewal sales.

While we plan to continue to vigorously litigate the pending matters in Rimini I and Rimini II, we are unable to predict the timing or outcome of these lawsuits. No assurance is or can be given that we will prevail on any appeal, contempt proceeding, claim, or counterclaim.

See the section titled “Legal Proceedings” in Part II, Item 1 and Note 9 of our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report for more information related to this litigation.

The Oracle software products that are part of our ongoing litigation with Oracle represent a significant portion of our current revenue.

In Rimini II, Oracle has filed counterclaims relating to our support services for Oracle’s PeopleSoft, J.D. Edwards, Siebel, E-Business Suite, and Database software products. For the three months ended September 30, 2021, approximately 62% of our revenue was derived from the support services that we provide for our clients using Oracle’s PeopleSoft, J.D. Edwards, Siebel, E-Business Suite and Database software products. The percentage of revenue derived from services we provide for

44

PeopleSoft software only was approximately 11% of our total revenue during this same period. Although we provide support services for additional Oracle product lines that are not subject to litigation and support services for software products provided by companies other than Oracle, our current revenue depends significantly on the product lines that are the subject of the Rimini II litigation. Should Oracle prevail on its claims in Rimini II or should a contempt action result in a finding that we are in violation of the injunction, we could be required to change the way we provide support services to some of our clients, which could result in the loss of clients and revenue, and may also give rise to claims for compensation from our clients, any of which could have a material adverse effect on our business, financial condition and results of operations.

Our ongoing litigation with Oracle presents challenges for growing our business.

We have experienced challenges growing our business as a result of our ongoing litigation with Oracle. Many of our existing and prospective clients have expressed concerns regarding our ongoing litigation and, in some cases, have been subjected to various negative communications by Oracle in connection with the litigation. We have experienced in the past, and may continue to experience in the future, volatility and slowness in acquiring new clients, as well as clients not renewing their agreements with us, due to these challenges relating to our ongoing litigation with Oracle. Further, certain of our prospective and existing clients may be subject to additional negative communications from software vendors. We have taken steps to minimize disruptions to our existing and prospective clients regarding the litigation, but we continue to face challenges growing our business while the litigation remains ongoing. In certain cases, we have agreed to pay certain liquidated damages to our clients if we are no longer able to provide services to these clients, and/or reimburse our clients and our former lenders for their reasonable legal fees incurred in connection with any litigation-related subpoenas and depositions or to provide certain client indemnification or termination rights if any outcome of litigation results in our inability to continue providing any of the paid-for services. In addition, we believe the length of our sales cycle is longer than it otherwise would be due to prospective client diligence on possible effects of the Oracle litigation on our business. We cannot assure you that we will continue to overcome the challenges we face as a result of the litigation and continue to renew existing clients or secure new clients.

Additionally, the existence of this ongoing litigation and, specifically, Oracle’s July 2020 contempt filing and related March 31, 2021 District Court order, could negatively impact the value of our equity securities, and could negatively impact our ability to raise additional equity or debt financing.

We are self-insured for any costs related to any current or future intellectual property litigation, although we maintain and have tendered our errors and omissions insurance coverage for the wrongful acts alleged in Oracle’s contempt proceeding in order to seek a determination of a duty to defend. We cannot provide assurances that we will prevail on this claim or any other similar claims that we may tender in the future.

While we currently believe our cash on hand, accounts receivable and contractually committed backlog provides us with liquidity to cover costs related to litigation with Oracle, we cannot assure our liquidity will be sufficient.

Oracle has a history of litigation against companies offering alternative support programs for Oracle products, and Oracle could pursue additional litigation with us.

Oracle has been active in litigating against companies that have offered competing maintenance and support services for their products. For example, in March 2007, Oracle filed a lawsuit against SAP and its wholly-owned subsidiary, TomorrowNow, Inc. After a jury verdict awarding Oracle $1.3 billion, the parties stipulated to a final judgment of $306 million subject to appeal. After the appeal, the parties settled the case in November 2014 for $356.7 million. In February 2012, Oracle filed suit against ServiceKey, Inc. and settled the case in October 2013 after the District Court issued an injunction against ServiceKey and its CEO. Oracle also filed suit against CedarCrestone Corporation in September 2012 and settled the case in July 2013. TomorrowNow and CedarCrestone offered maintenance and support for Oracle software products, and Service Key offered maintenance and support for Oracle technology products. Given Oracle’s history of litigation against companies offering alternative support programs for Oracle products, we can provide no assurance, regardless of the outcome of our current litigations with Oracle, that Oracle will not pursue additional litigation against us. Such additional litigation could be costly, distract our management team from running our business and reduce client interest and our sales revenue.

Other Risks Related to Our Business, Operations and Industry

The duration of and economic, operational and financial impacts on our business of the COVID-19 pandemic, as well as the actions taken by governmental authorities, clients or others in response to the COVID-19 pandemic may have a material adverse effect on our business, financial condition, results of operations, or cash flows.

45

In response to the uncertain and rapidly evolving situation relating to the COVID-19 pandemic, we have taken precautionary measures to protect the health and well-being of our employees, clients, and the communities in which we operate. We have established work-at-home arrangements for most of our employees, placed restrictions on non-essential business travel, transitioned to a no in-person event marketing strategy and implemented a fully remote sales model. We believe that many of our clients are doing and will continue to do the same. These precautionary measures could impact our clients’ and potential clients’ ability or willingness to participate in our sales, marketing and client success efforts, which could adversely affect our business, financial condition and results of operations. Further, there is significant uncertainty around the breadth and duration of business disruptions related to COVID-19, as well as its impact on the global economy and consumer confidence. While some of our offices have partially re-opened with limited staffing, our offices will not fully re-open until local authorities permit us to, and our own criteria and conditions to ensure employee held and safety are satisfied. The COVID-19 pandemic could have a sustained adverse impact on economic and market conditions and trigger a period of global economic slowdown, which may delay prospective clients’ decisions regarding engaging our services, impair the ability of our current clients to make timely payments to us, cause our current clients to ask for payment concessions or discounts, impact client renewal rates and adversely affect our revenue. If such conditions occur, we may be required to increase our reserves, allowances for doubtful accounts and write-offs of accounts receivable, and our results of operations would be harmed.

We are unable to accurately predict the ultimate impact of the COVID-19 pandemic due to various uncertainties, including the duration and scope of the outbreak, particularly if virus variants result in additional outbreaks, the effectiveness of the vaccines developed to slow or stop the spread of the virus and actions that may be taken by governmental authorities to contain the virus. We closely monitor the impact of the COVID-19 pandemic, continually assessing its potential effects on our business. The extent to which our results are affected by COVID-19 will largely depend on future developments which cannot be accurately predicted and are uncertain, but the COVID-19 pandemic or the perception of its effects could have a material adverse effect on our business, financial condition, results of operations, or cash flows. Further, due to our subscription-based business model, the effect of the pandemic may not be fully reflected in our results of operations until future periods, and the global macroeconomic effects of the pandemic may persist for an indefinite period, even after the pandemic has subsided. The COVID-19 pandemic may also have the effect of heightening many of the other risks described in this “Risk Factors” section. Refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Impact of COVID-19” in this Report for additional information.

The market for independent software support services is relatively undeveloped and may not grow.

The market for independent enterprise software support services is still relatively undeveloped, has not yet achieved widespread acceptance and may not grow quickly or at all. Our success will depend to a substantial extent on the willingness of companies to engage a third party such as us to provide software support services for their enterprise software. Many enterprise software licensees are still hesitant to use a third party to provide such support services, choosing instead to rely on support services provided by the enterprise software vendor. Other enterprise software licensees have invested substantial personnel, infrastructure and financial resources in their own organizations with respect to support of their licensed enterprise software products and may choose to self-support with their own internal resources instead of purchasing services from the enterprise software vendor or an independent provider such as ourselves. Companies may not engage us for other reasons, including concerns regarding our ongoing litigation with Oracle, the potential for future litigation, the potential negative effect our engagement could have on their relationships with their enterprise software vendor, or concerns that they could infringe third party intellectual property rights or breach one or more software license agreements if they engage us to provide support services. New concerns or considerations may also emerge in the future. Particularly because our market is relatively undeveloped, we must address our potential clients’ concerns and explain the benefits of our approach to convince them of the value of our services. If companies are not sufficiently convinced that we can address their concerns and that the benefits of our services are compelling, then the market for our services may not develop as we anticipate, and our business will not grow.

We have had a history of losses and may not achieve or sustain profitability in the future.

We had net income of $1.9 million for the three months ended September 30, 2021 and we had an accumulated deficit of $295.8 million as of September 30, 2021. We will need to generate and sustain increased revenue levels in future periods while managing our costs to become profitable, and, even if we do, we may not be able to maintain or increase our level of profitability. We intend to continue to expend significant funds to expand our sales and marketing operations, enhance our service offerings, expand into new markets, launch new product offerings and meet the increased compliance requirements associated with our operations as a public company. Our efforts to grow our business may be costlier than we expect, and we may not be able to increase our revenue enough to offset our higher operating expenses. We may incur significant losses in the future for a number of reasons, including, as a result of our ongoing litigation with Oracle, the potential for future litigation, impact of the COVID-19 pandemic, other risks described herein, unforeseen expenses, difficulties, complications and delays

46

and other unknown events. If we are unable to achieve and sustain profitability, the market price of our securities may significantly decrease.

If we are unable to attract new clients or retain and/or sell additional products or services to our existing clients, our revenue growth will be adversely affected.

To increase our revenue, we must add new clients, encourage existing clients to renew or extend their agreements with us on terms favorable to us and sell additional products and services to existing clients. As competitors introduce lower-cost and/or differentiated services that are perceived to compete with ours, or as enterprise software vendors introduce competitive pricing or additional products and services or implement other strategies to compete with us, our ability to sell to new clients and renew agreements with existing clients based on pricing, service levels, technology and functionality could be impaired. As a result, we may be unable to renew or extend our agreements with existing clients or attract new clients or new business from existing clients on terms that would be favorable or comparable to prior periods, which could have an adverse effect on our revenue and growth. In addition, certain of our existing clients may choose to license a new or different version of enterprise software from an enterprise software vendor, and such clients’ license agreements with the enterprise software vendor will typically include a minimum one-year mandatory maintenance and support services agreement. In such cases, it is unlikely that these clients would renew their maintenance and support services agreements with us, at least during the early term of the license agreement. In addition, such existing clients could move to another enterprise software vendor, product or release for which we do not offer any products or services.

If our retention rates decrease, or we do not accurately predict retention rates, our future revenue and results of operations may be harmed.

Our clients have no obligation to renew their product or service subscription agreements with us after the expiration of a non-cancelable agreement term. In addition, the majority of our multi-year, non-cancelable client agreements are not pre-paid other than the first year of the non-cancelable service period. We may not accurately predict retention rates for our clients. Our retention rates may decline or fluctuate as a result of a number of factors, including our clients’ decision to license a new product or release from an enterprise software vendor, our clients’ decision to move to another enterprise software vendor, product or release for which we do not offer products or services, the impact of the COVID-19 pandemic on our clients’ businesses, client satisfaction with our products and services, the acquisition of our clients by other companies, and clients going out of business. If our clients do not renew their agreements for our products and services or if our clients decrease the amount they spend with us, our revenue will decline and our business will suffer.

We face significant competition from both enterprise software vendors and other companies offering independent enterprise software support services, as well as from software licensees that attempt to self-support, which may harm our ability to add new clients, retain existing clients and grow our business.

We face intense competition from enterprise software vendors, such as Oracle and SAP, who provide software support services for their own products. Enterprise software vendors have offered discounts to companies to whom we have marketed our services. In addition, our current and potential competitors and enterprise software vendors may develop and market new technologies that render our existing or future services less competitive or obsolete. Competition could significantly impede our ability to sell our services on terms favorable to us and we may need to decrease the prices for our services to remain competitive. If we are unable to maintain our current pricing due to competitive pressures, our margins will be reduced and our results of operations will be negatively affected.

There are also several smaller vendors in the independent enterprise software support services market with whom we compete with respect to certain of our services. We expect competition to continue to increase in the future, particularly if we prevail in Rimini II, which could harm our ability to increase sales, maintain or increase renewals and maintain our prices.

Our current and potential competitors may have significantly more financial, technical and other resources than we have, may be able to devote greater resources to the development, promotion, sale and support of their products and services, have more extensive customer bases and broader customer relationships than we have and may have longer operating histories and greater name recognition than we have. As a result, these competitors may be better able to respond quickly to new technologies and provide more robust support offerings. In addition, certain independent enterprise software support organizations may have or may develop more cooperative relationships with enterprise software vendors, which may allow them to compete more effectively over the long term. Enterprise software vendors may also offer support services at reduced or no additional cost to their customers. In addition, enterprise software vendors may take other actions in an attempt to maintain their support service business, including changing the terms of their customer agreements, the functionality of their products or services, or their pricing terms. For example, starting in the second quarter of 2017 Oracle has prohibited us from accessing its

47

support websites to download software updates on behalf of our clients who are authorized to do so and permitted to authorize a third party to do so on their behalf. In addition, various support policies of Oracle and SAP may include clauses that could penalize customers that choose to use independent enterprise software support vendors or that, following a departure from the software vendor’s support program, seek to return to the software vendor to purchase new licenses or services. To the extent any of our competitors have existing relationships with potential clients for enterprise software products and support services, those potential clients may be unwilling to purchase our services because of those existing relationships. If we are unable to compete with such companies, the demand for our services could be substantially impacted.

Our past growth is not indicative of our future growth, and if we grow rapidly, we may not be able to manage our growth effectively.

Our revenue grew from $82.5 million for the three months ended September 30, 2020 to $95.6 million for the three months ended September 30, 2021, representing a period over period increase of 16%. You should not consider our past growth as indicative of our future performance. We believe growth of our revenue depends on a number of factors, including our ability to:

•price our products and services effectively so that we are able to attract new clients and retain existing clients without compromising our profitability;

•introduce our products and services to new geographic markets;

•introduce new enterprise software products and services supporting additional enterprise software vendors, products and releases;

•satisfactorily conclude the Oracle litigation and any other litigation or governmental inquiry that may occur; and

•increase awareness of our company, products and services on a global basis.

We may not successfully accomplish all or any of these objectives. We plan to continue our investment in future growth. We expect to continue to expend substantial financial and other resources on, among others:

•sales and marketing efforts;

•training to optimize our opportunities to overcome litigation risk concerns of our clients;

•expanding in new geographical areas;

•growing our product and service offerings and related capabilities;

•adding additional product and service offerings;

•servicing the debt under our Credit Facility; and

•general administration, including legal and accounting expenses related to being a public company.

In addition, our historical rapid growth has placed and may continue to place significant demands on our management and our operational and financial resources. Our organizational structure is becoming more complex as we add additional staff, and we will need to improve our operational, financial and management controls, as well as our reporting systems and procedures. We will require significant capital expenditures and the allocation of valuable management resources to grow and change in these areas without undermining our corporate culture of rapid innovation, teamwork and attention to client service that has been central to our growth.

Our failure to generate significant capital through our operations or raise additional capital necessary to fund and expand our operations, invest in new services and products, and service our debt could reduce our ability to compete and could harm our business.

We may need to raise additional capital beyond borrowings under our Credit Facility, and funds raised from our August 2020 Offering and our March 2021 Offering if we cannot fund our growth and capital optimization efforts sufficiently or service our debt through our operating cash flows. Should this occur, we may not be able to obtain additional debt or additional equity financing on favorable terms, if at all. We are also subject to certain restrictions for future financings as discussed in the risk factor “The terms of our Credit Facility impose operating and financial restrictions on us.” If we raise additional equity financing, our stockholders may experience significant dilution of their ownership interests and the value of our Common Stock could decline. If we engage in additional debt financings, the holders of the debt securities or lenders would have priority over the holders of our Common Stock. We may also be required to accept terms that further restrict our ability to incur additional indebtedness, take other actions that would otherwise not be in the best interests of our stockholders, or force us to maintain specified liquidity or other ratios, any of which could harm our business, results of operations and financial condition. If we cannot raise or generate additional capital on acceptable terms, we may not be able to, among other things:

•maintain our operations;

48

•develop or enhance our products and services;

•continue to expand our sales and marketing functions;

•devote resources to research and development activities;

•acquire complementary technologies, products or businesses;

•expand operations, in the United States or globally;

•hire, train and retain employees; or

•respond to competitive pressures or unanticipated working capital requirements.

Our failure to do any of these things could impact our ability to grow our revenue and seriously harm our business, financial condition and results of operations.

Our business may suffer if it is alleged or determined that our technology infringes the intellectual property rights of others.

The software industry is characterized by the existence of a large number of patents, copyrights, trademarks, trade secrets and other intellectual and proprietary rights. Companies in the software industry are often required to defend against claims and litigation alleging infringement or other violations of intellectual property rights. Many of our competitors and other industry participants have been issued patents and/or have filed patent applications and may assert patent or other intellectual property rights within the industry. From time to time, we may receive threatening letters or notices alleging infringement or may be the subject of claims that our services and underlying technology infringe or violate the intellectual property rights of others. Any allegation of infringement, whether innocent or intentional, can adversely impact marketing, sales and our reputation.

For example, as described further in the section titled “Risk Factors-Risks Related to Litigation” above, we are engaged in litigation with Oracle relating in part to copyright infringement claims. See the risk factor “We and our Chief Executive Officer are involved in litigation with Oracle. An adverse outcome in the ongoing litigation could result in the payment of substantial damages and/or an injunction against certain of our business practices, either of which could have a material adverse effect on our business and financial results” above for additional information regarding the Rimini I and Rimini II cases.

We rely on our management team and other key employees, including our Chief Executive Officer, and the loss of one or more key employees could harm our business.

Our success and future growth depend upon the continued services of our management team, including Seth Ravin, our Chief Executive Officer, and other key employees. Since 2008, Mr. Ravin has been under the regular care of a physician for kidney disease, which includes ongoing treatment. During this time, Mr. Ravin has continuously performed all of his duties as Chief Executive Officer of our company on a full-time basis. Although Mr. Ravin’s condition has not had any impact on his performance in his role as Chief Executive Officer or on the overall management of the Company, we can provide no assurance that his condition will not affect his ability to perform the role of Chief Executive Officer in the future. In addition, from time to time, there may be changes in our management team resulting from the hiring or departure of executives, which could disrupt our business. We may terminate any employee at any time, with or without cause, and any employee may resign at any time, with or without cause. We do not maintain key man life insurance on any of our employees. The loss of one or more of our key employees could harm our business.

The failure to attract and retain additional qualified personnel could prevent us from executing our business strategy.

To execute our business strategy, we must attract and retain highly qualified personnel, including sales personnel. We have from time to time experienced, and we expect to continue to experience, difficulty in hiring and retaining highly skilled sales personnel and other employees with appropriate qualifications. In particular, we have experienced an extremely competitive hiring environment in the San Francisco Bay Area, where we have a significant amount of operations, but also face extremely competitive hiring environments across the United States and the other countries in which we operate. Further, our efforts to attract, develop, integrate and retain highly skilled employees with appropriate qualifications may be compounded by intensified restrictions on travel (including during the COVID-19 pandemic), immigration, or the availability of work visas. Many of the companies with which we compete for experienced personnel have greater resources than we do. In addition, in making employment decisions, job candidates often consider the value of the stock options or other equity incentives they are to receive in connection with their employment. If the price of our stock declines or experiences significant volatility, our ability to attract or retain qualified employees will be adversely affected. In addition, as we continue to expand into new geographic markets, there can be no assurance that we will be able to attract and retain the required management, sales, marketing and support services personnel to profitably grow our business. If we fail to attract highly qualified new sales and other personnel or fail to retain and motivate our current personnel, our growth prospects could be severely harmed.

49

Because we recognize revenue from subscriptions over the term of the relevant contract, downturns or upturns in sales are not immediately reflected in full in our results of operations.

As a subscription-based business, we recognize revenue over the service period of our contracts. As a result, much of our reported revenue each quarter results from contracts entered into during previous quarters. Consequently, while a shortfall in demand for our products and services or a decline in new or renewed contracts in any one quarter may not significantly reduce our revenue for that quarter, it could negatively affect our revenue in future quarters. Accordingly, the effect of significant downturns in new sales, renewals or extensions of our service agreements will not be reflected in full in our results of operations until future periods. Our revenue recognition model also makes it difficult for us to rapidly increase our revenue through additional sales in any period, as revenue from new clients must be recognized over the applicable service contract term.

Failure to effectively develop and expand our marketing and sales capabilities could harm our ability to increase our client base and achieve broader market acceptance of our products and services.

Our ability to increase our client base and achieve broader market acceptance of our products and services will depend to a significant extent on our ability to expand our marketing and sales operations. We plan to continue expanding our sales force globally. These efforts will require us to invest significant financial and other resources. Moreover, our sales personnel typically take an average of between nine to twelve months before any new sales personnel can operate at the capacity typically expected of experienced sales personnel. This ramp cycle, combined with our typical six- to twelve-month sales cycle for engaged prospects, means that we will not immediately recognize a return on this investment in our sales department. In addition, the cost to acquire clients is high due to the cost of these marketing and sales efforts. Our business may be materially harmed if our efforts do not generate a correspondingly significant increase in revenue. We may not achieve anticipated revenue growth from expanding our sales force if we are unable to hire, develop and retain talented sales personnel, if our new sales personnel are unable to achieve desired productivity levels in a reasonable period of time or if our sales and marketing programs are not effective.

Interruptions to or degraded performance of our service could result in client dissatisfaction, damage to our reputation, loss of clients, limited growth and reduction in revenue.

Our software support agreements with our clients generally guarantee a 10-minute response time with respect to certain high-priority issues. To the extent that we do not meet the 10-minute guarantee, our clients may in some instances be entitled to liquidated damages, service credits or refunds. To date, no such payments have been made.

We also deliver tax, legal and regulatory updates to our clients and generally have done so faster than our competitors. If there are inaccuracies in these updates, or if we are not able to deliver them on a timely basis to our clients, our reputation may be damaged, and we could face claims for compensation from our clients, lose clients, or both.

Any interruptions or delays in our service, whether as a result of third-party error, our own error, natural disasters or other catastrophic events, security breaches or a result of any other issues, whether accidental or willful, could harm our relationships with clients and cause our revenue to decrease and our expenses to increase. Also, in the event of damage or interruption, our insurance policies may not adequately compensate us for any losses that we may incur. These factors, in turn, could further reduce our revenue, subject us to liability, cause us to pay liquidated damages, issue credits or cause clients not to renew their agreements with us, any of which could materially adversely affect our business.

We may experience fluctuations in our results of operations due to a number of factors, including the sales cycles for our products and services, which makes our future results difficult to predict and could cause our results of operations to fall below expectations or our guidance.

Our results of operations have fluctuated in the past and are expected to fluctuate in the future due to a variety of factors, many of which are outside of our control. Accordingly, the results of any one quarter should not be relied upon as an indication of future performance. Historically, our sales cycle has been tied to the renewal dates for our clients’ existing and prior vendor support agreements for the products that we support. Because our clients make support vendor selection decisions in conjunction with the renewal of their existing support agreements with Oracle and SAP, among other enterprise software vendors, we have experienced an increase in business activity during the periods in which those agreements are up for renewal. Because we have introduced and intend to continue to introduce products and services for additional software products that do not follow the same renewal timeline or pattern, our past results may not be indicative of our future performance, and comparing our results of operations on a period-to-period basis may not be meaningful. Also, if we are unable to engage a

50

potential client before its renewal date for software support services in a particular year, it will likely be at least another year before we would have the opportunity to engage that potential client again, given that such potential client likely had to renew or extend its existing support agreement for at least an additional year’s worth of service with its existing support provider. Furthermore, our existing clients generally renew their agreements with us at or near the end of each calendar year, so we have also experienced and expect to continue to experience heavier renewal rates in the fourth quarter. In addition to the other risks described herein, factors that may affect our quarterly results of operations include the following:

•changes in spending on enterprise software products and services by our current or prospective clients;

•pricing of our products and services so that we are able to attract and retain clients;

•acquisition of new clients and increases of our existing clients’ use of our products and services;

•client renewal rates and the amounts for which agreements are renewed;

•budgeting cycles of our clients;

•the occurrence of catastrophic events that may disrupt our business, including the COVID-19 pandemic;

•changes in the competitive dynamics of our market, including consolidation among competitors or clients;

•the amount and timing of payment for operating expenses, particularly sales and marketing expenses and employee benefit expenses, as well as the debt service obligations under our Credit Facility;

•the amount and timing of non-cash expenses, including stock-based compensation and other non-cash charges;

•the amount and timing of costs associated with recruiting, training and integrating new employees;

•the amount and timing of cash collections from our clients;

•unforeseen costs and expenses related to the expansion of our business, operations, infrastructure and new products and services such as Application Management Services (AMS);

•the amount and timing of our legal costs, particularly related to our litigation with Oracle;

•changes in the levels of our capital expenditures; foreign currency exchange rate fluctuations; and

•general economic and political conditions in our global markets, including pandemic and other catastrophic conditions outside our control.

We may not be able to accurately forecast the amount and mix of future product and service subscriptions, revenue and expenses, and as a result, our results of operations may fall below our estimates or the expectations of securities analysts and investors. If our revenue or results of operations fall below the expectations of investors or securities analysts, or below any guidance we may provide, the price of our Common Stock could decline.

Our future liquidity and results of operations may be adversely affected by the timing of new orders, the level of client renewals and cash receipts from clients.

Due to the collection of cash from our clients before services are provided, our revenue is recognized over future periods when there are no corresponding cash receipts from such clients. Accordingly, our future liquidity depends upon the ability to continue to attract new clients and to enter into renewal arrangements with existing clients. If we experience a decline in orders from new clients or renewals from existing clients, our revenue may continue to increase while our liquidity and cash levels decline. Any such decline, however, will negatively affect our revenues in future quarters. Accordingly, the effect of declines in orders from new clients or renewals from existing clients may not be fully reflected in our results of operations and cash flows until future periods. Comparing our revenues and operating results on a period-to-period basis may not be meaningful, as it may not be an indicator of the future sufficiency of our cash and cash equivalents to meet our liquidity requirements. You should not rely on our past results as an indication of our future performance or liquidity.

We may be subject to additional obligations to collect and remit sales tax and other taxes, and we may be subject to tax liability, interest and/or penalties for past sales, which could adversely harm our business.

State, local and foreign jurisdictions have differing rules and regulations governing sales, use, value-added and other taxes, and these rules and regulations can be complex and are subject to varying interpretations that may change over time. In particular, the applicability of such taxes to our products and services in various jurisdictions is unclear. Further, these jurisdictions’ rules regarding tax nexus are complex and can vary significantly. As a result, we could face the possibility of tax assessments and audits, and our liability for these taxes and associated interest and penalties could exceed our original estimates. A successful assertion that we should be collecting additional sales, use, value-added or other taxes in those jurisdictions where we have not historically done so and in which we do not accrue for such taxes could result in substantial tax liabilities and related penalties for past sales, discourage clients from purchasing our products and services or otherwise harm our business and results of operations.

We may need to change our pricing models to compete successfully.

51

We currently offer our clients support services for a fee that is equal to a percentage of the annual fees charged by the enterprise software vendor, so changes in such vendors’ fee structures would impact the fees we would receive from our clients. If the enterprise software vendors offer deep discounts on certain services or lower prices generally, we may need to change our pricing models or suffer adverse effect on our results of operations. In addition, we have recently begun to offer new products and services and do not have substantial experience with pricing such products and services, so we may need to change our pricing models for these new products and services over time to ensure that we remain competitive and realize a return on our investment in developing these new products and services. If we do not adapt our pricing models as necessary or appropriate, our revenue could decrease and adversely affect our results of operations.

We may not be able to scale our business systems quickly enough to meet our clients’ growing needs, and if we are not able to grow efficiently, our results of operations could be harmed.

As enterprise software products become more advanced and complex, we will need to devote additional resources to innovating, improving and expanding our offerings to provide relevant products and services to our clients using these more advanced and complex products. In addition, we will need to appropriately scale our internal business systems and our global operations and client engagement teams to serve our growing client base, particularly as our client demographics expand over time. Any such expansion may be expensive and complex, requiring financial investments, management time and attention. Any failure of or delay in these efforts could adversely affect the quality or success of our services and negatively impact client satisfaction, resulting in potential decreased sales to new clients and possibly lower renewal rates by existing clients.

We could also face inefficiencies or operational failures as a result of our efforts to scale our infrastructure. There can be no assurance that the expansion and improvements to our infrastructure and systems will be fully or effectively implemented within budgets or on a timely basis, if at all. Any failure to efficiently scale our business could result in reduced revenue and adversely impact our operating margins and results of operations.

We have experienced significant growth resulting in changes to our organization and structure, which if not effectively managed, could have a negative impact on our business.

Our headcount and operations have grown in recent years. We increased the number of full-time employees from over 1,380 as of September 30, 2020 to over 1,590 as of September 30, 2021. We believe that our corporate culture has been a critical component of our success. We have invested substantial time and resources in building our team and nurturing our culture. As we expand our business and operate as a public company, we may find it difficult to maintain our corporate culture while managing our employee growth. Any failure to manage our anticipated growth and related organizational changes in a manner that preserves our culture could negatively impact future growth and achievement of our business objectives.

In addition, our organizational structure has become more complex as a result of our significant growth. We have added employees and may need to continue to scale and adapt our operational, financial and management controls, as well as our reporting systems and procedures. The expansion of our systems and infrastructure may require us to commit additional financial, operational and management resources before our revenue increases and without any assurances that our revenue will increase. If we fail to successfully manage our growth, we likely will be unable to successfully execute our business strategy, which could have a negative impact on our business, financial condition and results of operations.

Because our long-term growth strategy involves further expansion of our sales to clients outside the United States, our business will be susceptible to risks associated with global operations.

A significant component of our growth strategy involves the further expansion of our operations and client base outside the United States. Accordingly, our international revenue grew from $34.3 million for the three months ended September 30, 2020 to $45.2 million for the three months ended September 30, 2021, an increase of $10.8 million or 31%. We currently have subsidiaries outside of the United States in Australia, Brazil, Canada, UAE (Dubai), France, Germany, Hong Kong, India, Israel, Japan, Korea, Malaysia, Mexico, Netherlands, New Zealand, Poland, Singapore, Sweden, Taiwan and the United Kingdom, which focus primarily on selling our services in those regions.

In the future, we may expand to other locations outside of the United States. Our current global operations and future initiatives will involve a variety of risks, including:

•changes in a specific country’s or region’s political or economic conditions;

•the occurrence of catastrophic events that may disrupt our business;

•changes in regulatory requirements, taxes or trade laws such as the United Kingdom’s exit from the European Union (“Brexit”);

52

•more stringent regulations relating to data security, such as where and how data can be housed, accessed and used, and the unauthorized use of, or access to, commercial and personal information;

•differing labor regulations, especially in countries and geographies where labor laws are more advantageous to employees as compared to the United States, including deemed hourly wage and overtime regulations;

•challenges inherent in efficiently managing an increased number of employees over large geographic distances, including the need to implement appropriate systems, policies, benefits and compliance programs as well as hire and retain local management, sales, marketing and support personnel, along with the ability to recapture costs to open up new geographies;

•difficulties in managing a business in new markets with diverse cultures, languages, customs, legal systems, alternative dispute systems and regulatory systems;

•increased logistics, travel, real estate, infrastructure and legal compliance costs associated with global operations;

•currency exchange rate fluctuations and the resulting effect on our revenue and expenses, and the cost and risk of entering into hedging transactions if we choose to do so in the future;

•limitations on our ability to reinvest earnings from operations in one country to fund the capital needs of our operations in other countries;

•laws and business practices favoring local competitors or general preferences for local vendors;

•limited or insufficient intellectual property protection;

•political instability or terrorist activities;

•exposure to liabilities under anti-corruption and anti-money laundering laws, including the U.S. Foreign Corrupt Practices Act and similar laws and regulations in other jurisdictions; and

•adverse tax burdens and foreign exchange controls that could make it difficult to repatriate earnings and cash.

Our limited experience in operating our business globally and the unique challenges of each new geography increase the risk that any potential future expansion efforts that we may undertake will not be successful. If we invest substantial time and resources to expand our global operations and are unable to do so successfully and in a timely manner, our business and results of operations will be adversely affected.

If we fail to forecast our revenue accurately, or if we fail to match our expenditures with corresponding revenue, our results of operations and liquidity could be adversely affected.

Because our recent growth has resulted in the rapid expansion of our business, we do not have a long history upon which to base forecasts of future operating revenue. In addition, the variability of the sales cycle for the evaluation and implementation of our products and services, which typically has been six to twelve months once a client is engaged, may also cause us to experience a delay between increasing operating expenses for such sales efforts, and the generation of corresponding revenue. Accordingly, we may be unable to prepare accurate internal financial forecasts or replace anticipated revenue that we do not receive as a result of delays arising from these factors. As a result, our results of operations and liquidity in future reporting periods may be significantly below the expectations of the public market, securities analysts or investors, which could negatively impact the price of our Common Stock.

Consolidation in our target sales markets is continuing at a rapid pace, which could harm our business in the event that our clients are acquired and their agreements are terminated, or not renewed or extended.

Consolidation among companies in our target sales markets has been robust in recent years, and this trend poses a risk for us. If such consolidation continues, we expect that some of the acquiring companies will terminate, renegotiate and elect not to renew our agreements with the clients they acquire, which may have an adverse effect on our business and results of operations.

If there is a widespread shift by clients or potential clients to enterprise software vendors, products and releases for which we do not provide software products or services, our business would be adversely impacted.

Our current revenue is primarily derived from the provision of support services for Oracle and SAP enterprise software products. If other enterprise software vendors, products and releases emerge to take substantial market share from current Oracle and SAP products and releases we support, and we do not provide products or services for such vendors, products or releases, demand for our products and services may decline or our products and services may become obsolete. Developing new products and services to address different enterprise software vendors, products and releases could take a substantial investment of time and financial resources, and we cannot guarantee that we will be successful. If fewer clients use enterprise software products for which we provide products and services, and we are not able to provide services for new vendors, products or releases, our business may be adversely impacted.

53

Delayed or unsuccessful investment in new technology, products, services and markets may harm our financial condition and results of operations.

We plan to continue investing resources in research and development in order to enhance our current product and service offerings, and other new offerings that will appeal to clients and potential clients, for example, our partnership with Salesforce to support SaaS solutions and our Application Management Services (AMS) for SAP and Oracle products. The development of new product and service offerings could divert the attention of our management and our employees from the day-to-day operations of our business, the new product and service offerings may not generate sufficient revenue to offset the increased research and development expenses, they may not generate gross profit margins consistent with our current margins, and if we are not successful in implementing the new product and service offerings, we may need to write off the value of our investment. Also, these new product and service offerings may be in markets that are more competitive than markets for our existing product and service offerings, making it more difficult to introduce them to clients and potential clients effectively or provide them profitably. Furthermore, if our new or modified products, services or technology do not work as intended, are not responsive to client needs or industry or regulatory changes, are not appropriately timed with market opportunity, or are not effectively brought to market, we may lose existing and prospective clients or related opportunities, in which case our financial condition and results of operations may be adversely impacted.

If our data security measures are compromised or unauthorized access to or misuse of client data occurs, our services may be perceived as not being secure, clients may curtail or cease their use of our services, our reputation may be harmed, and we may incur significant liabilities. Further, we are subject to governmental and other legal obligations related to privacy, and our actual or perceived failure to comply with such obligations could harm our business.

Our services sometimes involve accessing, processing, sharing, using, storing and transmitting proprietary information and protected data of our clients. We rely on proprietary and commercially available systems, software, tools and monitoring, as well as other processes, to provide security for accessing, processing, sharing, using, storing and transmitting such information and data. If our security measures are compromised as a result of third-party action, employee, vendor or client error, malfeasance, stolen or fraudulently obtained log-in credentials or otherwise, our reputation could be damaged, our business and our clients may be harmed, and we could incur significant liabilities. In particular, cyberattacks, such as a recent phishing incident of which we were a victim, continue to increase in frequency and in magnitude generally, and these threats are being driven by a variety of sources, including nation-state sponsored espionage and hacking activities, industrial espionage, organized crime, sophisticated organizations and hacking groups and individuals. In addition, if the security measures of our clients are compromised, even without any actual compromise of our own systems or security measures, we may face negative publicity or reputational harm if our clients or anyone else incorrectly attributes the blame for such security breaches to us, our products and services, or our systems. We may also be responsible for repairing any damage caused to our clients’ systems that we support, and we may not be able to make such repairs in a timely manner or at all. We may be unable to anticipate or prevent techniques used to obtain unauthorized access or to sabotage systems because they change frequently and generally are not detected until after an incident has occurred. As we increase our client base and our brand becomes more widely known and recognized, we may become more of a target for third parties seeking to compromise our systems or security measures or gain unauthorized access to our clients’ proprietary information and protected data as was the case in a recent phishing incident, which we believe did not significantly impact our business or client relationships as no proprietary client information was accessed.

Many governments have enacted laws requiring companies to notify individuals of data security incidents involving certain types of personal data. In addition, some of our clients contractually require notification of any data security compromise. In the event of a data security compromise, we may have difficulty timely complying with notification requirements that are unreasonably short or burdensome. Security compromises experienced by our clients, by our competitors or by us may lead to public disclosures, which may lead to widespread negative publicity. Any data security compromise in our industry, whether actual or perceived, could harm our reputation, erode client confidence in the effectiveness of our security measures, negatively impact our ability to attract new clients, cause existing clients to elect not to renew their agreements with us, or subject us to third party lawsuits, government investigations, regulatory fines or other action or liability, all or any of which could materially and adversely affect our business, financial condition and results of operations.

We cannot assure you that any limitations of liability provisions in our contracts for a security breach would be enforceable or adequate or would otherwise protect us from any such liabilities or damages with respect to any particular claim. We also cannot be sure that our existing general liability insurance coverage and coverage for errors or omissions will continue to be available on acceptable terms or will be available in sufficient amounts to cover one or more claims, or that the insurer will not deny coverage as to any future claim. The successful assertion of one or more claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of

54

substantial deductible or co-insurance requirements, could have a material adverse effect on our business, financial condition and results of operations.

As a global company, we are subject to the laws and regulations of numerous jurisdictions worldwide regarding accessing, processing, sharing, using, storing, transmitting, disclosure and protection of personal data, the scope of which are constantly changing, subject to differing interpretation, and may be inconsistent between countries or in conflict with other laws, legal obligations or industry standards. For example, the General Data Protection Regulation (GDPR), in effect in the European Union (EU), creates a broad range of new compliance requirements and imposes substantial penalties for non-compliance, including possible fines of up to 4% of global annual revenue for the preceding financial year or €20 million (whichever is higher) for the most serious infringements. We are also subject to certain requirements of the California Consumer Privacy Act of 2018, effective on January 1, 2020, which adds to the range of privacy-related compliance requirements. We generally comply with industry standards and strive to comply with all applicable laws and other legal obligations relating to privacy and data protection, but it is possible that these laws and legal obligations may be interpreted and applied in a manner that is inconsistent from one jurisdiction to another and may conflict with industry standards or our practices or may be mandated at a pace that exceeds our ability to comply. Compliance with such laws and other legal obligations may be costly and may require us to modify our business practices, which could adversely affect our business and profitability. Any failure or perceived failure by us to comply with these laws, policies or other obligations may result in governmental enforcement actions or litigation against us, potential fines and other expenses related to such governmental actions, result in an order requiring that we change our data practices or business practices, and could cause our clients to lose trust in us, any of which could have an adverse effect on our business.

If our products and services fail due to defects or similar problems, and if we fail to correct any defect or other software problems, we could lose clients, become subject to service performance or warranty claims or incur significant costs.

Our products and services and the systems infrastructure necessary for the successful delivery of our products and services to clients are inherently complex and may contain material defects or errors. We have from time to time found defects in our products and services and may discover additional defects in the future. In particular, we have developed our own tools and processes to deliver comprehensive tax, legal and regulatory updates tailored for each client, which we endeavor to deliver to our clients in a shorter timeframe than our competitors, which may result in an increased risk of material defects or errors. We may not be able to detect and correct defects or errors before clients begin to use our products and services. Consequently, defects or errors may be discovered after our products and services are provided and used. These defects or errors could also cause inaccuracies in the data we collect and process for our clients, or even the loss, damage or inadvertent release of such confidential data. Even if we are able to implement fixes or corrections to our tax, legal and regulatory updates in a timely manner, any history of defects or inaccuracies in the data we collect for our clients, or the loss, damage or inadvertent release of such confidential data could cause our reputation to be harmed, and clients may elect not to renew, extend or expand their agreements with us and subject us to service performance credits, warranty or other claims or increased insurance costs. The costs associated with any material defects or errors in our products and services or other performance problems may be substantial and could materially adversely affect our financial condition and results of operations.

We are a currently a smaller reporting company within the meaning of the Securities Act, and if we take advantage of certain exemptions from reporting and disclosure requirements available to smaller reporting companies that are also accelerated filers within the meaning of the Securities Act, this could make our common stock less attractive to investors.

While we are an accelerated filer, we are also a smaller reporting company (“SRC”), which allows us to take advantage of certain exemptions from various reporting requirements that are applicable to other accelerated filers that are not SRCs, including reduced disclosure obligations regarding executive compensation in our Annual Report and our periodic reports and proxy statements. Such reporting status will continue for reported periods until the end of 2021.

As a result, our stockholders may not have access to certain information they may deem important. We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the market prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the market prices of our securities may be more volatile.

If we are not able to maintain an effective system of internal control over financial reporting, current and potential investors could lose confidence in our financial reporting, which could harm our business and have an adverse effect on our stock price.

55

We have had material weaknesses in our internal control over financial reporting. As described above under Part I, Item 4 of this Report, our management concluded that we had a material weakness in our internal control over financial reporting as of March 31, 2021 and December 31, 2020, due to inadequate controls in relation to improperly applying the accounting guidance for our GP Sponsor Private Placement Warrants, recognizing the warrants as equity instead of as a liability.

In addition, in connection with the audit of our consolidated financial statements for the years ended December 31, 2016 and 2015, our management determined that we had material weaknesses in our internal control over financial reporting related to the following:

•inadequate controls in relation to recognition of liabilities for embedded derivatives in connection with our former credit facility, which was repaid in 2018 (2016);

•inadequate controls in relation to revenue recognition from support service sales contracts whereby we incorrectly accounted for multi-year, non-cancelable support service sales contracts as a single delivery arrangement and incorrectly accounting for revenue for certain non-standard contract provisions (2015 and 2016);

•various sales tax control matters related to manual processes and determination of tax liabilities in certain states (2015); and

•inadequate controls for accrual of loss contingencies related to our litigation with Oracle (2015).

As described below and in Part I, Item 4 of this Report, we remediated the material weakness in relation to the accounting for our GP Sponsor Private Placement Warrants. We previously remediated the remaining material weaknesses described above during the years ended December 31, 2017 and 2016; however, we cannot provide assurance that material weaknesses in our internal control over financial reporting will not be identified in the future.

With respect to controls over revenue accounting procedures, we intend to continue to work on automating our processes, especially around the new FASB revenue accounting standard, as well as to continue to enhance our review processes around new and renewal contracts. In addition, we are required to have our independent public accounting firm attest to and report on management’s assessment of the effectiveness of our internal control over financial reporting. If we are unable to conclude that we have effective internal control over financial reporting, or if our independent auditors are unable to provide us with an attestation and an unqualified report as to the effectiveness of our internal control over financial reporting, investors could lose confidence in the reliability of our financial statements, which could result in a decrease in the value of our securities. For further information regarding our controls and procedures, see Part I, Item 4 of this Report.

Economic uncertainties or downturns in the general economy or the industries in which our clients operate could disproportionately affect the demand for our products and services and negatively impact our results of operations.

General worldwide economic conditions have experienced significant fluctuations in recent years, and market volatility and uncertainty remain widespread, with the expectation that inflation, other economic challenges and possible recession will be exacerbated for an extended period in the wake of the COVID-19 pandemic. As a result, we and our clients find it extremely difficult to accurately forecast and plan future business activities. In addition, these conditions could cause our clients or prospective clients to reduce their IT budgets, which could decrease corporate spending on our products and services, resulting in delayed and lengthened sales cycles, a decrease in new client acquisition and loss of clients. Furthermore, during challenging economic times, our clients may face issues with their cash flows and in gaining timely access to sufficient credit or obtaining credit on reasonable terms, which could impair their ability to make timely payments to us, impact client renewal rates and adversely affect our revenue. If such conditions occur, we may be required to increase our reserves, allowances for doubtful accounts and write-offs of accounts receivable, and our results of operations would be harmed. We cannot predict the timing, strength or duration of any economic slowdown or recovery, whether global, regional or within specific markets. If the conditions of the general economy or markets in which we operate worsen, our business could be harmed. In addition, even if the overall economy improves, the market for our products and services may not experience growth. Moreover, recent events, including Brexit, change in U.S. trade policies and responsive changes in policy by foreign jurisdictions, governmental and multinational organizations’ responses to the COVID-19 pandemic and similar geopolitical developments and uncertainty in the European Union and elsewhere have increased levels of political and economic unpredictability globally, and may increase the volatility of global financial markets and the global and regional economies.

Catastrophic events may disrupt our business.

We rely heavily on our network infrastructure and information technology systems for our business operations. A disruption or failure of these systems in the event of online attack, earthquake, fire, terrorist attack, power loss, telecommunications failure, extreme weather conditions (such as hurricanes, wildfires or floods) or other catastrophic event

56

could cause system interruptions, delays in accessing our service, reputational harm, loss of critical data or could prevent us from providing our products and services to our clients. In addition, several of our employee groups reside in areas particularly susceptible to earthquakes, such as the San Francisco Bay Area and Japan, and a major earthquake or other catastrophic event could affect our employees, who may not be able to access our systems, or otherwise continue to provide our services to our clients. A catastrophic event that results in the destruction or disruption of our data centers, or our network infrastructure or information technology systems, or access to our systems could affect our ability to conduct normal business operations and adversely affect our business, financial condition and results of operations. Additionally, the emergence or spread of a pandemic or other widespread health emergency (or concerns over and response to the possibility of such an emergency), including COVID-19, that causes any of our employee groups to become ill, quarantined or otherwise unable to work and/or travel due to health reasons or governmental or client corporate restrictions, or causes our clients to have ill or logistically restricted workforces, or who choose to cease or delay meetings with us or decisions regarding engaging our services could adversely affect our business, financial condition and results of operations.

If we fail to enhance our brand, our ability to expand our client base will be impaired and our financial condition may suffer.

We believe that our development of the Rimini Street brand is critical to achieving widespread awareness of our products and services, and as a result, is important to attracting new clients and maintaining existing clients. We also believe that the importance of brand recognition will increase as competition in our market increases. Successful promotion of our brand will depend largely on the effectiveness of our marketing efforts and on our ability to provide reliable products and services at competitive prices, as well as the outcome of our ongoing litigation with Oracle. Brand promotion activities may not yield increased revenue, and even if they do, any increased revenue may not offset the expenses we incurred in building our brand. If we fail to successfully promote and maintain our brand, our business could be adversely impacted.

If we fail to adequately protect our proprietary rights, our competitive position could be impaired and we may lose valuable assets, experience reduced revenue and incur costly litigation to protect our rights.

Our success depends, in part, upon protecting our proprietary products, services, knowledge, software tools and processes. We rely on a combination of copyrights, trademarks, service marks, trade secret laws and contractual restrictions to establish and protect our proprietary rights. However, the steps we take to protect our intellectual property may be inadequate. We will not be able to protect our intellectual property if we are unable to enforce our rights or if we do not detect unauthorized use of our intellectual property. Any of our copyrights, trademarks, service marks, trade secret rights or other intellectual property rights may be challenged by others or invalidated through administrative process or litigation. Furthermore, legal standards relating to the validity, enforceability and scope of protection of intellectual property rights are uncertain. Despite our precautions, it may be possible for unauthorized third parties to copy or use information that we regard as proprietary to create products and services that compete with ours. In addition, the laws of some countries do not protect proprietary rights to the same extent as the laws of the United States. To the extent we expand our global activities, our exposure to unauthorized copying and use of our processes and software tools may increase.

We enter into confidentiality and invention assignment agreements with our employees and consultants and enter into confidentiality agreements with the parties with whom we have strategic relationships and business alliances. No assurance can be given that these agreements will be effective in controlling access to and distribution of our proprietary intellectual property. Further, these agreements may not prevent our competitors from independently developing products and services that are substantially equivalent or superior to our products and services.

Although we have been successful in the past, there can be no assurance that we will receive any additional patent protection for our proprietary software tools and processes. Even if we were to receive patent protection, those patent rights could be invalidated at a later date. Furthermore, any such patent rights may not adequately protect our processes, our software tools or prevent others from designing around our patent claims.

To protect our intellectual property rights, we may be required to spend significant resources to monitor and protect these rights. Litigation may be necessary in the future to enforce our intellectual property rights and to protect our trade secrets. Litigation brought to protect and enforce our intellectual property rights could be costly, time consuming and distracting to management and could result in the impairment or loss of portions of our intellectual property. Furthermore, our efforts to enforce our intellectual property rights may be met with defenses, counterclaims and countersuits attacking the validity and enforceability of our intellectual property rights. Our inability to protect our products, processes and software tools against unauthorized copying or use, as well as any costly litigation or diversion of our management’s attention and resources, could delay further sales or the implementation of our products and services, impair the functionality of our products and services,

57

delay introductions of new products and services, result in our substituting inferior or more costly technologies into our products and services, or injure our reputation.

We may not be able to use a significant portion of our net operating loss carryforwards, which could adversely affect our profitability.

We have U.S. federal and state net operating loss carryforwards due to prior period losses, which could expire unused and be unavailable to offset future income tax liabilities, which could adversely affect our profitability.

In addition, under Section 382 of the Internal Revenue Code of 1986, as amended, our ability to utilize net operating loss carryforwards or other tax attributes in any taxable year may be limited if we experience an “ownership change.” A Section 382 “ownership change” generally occurs if one or more stockholders or groups of stockholders who own at least 5% of our stock increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Similar rules may apply under state tax laws in the United States. While our ownership changes to date have not triggered any limitations under Section 382, it is possible that any future ownership changes or issuances of our capital stock, could have a material effect on the use of our net operating loss carryforwards or other tax attributes, which could adversely affect our profitability.

We are a multinational organization faced with increasingly complex tax issues in many jurisdictions, and we could be obligated to pay additional taxes in various jurisdictions.

As a multinational organization, we may be subject to taxation in several jurisdictions worldwide with increasingly complex tax laws, the application of which can be uncertain. Significant judgment is required in determining our worldwide provision for income taxes. In the ordinary course of our business, there are many transactions and calculations where the ultimate tax determination is uncertain. As such, our results may differ from previous estimates and may materially affect our financial position.

The amount of taxes we pay in jurisdictions in which we operate could increase substantially as a result of changes in the applicable tax principles, including increased tax rates, new tax laws or revised interpretations of existing tax laws and precedents, which could have a material adverse effect on our liquidity and results of operations. In addition, the authorities in these jurisdictions could review our tax returns and impose additional tax, interest and penalties, and the authorities could claim that various withholding requirements apply to us or our subsidiaries or assert that benefits of tax treaties are not available to us or our subsidiaries, any of which could have a material impact on us and the results of our operations.

Future acquisitions, strategic investments, partnerships or alliances could be difficult to identify and integrate, divert the attention of management, disrupt our business, dilute stockholder value and adversely affect our financial condition and results of operations.

We may in the future seek to acquire or invest in businesses, products or technologies that we believe could complement or expand our services, enhance our technical capabilities or otherwise offer growth opportunities. The pursuit of potential acquisitions may divert the attention of management and cause us to incur various expenses in identifying, investigating and pursuing suitable acquisitions, whether or not the acquisition purchases are completed. If we acquire businesses, we may not be able to integrate successfully the acquired personnel, operations and technologies, or effectively manage the combined business following the acquisition. We may not be able to find and identify desirable acquisition targets or be successful in entering into an agreement with any particular target or obtain adequate financing to complete such acquisitions. Acquisitions could also result in dilutive issuances of equity securities or the incurrence of debt, which could adversely affect our results of operations. In addition, if an acquired business fails to meet our expectations, our business, financial condition and results of operations may be adversely affected.

Changes in financial accounting standards or practices may cause adverse, unexpected financial reporting fluctuations and affect our reported results of operations.

Generally accepted accounting principles in the United States are subject to interpretation by the FASB, the SEC and various bodies formed to promulgate and interpret appropriate accounting principles. A change in accounting standards or practices can have a significant effect on our reported results and may even affect our reporting of transactions completed before the change is effective. New accounting pronouncements and varying interpretations of accounting pronouncements have occurred and will likely occur in the future. Changes to existing rules or the questioning of current practices may adversely affect our reported financial results or the way we conduct our business.

58

From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by us as of the specified effective date.

Risks Related to Capitalization Matters and Corporate Governance

Risks Related to our Indebtedness and Securities

Our level of indebtedness and any future indebtedness we may incur may limit our operational and financing flexibility and negatively impact our business.

On September 30, 2021, our outstanding indebtedness under the Credit Facility and finance leases totaled $89.6 million. We may incur substantial additional indebtedness in the future. Our Credit Facility and other debt instruments we may enter into in the future may significantly impact our business, including the following:

•our ability to obtain additional financing for working capital, capital expenditures, acquisitions or general corporate purposes may be impaired;

•we are required to use a significant portion of our cash flows from operations to pay principal and interest on our indebtedness, which will reduce the funds available to us for operations and other purposes;

•our level of indebtedness could place us at a competitive disadvantage compared to our competitors that may have proportionately less debt;

•our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate may be limited; and

•our level of indebtedness may make us more vulnerable to economic downturns and adverse developments in our business.

We expect to depend primarily on cash generated by our operations for funds to pay our expenses and any amounts due under our Credit Facility and any other indebtedness we may incur. Our ability to make these payments depends on our future performance, which will be affected by financial, business, economic and other factors, many of which we cannot control, including the impacts of the COVID-19 pandemic. Our business may not generate sufficient cash flows from operations in the future and our currently anticipated growth in net sales and cash flows may not be realized, either or both of which could result in our being unable to repay indebtedness or to fund other liquidity needs. If we do not generate adequate resources, we may be required to refinance all or part of our then existing debt, sell assets or borrow more money, in each case on terms that may not be acceptable to us. In addition, the terms of existing or future debt agreements, including our existing Credit Facility, may restrict us from adopting some or any of these alternatives. Our inability to incur additional debt in the future could also delay or prevent a change in control of our Company, make some transactions more difficult and impose additional financial or other covenants on us. In addition, any significant levels of indebtedness in the future could make us more vulnerable to economic downturns and adverse developments in our business. Our current indebtedness and any inability to pay our debt obligations as they come due or an inability to incur additional debt could adversely affect our business and results of operations.

The terms of our Credit Facility impose operating and financial restrictions on us.

Our Credit Facility contains certain restrictions and covenants that generally limit our ability to, among other things, create liens on assets, sell assets, engage in mergers or consolidations, make loans or investments, incur additional indebtedness, engage in certain transactions with affiliates, incur certain material ERISA or pension liabilities and pay dividends or repurchase capital stock and in each case, subject to certain exceptions set forth in the agreement underlying the Credit Facility. Our Credit Facility may limit our ability to engage in these types of transactions even if we believe that a specific transaction would contribute to our future growth or improve our operating results. Our Credit Facility also requires us to achieve specified financial and operating results and maintain compliance with specified financial ratios, including as a condition to accessing additional amounts available for borrowing. As of the date of filing this Report, we were in compliance with each of these financial covenants. Our ability to comply with these provisions may be affected by events beyond our control. A breach of any of these financial covenants or our inability to comply with required financial ratios in our Credit Facility could result in a default under the Credit Facility in which case the lenders would have the right to declare all borrowings, which includes any principal amount outstanding, together with all accrued, unpaid interest and other amounts owing in respect thereof, to be immediately due and payable. If we are unable to repay all borrowings when due, whether at maturity or if declared due and payable following a default, the lenders would have the right to proceed against the collateral granted to secure the indebtedness. If we breach these covenants or fail to comply with the terms of the Credit Facility and the lenders accelerate the amounts outstanding under the Credit Facility, our business and results of operations would be adversely

59

affected. Additionally, we may need to refinance our Credit Facility at maturity or upon default, and future financing may not be available on acceptable terms, or at all.

Our variable rate indebtedness subjects us to interest rate risk, which could cause our indebtedness service obligations to increase significantly.

As a result of market interest rate fluctuations, interest rates under our Credit Facility or other variable rate indebtedness we may incur in the future could be higher or lower than current levels. If interest rates increase, our debt service obligations under our Credit Facility would increase even though the amounts borrowed remain the same, and our net income and cash flows, including cash available for servicing our indebtedness, would correspondingly decrease. In addition, a transition away from LIBOR as a benchmark for establishing the applicable interest rate may affect the cost of servicing our debt under the Credit Facility. In July 2017, the Financial Conduct Authority of the U.K. announced that it plans to phase out LIBOR by the end of calendar year 2021. On March 5, 2021, however, the ICE Benchmark Administration, the administrator of LIBOR, announced its intention to cease the publication of all settings of non-U.S. dollar LIBOR and only the one-week and two-month U.S. dollar LIBOR settings on December 31, 2021, with the publication of the remaining U.S. dollar LIBOR settings being discontinued after September 30, 2023. It is unclear if LIBOR will cease to exist at that time or if new methods of calculating LIBOR will be established. Our borrowing arrangements provide for alternative base rates, but such alternative base rates may or may not be related to LIBOR, and the consequences of the phase out of LIBOR cannot be entirely predicted at this time. For example, if any alternative base rate or means of calculating interest with respect to our outstanding variable rate indebtedness leads to an increase in the interest rates charged, it could result in an increase in the cost of such indebtedness, impact our ability to refinance some or all of our existing indebtedness or otherwise have a material adverse impact on our business, financial condition and results of operations.

The price of our Common Stock, warrants and units may be volatile.

The price of our Common Stock, warrants and units may fluctuate due to a variety of factors, including:

•developments in our continuing litigation with Oracle;

•our ability to effectively service our outstanding debt obligations under our Credit Facility;

•any future equity or additional debt financing or other capitalization optimization transactions by us;

•the announcement of new products or product enhancements by us or our competitors;

•developments concerning intellectual property rights;

•changes in legal, regulatory and enforcement frameworks impacting our products;

•variations in our and our competitors’ results of operations;

•the addition or departure of key personnel;

•announcements by us or our competitors of acquisitions, investments or strategic alliances;

•actual or anticipated fluctuations in our quarterly and annual results and those of other public companies in our industry;

•macroeconomic conditions and the economic impact of the COVID-19 pandemic;

•the level and changes in our year-over-year revenue growth rate;

•the failure of securities analysts to publish research about us, or shortfalls in our results of operations compared to levels forecast by securities analysts;

•any delisting of our Common Stock from Nasdaq Global Market due to any failure to meet listing requirements;

•our Public Warrants and units are quoted on the OTC Pink Current Information Marketplace which is a significantly more limited market than Nasdaq; and

•the general state of securities markets.

These market and industry factors may materially reduce the market price of our Common Stock, regardless of our operating performance.

Certain of our common stockholders can exercise significant control, which could limit our stockholders’ ability to influence the outcome of key transactions, including a change of control.

Based on the number of shares of Common Stock outstanding as of September 30, 2021, two of our stockholders have aggregate voting power of 42.1% of our outstanding capital stock. As of July 20, 2021, (i) approximately 27.2% of our outstanding voting capital stock is held by Adams Street Partners LLC and certain Adams Street fund limited partnerships and (ii) approximately 14.9% of our outstanding voting capital stock is beneficially owned by our Chief Executive Officer. Our directors and officers or persons affiliated with our directors and officers have aggregate voting power of approximately 55.9% as of September 30, 2021.

60

As a result, these stockholders, acting together, have significant influence over all matters that require approval by our stockholders, including the election of directors and approval of significant corporate transactions. Corporate action might be taken even if other stockholders oppose them. This concentration of ownership might also have the effect of delaying or preventing a change of control of our company that other stockholders may view as beneficial.

Future resales of our Common Stock held by our significant stockholders may cause the market price of our Common Stock to drop significantly.

We have registered for resale the shares of Common Stock of certain of our stockholders with significant stockholdings. Any sale of large amounts of our Common Stock on the open market or in privately negotiated transactions could have the effect of increasing the volatility in the price of our Common Stock or putting significant downward pressure on the price of our Common Stock.

Any issuance of Common Stock upon the exercise of warrants will cause dilution to existing stockholders and may depress the market price of our Common Stock.

The issuance of Common Stock upon exercise of warrants may result in immediate and substantial dilution to the equity interests of our existing common stockholders and might result in dilution in the tangible net book value of a share of Common Stock, depending upon the price on which the additional shares are issued.

We do not currently intend to pay dividends on our Common Stock and, consequently, the ability to achieve a return on investment in our Common Stock will depend on appreciation in the price of our Common Stock.

We have not paid any cash dividends on our Common Stock to date. The payment of any cash dividends on our Common Stock will depend upon our revenue, earnings and financial condition from time to time. The payment of any dividends will be within the discretion of our Board of Directors, and our ability to do so is limited under the terms of our Credit Facility. It is presently expected that we will retain all earnings for use in our business operations and, accordingly, it is not expected that our Board of Directors will declare any dividends on our Common Stock in the foreseeable future. Our ability to declare dividends on our Common Stock may also be limited by the terms of future financing and other agreements entered into by us or our subsidiaries from time to time. Therefore, stockholders are not likely to receive any dividends on Common Stock for the foreseeable future and the success of an investment in shares of our Common Stock will depend upon any future appreciation in its value. There is no guarantee that shares of our Common Stock will appreciate in value or even maintain the price at which our stockholders have purchased their shares.

We may seek to engage in capital optimization transactions in the future in respect of our outstanding warrants or units, the result of which may also trigger some dilution and not achieve an improved capital structure.

Risks Relating to our Corporate Governance

The DGCL and our certificate of incorporation and bylaws contain certain provisions, including anti-takeover provisions that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable.

Our certificate of incorporation and bylaws, and Delaware General Corporation Law (the “DGCL”), contain provisions that could have the effect of rendering more difficult, delaying, or preventing an acquisition deemed undesirable by our Board of Directors and therefore depress the trading price of our Common Stock. These provisions could also make it difficult for stockholders to take certain actions, including electing directors who are not nominated by the current members of our Board of Directors or taking other corporate actions, including effecting changes in our management. Among other things, our certificate of incorporation and bylaws include provisions regarding:

•a classified Board of Directors with three-year staggered terms, which could delay the ability of stockholders to change the membership of a majority of our Board of Directors;

•the ability of our Board of Directors to issue shares of preferred stock, including “blank check” preferred stock, and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer, pursuant to which we have previously issued Series A Preferred Stock entitled to receive a liquidation preference and certain amounts in connection with a change of control of the Company and other similar extraordinary transactions;

•the limitation of the liability of, and the indemnification of our directors and officers;

61

•the exclusive right of our Board of Directors to elect a director to fill a vacancy created by the expansion of the Board of Directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our Board of Directors;

•the requirement that directors may only be removed from our Board of Directors for cause;

•a prohibition on common stockholder action by written consent, which forces common stockholder action to be taken at an annual or special meeting of stockholders and could delay the ability of stockholders to force consideration of a stockholder proposal or to take action, including the removal of directors;

•the requirement that a special meeting of stockholders may be called only by our Board of Directors, the chairperson of our Board of Directors, our chief executive officer or our president (in the absence of a chief executive officer), which could delay the ability of stockholders to force consideration of a proposal or to take action, including the removal of directors;

•controlling the procedures for the conduct and scheduling of Board of Directors and stockholder meetings;

•the requirement for the affirmative vote of holders of at least 66 2/3% of the voting power of all of the then outstanding shares of the voting stock, voting together as a single class, to amend, alter, change or repeal any provision of our certificate of incorporation or our bylaws, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in our Board of Directors and also may inhibit the ability of an acquirer to effect such amendments to facilitate an unsolicited takeover attempt;

•the ability of our Board of Directors to amend the bylaws, which may allow our Board of Directors to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the bylaws to facilitate an unsolicited takeover attempt; and

•advance notice procedures with which stockholders must comply to nominate candidates to our Board of Directors or to propose matters to be acted upon at a stockholders’ meeting, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in our Board of Directors and also may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of our company.

These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our Board of Directors or management.

In addition, as a Delaware corporation, we are subject to provisions of Delaware law, including Section 203 of the DGCL, which may prohibit certain stockholders holding 15% or more of our outstanding capital stock from engaging in certain business combinations with us for a specified period of time.

Any provision of our certificate of incorporation, bylaws or DGCL that has the effect of delaying or preventing a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our capital stock and could also affect the price that some investors are willing to pay for our Common Stock.

Our bylaws designate a state or federal court located within the State of Delaware as the sole and exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, stockholders or employees.

Our bylaws provide that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for:

•any derivative action or proceeding brought on behalf of us;

•any action asserting a claim of breach of a fiduciary duty owed to us or our stockholders by any of our directors, officers or other employees;

•any action asserting a claim against us or any of our directors, officers or employees arising out of or relating to any provision of the DGCL, our certificate of incorporation or our bylaws; or

•any action asserting a claim against us or any of our directors, officers, stockholders or employees that is governed by the internal affairs doctrine of the Court of Chancery.

This choice of forum provision may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, or other employees, which may discourage lawsuits with respect to such claims. Alternatively, if a court were to find the choice of forum provision to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations and financial condition. This choice of forum provision does not apply to suits brought to enforce any liability or duty created by the Securities Act or the Exchange Act.

General Risks

62

Failure to comply with laws and regulations applicable to our operations could harm our business.

Our business is subject to regulation by various global governmental agencies, including agencies responsible for monitoring and enforcing employment and labor laws, workplace safety, environmental laws, consumer protection laws, anti-bribery laws, import/export controls, securities laws and tax laws and regulations. For example, transfer of certain software outside of the United States or to certain persons is regulated by export controls. In addition, in response to the COVID-19 pandemic, federal, state, local and foreign governmental authorities have imposed, and may continue to impose, protocols and restrictions intended to contain the spread of the virus, including limitations on the size of gatherings, closures of work facilities, schools, public buildings and businesses, quarantines, lockdowns and travel restrictions. Such restrictions have disrupted and may continue to disrupt our business operations and limit our ability to perform critical functions.

In certain jurisdictions, these regulatory requirements may be more stringent than those in the United States. Noncompliance with applicable requirements could subject us to investigations, sanctions, enforcement actions, disgorgement of profits, fines, damages, civil and criminal penalties or injunctions and may result in our inability to provide certain products and services. If any governmental sanctions are imposed, or if we do not prevail in any possible civil or criminal litigation, or if clients made claims against us for compensation for such non-compliance, our business, financial condition and results of operations could be harmed. In addition, responding to any action will likely result in a significant diversion of management’s attention and resources and an increase in professional fees and costs. Enforcement actions and sanctions could further harm our business, financial condition and results of operations.

Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our Common Stock.

Securities research analysts may establish and publish their own periodic projections for us. These projections may vary widely and may not accurately predict the results we actually achieve. Our share price may decline if our actual results do not meet the projections of these securities research analysts. Similarly, if one or more of the analysts who write reports on us downgrades our stock or publishes inaccurate or unfavorable research about our business, our share price could decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly, our share price or trading volume could decline. If no additional analysts commence coverage of us, the market price and volume for our common shares could be adversely affected.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds.

    There were no sales of unregistered shares of the Company's securities during the quarter. The Company issued PIK Dividends as disclosed in Note 6 to the unaudited condensed financial statements included in Part I, Item I of this Report in satisfaction of the Company’s obligations as previously disclosed by the Company.

ITEM 3. Defaults Upon Senior Securities.

    None.

ITEM 4. Mine Safety Disclosures.

    Not applicable.

ITEM 5. Other Information.

    None.

63

ITEM 6. Exhibits.

    The following exhibits are filed as part of this Quarterly Report on Form 10-Q:

		Incorporated by Reference
Exhibit Number	Description	Form	File No.	Exhibit	Filing Date
3.1*	Amended and Restated Certificate of Incorporation of the Registrant	8-K	001-37397	3.1	October 16, 2017
3.2*	Amended and Restated Bylaws of the Registrant	8-K	001-37397	3.2	October 16, 2017
4.1*	Amended and Restated Investors’ Rights Agreement, dated October 31, 2016, between Rimini Street, Inc., a Nevada corporation, and certain holders of Rimini Street, Inc.’s, a Nevada corporation's, capital stock named therein	S-4	333-219101	4.7	June 30, 2017
31.1†	Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a)
31.2†	Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a)
32.1†	Certification of the Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350
32.2†	Certification of the Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350
101.INS†	XBRL Instance Document
101.SCH†	XBRL Taxonomy Extension Schema
101.CAL†	XBRL Taxonomy Extension Calculation Linkbase
101.DEF†	XBRL Taxonomy Extension Definition Linkbase
101.LAB†	XBRL Taxonomy Extension Label Linkbase
101.PRE†	XBRL Taxonomy Extension Presentation Linkbase
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

____________________

† Filed herewith.

* Previously filed and incorporated herein by reference.

64

SIGNATURES

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	RIMINI STREET, INC.
Date: November 3, 2021	/s/ Seth A. Ravin
	Name: Seth A. Ravin
	Title: Chief Executive Officer
	(Principal Executive Officer)

Date: November 3, 2021	/s/ Michael L. Perica
	Name: Michael L. Perica
	Title: Executive Vice President and Chief Financial Officer
	(Principal Financial Officer)

65

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Seth A. Ravin, certify that:

1.          I have reviewed this Quarterly Report on Form 10-Q of Rimini Street, Inc.;

2.          Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.          Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.          The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

(c)  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(d)  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.          The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)  All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: November 3, 2021 

/s/ Seth A. Ravin

Seth A. Ravin

Title: Chief Executive Officer

(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Michael L. Perica, certify that:

1.          I have reviewed this Quarterly Report on Form 10-Q of Rimini Street, Inc.;

2.          Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.          Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.          The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

(c)  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(d)  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.          The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)  All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: November 3, 2021 

/s/ Michael L. Perica

Michael L. Perica

Title: Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. 1350

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Seth A. Ravin, Chief Executive Officer of Rimini Street, Inc. (the “Company”), certify, that, to the best of my knowledge:

1.    The Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 3, 2021	By:	/s/ Seth A. Ravin
		Seth A. Ravin
		Title: Chief Executive Officer
		(Principal Executive Officer)

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. 1350

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Michael L. Perica, Executive Vice President and Chief Financial Officer of Rimini Street, Inc. (the “Company”), certify, that, to the best of my knowledge:

1.    The Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 3, 2021	By:	/s/ Michael L. Perica
		Michael L. Perica
		Title: Executive Vice President and Chief Financial Officer
		(Principal Financial Officer)

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover Page - shares shares in Thousands	9 Months Ended
	Sep. 30, 2021	Nov. 01, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-37397
Entity Registrant Name	Rimini Street, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	36-4880301
Entity Address, Address Line One	3993 Howard Hughes Parkway
Entity Address, Address Line Two	Suite 500
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89169
City Area Code	(702)
Local Phone Number	839-9671
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		86,790
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001635282
Current Fiscal Year End Date	--12-31
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	RMNI
Security Exchange Name	NASDAQ
Public Units
Document Information [Line Items]
Title of 12(b) Security	Public Units, each consisting of one share of CommonStock, $0.0001 par value, and one-half of one Warrant
Trading Symbol	RMNIU
Warrant
Document Information [Line Items]
Title of 12(b) Security	Warrants, exercisable for one share of Common Stock, $0.0001 par value
Trading Symbol	RMNIW

XML

Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 103,015	$ 87,575
Restricted cash	425	334
Accounts receivable, net of allowance of $566 and $723, respectively	76,258	117,937
Deferred contract costs, current	15,008	13,918
Prepaid expenses and other	17,041	13,456
Total current assets	211,747	233,220
Long-term assets:
Property and equipment, net of accumulated depreciation and amortization of $12,664 and $10,985, respectively	4,547	4,820
Operating lease right-of-use assets	15,023	17,521
Deferred contract costs, noncurrent	21,716	21,027
Deposits and other	1,940	1,476
Deferred income taxes, net	1,756	1,871
Total assets	256,729	279,935
Current liabilities:
Current maturities of long-term debt	3,670	0
Accounts payable	9,051	3,241
Accrued compensation, benefits and commissions	38,115	38,026
Other accrued liabilities	17,118	21,154
Operating lease liabilities, current	4,226	3,940
Deferred revenue, current	203,806	228,967
Total current liabilities	275,986	295,328
Long-term liabilities:
Long-term debt, net of current maturities	80,556	0
Deferred revenue, noncurrent	39,876	27,966
Operating lease liabilities, noncurrent	13,574	15,993
Accrued PIK dividends payable	0	1,193
Liability for redeemable warrants	5,145	2,122
Other long-term liabilities	1,756	2,539
Total liabilities	416,893	345,141
Commitments and contingencies (Note 9)
Redeemable Series A Preferred Stock:
Authorized 180 shares; issued and outstanding — shares and 155 shares, respectively. Liquidation preference of $0, net of discount of $0 and $154,911, net of discount of $17,057, respectively.	0	137,854
Stockholders’ deficit:
Preferred stock; $0.0001 par value. Authorized 99,820 shares (excluding 180 shares of Series A Preferred Stock); no other series has been designated	0	0
Common stock; $0.0001 par value. Authorized 1,000,000 shares; issued and outstanding 86,658 and 76,406 shares, respectively	9	8
Additional paid-in capital	139,505	98,258
Accumulated other comprehensive loss	(2,716)	(318)
Accumulated deficit	(295,846)	(301,008)
Treasury stock, at cost	(1,116)	0
Total stockholders' deficit	(160,164)	(203,060)
Total liabilities, redeemable preferred stock and stockholders' deficit	$ 256,729	$ 279,935

XML

Unaudited Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Allowance for accounts receivable	$ 566	$ 723
Accumulated depreciation and amortization	$ 12,664	$ 10,985
Redeemable preferred stock, shares authorized (shares)	180,000	180,000
Redeemable preferred stock, shares issued (shares)	0	155,000
Redeemable preferred stock, shares outstanding (shares)	0	155,000
Redeemable preferred stock, liquidation preference	$ 0	$ 154,911
Redeemable preferred stock, discount	$ 0	$ 17,057
Preferred stock, par value (USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (shares)	99,820,000	99,820,000
Common stock, par value (USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (shares)	86,658,000	76,406,000
Common stock, shares outstanding (shares)	86,658,000	76,406,000

XML

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenue	$ 95,642	$ 82,518	$ 275,151	$ 238,952
Cost of revenue	33,376	31,991	101,807	92,627
Gross profit	62,266	50,527	173,344	146,325
Operating expenses:
Sales and marketing	32,527	29,195	96,067	84,443
General and administrative	15,631	13,025	48,728	38,159
Impairment charge related to operating right of use assets	0	0	393	0
Litigation costs and related recoveries:
Professional fees and other costs of litigation	6,581	3,773	14,130	9,247
Insurance costs and recoveries, net	0	0	0	1,062
Litigation costs and related recoveries, net	6,581	3,773	14,130	10,309
Total operating expenses	54,739	45,993	159,318	132,911
Operating income	7,527	4,534	14,026	13,414
Non-operating income and (expenses):
Interest expense	(653)	(10)	(738)	(35)
Gain (loss) on change in fair value of redeemable warrants	(2,053)	303	(3,023)	(243)
Other income (expenses), net	(1,161)	54	(885)	(731)
Income before income taxes	3,660	4,881	9,380	12,405
Income tax expense	(1,729)	(1,272)	(4,218)	(3,327)
Net income	1,931	3,609	5,162	9,078
Other comprehensive income:
Foreign currency translation gain (loss)	(454)	520	(2,398)	109
Comprehensive income	1,477	4,129	2,764	9,187
Net loss attributable to common stockholders	$ (6,691)	$ (3,136)	$ (21,382)	$ (10,986)
Net loss per share attributable to common stockholders:
Basic (usd per share)	$ (0.08)	$ (0.04)	$ (0.26)	$ (0.16)
Diluted (usd per share)	$ (0.08)	$ (0.04)	$ (0.26)	$ (0.16)
Weighted average number of shares of Common Stock outstanding:
Weighted average number of shares outstanding, basic (shares)	86,189	72,377	83,449	69,521
Weighted average number of shares outstanding, diluted (shares)	86,189	72,377	83,449	69,521

XML

Unaudited Condensed Consolidated Statements of Stockholders' Deficit - USD ($) shares in Thousands, $ in Thousands	Total	Series A Preferred Stock	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Series A Preferred Stock	Accumulated Other Comprehensive Loss	Accumulated Deficit	March 2021 and August 2020 Offering Common Stock	March 2021 and August 2020 Offering Additional Paid-in Capital
Beginning balance (shares) at Dec. 31, 2019			67,503
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options for cash (shares)			1,540
Restricted stock units vested (shares)			1,064
Issuance of common stock (shares)								6,100
Treasury shares (in shares)			0
Ending balance (shares) at Sep. 30, 2020			76,207
Stockholders' deficit, beginning of period at Dec. 31, 2019	$ (223,321)		$ 7	$ 90,695		$ (1,429)	$ (312,594)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation expense				5,425
Exercise of stock options for cash				1,639
Issuance of Common Stock in March 2021 and August 2020 Offerings, net								$ 1	$ 25,103
Accretion related to redemption of Series A Preferred Stock		$ 0			$ 0
Make-whole dividends related to redemption of Series A Preferred Stock		0			0
Return on repurchase of Series A Preferred Stock shares		0			0
Accretion of discount on Series A Preferred Stock				(4,702)
Accrued dividends on Series A Preferred Stock:
Payable in cash				(11,817)
Payable in kind				(3,545)
Foreign currency translation gain (loss)	109					109
Net income	9,078						9,078
Treasury Stock							0
Stockholders' deficit, end of period at Sep. 30, 2020	(202,030)		$ 8	102,798		(1,320)	(303,516)
Beginning balance (shares) at Jun. 30, 2020			68,530
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options for cash (shares)			976
Restricted stock units vested (shares)			601
Issuance of common stock (shares)								6,100
Treasury shares (in shares)			0
Ending balance (shares) at Sep. 30, 2020			76,207
Stockholders' deficit, beginning of period at Jun. 30, 2020	(227,788)		$ 7	81,170		(1,840)	(307,125)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation expense				2,189
Exercise of stock options for cash				1,081
Issuance of Common Stock in March 2021 and August 2020 Offerings, net								$ 1	25,103
Accretion related to redemption of Series A Preferred Stock		0			0
Make-whole dividends related to redemption of Series A Preferred Stock		0			0
Return on repurchase of Series A Preferred Stock shares		0			0
Accretion of discount on Series A Preferred Stock				(1,587)
Accrued dividends on Series A Preferred Stock:
Payable in cash				(3,968)
Payable in kind				(1,190)
Foreign currency translation gain (loss)	520					520
Net income	3,609						3,609
Treasury Stock							0
Stockholders' deficit, end of period at Sep. 30, 2020	$ (202,030)		$ 8	102,798		(1,320)	(303,516)
Beginning balance (shares) at Dec. 31, 2020			76,406
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options for cash (shares)	1,184		1,183
Restricted stock units vested (shares)			1,456
Issuance of common stock (shares)								7,750
Treasury shares (in shares)			(137)
Ending balance (shares) at Sep. 30, 2021			86,658
Stockholders' deficit, beginning of period at Dec. 31, 2020	$ (203,060)		$ 8	98,258		(318)	(301,008)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation expense				7,104
Exercise of stock options for cash				5,046
Issuance of Common Stock in March 2021 and August 2020 Offerings, net								$ 1	55,641
Accretion related to redemption of Series A Preferred Stock		13,693			(13,693)
Make-whole dividends related to redemption of Series A Preferred Stock		(2,945)			(2,945)
Return on repurchase of Series A Preferred Stock shares		(38)			(38)
Accretion of discount on Series A Preferred Stock				(2,277)
Accrued dividends on Series A Preferred Stock:
Payable in cash				(5,839)
Payable in kind				(1,752)
Foreign currency translation gain (loss)	(2,398)					(2,398)
Net income	5,162						5,162
Treasury Stock							(1,116)
Stockholders' deficit, end of period at Sep. 30, 2021	(160,164)		$ 9	139,505		(2,716)	(295,846)
Beginning balance (shares) at Jun. 30, 2021			85,704
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options for cash (shares)			383
Restricted stock units vested (shares)			708
Issuance of common stock (shares)								0
Treasury shares (in shares)			(137)
Ending balance (shares) at Sep. 30, 2021			86,658
Stockholders' deficit, beginning of period at Jun. 30, 2021	(156,299)		$ 9	143,801		(2,262)	(297,777)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation expense				2,393
Exercise of stock options for cash				1,933
Issuance of Common Stock in March 2021 and August 2020 Offerings, net								$ 0	$ 0
Accretion related to redemption of Series A Preferred Stock		8,020			(8,020)
Make-whole dividends related to redemption of Series A Preferred Stock		(602)			(602)
Return on repurchase of Series A Preferred Stock shares		$ 0			$ 0
Accretion of discount on Series A Preferred Stock				0
Accrued dividends on Series A Preferred Stock:
Payable in cash				0
Payable in kind				0
Foreign currency translation gain (loss)	(454)					(454)
Net income	1,931						1,931
Treasury Stock							(1,116)
Stockholders' deficit, end of period at Sep. 30, 2021	$ (160,164)		$ 9	$ 139,505		$ (2,716)	$ (295,846)

XML

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 5,162	$ 9,078
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on change in fair value of redeemable warrants	3,023	243
Stock-based compensation expense	7,104	5,425
Depreciation and amortization	1,772	1,321
Accretion and amortization of debt discount and issuance costs	196	0
Deferred income taxes	1	(275)
Impairment charge related to operating right of use assets	393	0
Amortization and accretion related to operating right of use assets	4,625	4,628
Other	0	8
Changes in operating assets and liabilities:
Accounts receivable	41,021	42,367
Prepaid expenses, deposits and other	(4,289)	4,656
Deferred contract costs	(1,780)	(4,872)
Accounts payable	5,605	1,712
Accrued compensation, benefits, commissions and other liabilities	(3,940)	(3,632)
Deferred revenue	(11,079)	(28,826)
Net cash provided by operating activities	47,814	31,833
CASH FLOWS USED IN INVESTING ACTIVITIES:
Capital expenditures	(1,455)	(1,159)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds related to Common Stock issuances in March 2021 and August 2020 Offerings	56,965	25,657
Payments of professional fees related to Common Stock issuances in March 2021 and August 2020 Offerings	(1,296)	(253)
Net proceeds related	89,313	0
Debt issuance costs paid	(4,013)	0
Repayments of lines of credit	(1,125)	0
Payments to repurchase shares of Series A Preferred Stock	(156,753)	0
Payments of cash dividends on Series A Preferred Stock	(12,679)	(11,750)
Payments for treasury stock	(1,116)	0
Principal payments on capital leases	(330)	(170)
Proceeds from exercise of employee stock options	5,044	1,639
Net cash used in financing activities	(25,990)	15,123
Effect of foreign currency translation changes	(4,838)	(442)
Net change in cash, cash equivalents and restricted cash	15,531	45,355
Cash, cash equivalents and restricted cash at beginning of period	87,909	38,388
Cash, cash equivalents and restricted cash at end of period	103,440	83,743
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	524	37
Cash paid for income taxes	3,053	2,165
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Underwriter discounts and commissions	2,948	1,650
Underwriter expenses	1,050	143
Accrued professional fees related to the issuance of Common Stock	27	300
Accrued cash dividends	0	3,977
Accrued PIK dividends	0	1,182
Accretion of discount on Series A Preferred Stock	2,277	4,702
Issuance of Series A Preferred Stock for PIK dividends	2,891	3,498
Increase in payables for debt issuance costs	145	0
Increase in principal related to the Credit Facility discount	28	0
Purchase of equipment under capital lease obligations	0	1,641
Increase in payables for capital expenditures	$ 0	$ 2

XML

NATURE OF BUSINESS AND BASIS OF PRESENTATION

9 Months Ended

Sep. 30, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NATURE OF BUSINESS AND BASIS OF PRESENTATION

NATURE OF BUSINESS AND BASIS OF PRESENTATION

Nature of Business

Rimini Street, Inc. (the “Company”) is a global provider of enterprise software support services. The Company’s subscription-based software support products and services offer enterprise software licensees a choice of solutions that replace or supplement the support products and services offered by enterprise software vendors. 

Basis of Presentation and Consolidation

The unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly-owned subsidiaries, are prepared in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”). All significant intercompany balances and transactions have been eliminated. The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, certain information and footnote disclosures required by U.S. GAAP for complete financial statements have been condensed or omitted in accordance with such rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the unaudited condensed consolidated financial statements have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2020, included in the Company’s 2020 Annual Report on Form 10-K as filed with the SEC on March 3, 2021 and as subsequently amended on May 10, 2021 (as amended, the “2020 Form 10-K/A”).

The accompanying condensed consolidated balance sheet and related disclosures as of December 31, 2020 have been derived from the Company’s audited financial statements. The Company’s financial condition as of September 30, 2021, and operating results for the three months ended September 30, 2021, are not necessarily indicative of the financial condition and results of operations that may be expected for any future interim period or for the year ending December 31, 2021.

XML

LIQUIDITY AND SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

LIQUIDITY AND SIGNIFICANT ACCOUNTING POLICIES

LIQUIDITY AND SIGNIFICANT ACCOUNTING POLICIES

Liquidity

As of September 30, 2021, the Company’s current liabilities exceeded its current assets by $64.2 million, and the Company recorded net income of $1.9 million for the three months ended September 30, 2021. As of September 30, 2021, the Company had available cash, cash equivalents and restricted cash of $103.4 million. As of September 30, 2021, the Company’s current liabilities included $203.8 million of deferred revenue whereby the historical costs of fulfilling the Company's commitments to provide services to its clients was approximately 35% of the related deferred revenue for the three months ended September 30, 2021.

On July 20, 2021, the Company redeemed the remaining 87,802 shares of its 13.00% Series A Preferred Stock at an aggregate total redemption price of $88.4 million. The total redemption price consisted of $87.8 million related to the outstanding shares of Series A Preferred Stock with a face value of $1,000 per share and $0.6 million or $6.86 per share of Series A Preferred Stock related to the dividends earned for the period from July 1, 2021 through July 19, 2021. The redeemed shares of the Series A Preferred Stock, along with the dividends, were recorded on the redemption date of July 20, 2021.

The Company funded the July 20, 2021 redemption with borrowings from a five year term loan of $90 million, which was entered into on July 20, 2021 (the “Credit Facility”). Annual minimum principal payments over the five year term for the Credit Facility will be 5%, 5%, 7.5%, 7.5% and 10%, respectively, with the remaining balance due at the end of the term. See Note 5 for further information regarding the Company's Credit Facility.

As discussed in Note 7, the Company completed a firm commitment underwritten public offering on March 11, 2021 (the “March 2021 Offering”) of 7.8 million shares of its common stock, par value $0.0001 per share (“Common Stock”), at a price of $7.75 per share for total gross proceeds of $57.0 million. Underwriter discounts and commissions were $2.9 million and the underwriter expenses were $0.2 million. The Company also incurred additional professional fees and expenses of $1.3 million as part of the transaction, resulting in net proceeds from the March 2021 Offering of approximately $55.6 million. The Company had previously completed a firm commitment underwritten public offering on August 18, 2020 (the “August 2020 Offering”) of 6.1 million shares of its Common Stock at a price of $4.50 per share for total gross proceeds of $27.5 million. Underwriter discounts and commissions were $1.7 million and the underwriter expenses were $0.1 million. The Company also incurred additional professional fees of $0.6 million as part of the transaction, resulting in net proceeds from the August 2020 Offering of approximately $25.1 million.

Additionally, the Company is obligated to make operating and financing lease payments that are due within the next 12 months in the aggregate amount of $6.3 million. In March 2020, the World Health Organization declared the outbreak of a novel strain of the coronavirus (“COVID-19”) to be a pandemic. After the issuance date of these financial statements, the Company’s ability to operate continues not to be significantly adversely impacted by the COVID-19 pandemic, the Company believes that current cash, cash equivalents, restricted cash, and future cash flow from operating activities will be sufficient to meet the Company’s anticipated cash needs, including Credit Facility repayments, working capital needs, capital expenditures and other contractual obligations for at least 12 months from the issuance date of these financial statements.

Revision of Previously Issued Financial Statements

The Company has revised certain prior period amounts on the unaudited condensed consolidated financial statements to correct a misstatement with respect to improperly classifying certain warrants to purchase approximately 6.1 million shares of the Company’s Common Stock, at $11.50 per share (the “GP Sponsor Private Placement Warrants”) as equity instead of as a warrant liability that is adjusted through charges or credits to the income statement each quarter to reflect changes in the fair value of the warrants, under the guidance of Accounting Standards Codification (“ASC”) 815-40, Contracts in Entity’s Own Equity. The Company recorded a liability for the warrants of $2.1 million as of December 31, 2020 and adjusted its additional paid-in capital and accumulated deficit accordingly. The impact to the statement of operations and statement of cash flows for both the three and nine months ended September 30, 2020 was a gain of $0.3 million and a loss of $0.2 million, respectively. There was no income tax impact associated with this revision. Total stockholders’ deficit increased by $1.0 million and $0.7 million as of September 30, 2020 and December 31, 2019, respectively.

The Company has assessed the impact of improperly classifying the GP Sponsor Private Placement Warrants as equity rather than as a warranty liability that is adjusted through charges or credits to the income statement each quarter to reflect changes in the fair value of the warrants and determined the impact is not material, quantitatively or qualitatively, to the periods presented. Accordingly, the Company will adjust prior periods as those financial statements are presented for comparative purposes in future filings.

See Note 12 for additional information regarding the assumptions made to determine the fair value of the GP Sponsor Private Placement Warrants as of September 30, 2021 and December 31, 2020.

Use of Estimates

The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the amounts reported in its consolidated financial statements and accompanying notes. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes are reasonable under the circumstances to determine the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s significant accounting estimates include, but are not necessarily limited to, accounts receivable, valuation assumptions for stock options and leases, deferred income taxes and the related valuation allowances, and the evaluation and measurement of contingencies. To the extent there are material differences between the Company’s estimates and actual results, the Company’s future consolidated results of operation may be affected.

Recent Accounting Pronouncements

Recently Adopted Standards. The following accounting standards were adopted during the fiscal year 2021:

In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The guidance removes certain exceptions to the general income tax

accounting principles, and clarifies and amends existing guidance to facilitate consistent application of the accounting principles. The new guidance was effective for the Company as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU 2020-1, Investments—Equity Securities (Topic 321), Investments - Equity and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The guidance clarifies interactions between current accounting standards on equity securities, equity method and joint ventures, and derivatives and hedging. The new guidance addresses accounting for the transition into and out of the equity method and measuring certain purchased options and forward contracts to acquire investments. The new guidance was effective for the Company as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.

XML

DEFERRED CONTRACT COSTS AND DEFERRED REVENUE

9 Months Ended

Sep. 30, 2021

Revenue from Contract with Customer [Abstract]

DEFERRED CONTRACT COSTS AND DEFERRED REVENUE

DEFERRED CONTRACT COSTS AND DEFERRED REVENUE

Activity for deferred contract costs for the three and nine months ended September 30, 2021 and 2020 is shown below (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Deferred contract costs, current and noncurrent, as of the beginning of period	$	36,561	$	29,384	$	34,945	$	28,049
Capitalized commissions during the period	4,295		7,123		13,437		15,165
Amortized deferred contract costs during the period	(4,132)		(3,585)		(11,658)		(10,292)
Deferred contract costs, current and noncurrent, as of the end of period	$	36,724	$	32,922	$	36,724	$	32,922

Deferred revenue activity for the three and nine months ended September 30, 2021 and 2020 is shown below (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Deferred revenue, current and noncurrent, as of the beginning of period	$	265,638	$	218,506	$	256,933	$	235,498
Billings, net	73,686		68,309		261,900		207,751
Revenue recognized	(95,642)		(82,518)		(275,151)		(238,952)
Deferred revenue, current and noncurrent, as of the end of period	$	243,682	$	204,297	$	243,682	$	204,297

The transaction price allocated to the remaining performance obligations represents contracted revenue that has not yet been recognized. As of September 30, 2021, the remaining transaction price included in deferred revenue was $203.8 million in current and $39.9 million in noncurrent.

XML

OTHER FINANCIAL INFORMATION

9 Months Ended

Sep. 30, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

OTHER FINANCIAL INFORMATION

OTHER FINANCIAL INFORMATION

Other Accrued Liabilities

As of September 30, 2021 and December 31, 2020, other accrued liabilities consist of the following (in thousands): 

	2021		2020
Accrued sales and other taxes	$	4,238	$	5,213
Accrued professional fees	6,997		5,912
Accrued dividends on Redeemable Series A Preferred Stock	—		3,842
Current maturities of capital lease obligations	334		429
Income taxes payable	721		2,245
Other accrued expenses	4,828		3,513
Total other accrued liabilities	$	17,118	$	21,154

XML

DEBT

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

DEBT

DEBT

Debt is presented net of debt discounts and issuance costs in the Company's balance sheets. As of September 30, 2021 and December 31, 2020, debt consisted of the following (in thousands):

	2021		2020
Credit Facility	$	84,226	$	—
Less current maturities	3,670		—
Long-term debt, net of current maturities	$	80,556	$	—

Effective July 20, 2021, the Company received $89.3 million of net proceeds related to the Credit Facility. The borrowings under the Credit Facility were discounted at 0.375%.. As part of the transaction, the Company incurred issuance costs of $4.2 million, which were capitalized and will be amortized over the term of the Credit Facility.

The Credit Facility bears interest at the London Interbank Offered Rate (“LIBOR”), plus a margin ranging from 1.75% to 2.50%. For the three months ended September 30, 2021, the interest rate on the Credit Facility was 2.4%. The LIBOR rate as of September 30, 2021 was not materially different from the interest rate for the three months ended September 30, 2021. Hence the fair value of the Credit Facility approximated the book value as of September 30, 2021.

The Credit Facility contains certain financial covenants, including a minimum fixed charge coverage ratio greater than 1.25, a total leverage ratio less than 3.75, and a minimum liquidity of $20 million in U.S. cash. Annual minimum principal payments over the five year term for the Credit Facility will be 5%, 5%, 7.5%, 7.5%,and 10%, respectively, with the remaining balance due at the end of the term. On September 30, 2021, the Company made a principal payment of $1.1 million.

Pursuant to a Guaranty and Security Agreement, dated July 2, 2021 (the “Guaranty and Security Agreement”), among the Credit Parties and Capital One, National Association, as agent, the obligations under the Credit Agreement are guaranteed by certain of the Company’s subsidiaries (the Company and the guarantors, collectively, the “Credit Parties”) and are secured, subject to customary permitted liens and exceptions, by a lien on substantially all assets of the Credit Parties.

The components of interest expense for the three and nine months ended September 30, 2021 and 2020 are presented below (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Credit Facility:
Interest expense	$	435	$	—	$	435	$	—
Accretion expense related to discount and issuance costs	196		—		196		—
Interest on finance leases	22		10		107		35
	$	653	$	10	$	738	$	35

XML

REDEEMABLE SERIES A PREFERRED STOCK

9 Months Ended

Sep. 30, 2021

Temporary Equity Disclosure [Abstract]

REDEEMABLE SERIES A PREFERRED STOCK

REDEEMABLE SERIES A PREFERRED STOCK

2018 Securities Purchase Agreement

On July 19, 2018, the Company closed a Securities Purchase Agreement (the “2018 SPA”) with several accredited investors (the “Purchasers”) for a private placement (the “Initial Private Placement”) of (i) 140,000 shares of Series A Preferred Stock, (ii) approximately 2.9 million shares of Common Stock, and (iii) convertible secured promissory notes (the “Convertible Notes”), with no principal amount outstanding at issuance that solely collateralize amounts, if any, that may become payable by the Company pursuant to certain redemption provisions of the Series A Preferred Stock.

Pursuant to the 2018 SPA, the Purchasers acquired an aggregate of 140,000 shares of Series A Preferred Stock, 2.9 million shares of Common Stock, and Convertible Notes with no principal amount outstanding as of the issuance date, for an aggregate purchase price equal to $133.0 million in cash (after taking into account a discount of $7.0 million, but before the incremental and direct transaction costs associated with the Private Placement of $4.6 million). The allocation of the net proceeds as of the closing date, along with changes in the net carrying value of the Series A Preferred Stock through September 30, 2021, are set forth below (dollars in thousands):

	Series A Preferred Stock				Common			Convertible
	Shares	Amount			Stock			Notes		Total
Fair value on July 19, 2018:
Series A Preferred Stock	140,000	$	126,763	(1)	$	—		$	—	$	126,763
Common Stock	—	—			20,131		(2)	—		20,131
Convertible Notes	—	—			—			—		—
Total	140,000	$	126,763		$	20,131		$	—	$	146,894
Relative fair value allocation on July 19, 2018
Aggregate cash proceeds on July 19, 2018	140,000	$	114,773	(3)	$	18,227	(3)	$	—	$	133,000
Incremental and direct costs	—	(3,994)		(4)	(634)		(4)	—		(4,628)
Net carrying value on July 19, 2018	140,000	$	110,779		$	17,593		$	—	$	128,372

_________________

(1)The liquidation preference for each share of Series A Preferred Stock on the closing date for the Initial Private Placement was $1,000 per share for an aggregate liquidation preference of $140.0 million. The estimated fair value of the Series A Preferred Stock was approximately $126.8 million on July 19, 2018, which is the basis for allocation of the net proceeds. Please refer to Note 12 for further discussion of the valuation methodology employed.

(2)The fair value of the issuance of approximately 2.9 million shares of Common Stock was based on the last closing price of $6.95 per share on the date prior to closing the transaction.

(3)The aggregate cash proceeds of $133.0 million on July 19, 2018 were allocated pro rata based on the fair value of all consideration issued.

(4)Incremental and direct costs of the Initial Private Placement were allocated pro rata based on the fair value of all consideration issued. Such costs include financial advisory and professional fees of $2.7 million that were incurred by the Company, and due diligence and professional fees incurred by the investors of $1.9 million.

At the closing, the Company used the $133.0 million of proceeds from the Initial Private Placement plus cash and cash equivalents of $2.7 million to (i) repay all outstanding indebtedness and various operating and financing fees and expenses under its former credit facility in the aggregate amount of $132.8 million, (ii) pay incremental and direct transaction costs of $2.7 million, and (iii) pay a professional services retainer of $0.2 million.

March 2019 Securities Purchase Agreement

On March 7, 2019, the Company entered into a securities purchase agreement (the “March 2019 SPA”) with an accredited investor for a private placement (the “March 2019 Private Placement”) of (i) 6,500 shares of Series A Preferred Stock, (ii) 134,483 shares of Common Stock, and (iii) a Convertible Note with no principal balance outstanding. The shares of Series A Preferred Stock were authorized pursuant to the CoD and are subject to the provisions set forth in an amended Security Agreement, a Convertible Note and a registration rights agreement that is substantially similar in all material respects to the Registration Rights Agreement entered into in connection with the 2018 SPA discussed above. The accredited investor in the March 2019 Private Placement is affiliated with one of the accredited investors in the Initial Private Placement.

The aggregate cash proceeds from the March 2019 Private Placement were $5.8 million in cash (after an 11.0% discount or $0.7 million). The net proceeds were approximately $5.0 million after estimated transaction costs payable by the Company of $0.8 million. The transaction costs consisted of 85,000 shares of Common Stock issued to the existing holders of the Series A Preferred Stock for their consent at a cost of approximately $0.5 million and direct transaction costs of approximately $0.3 million related to due diligence and professional fees. The net proceeds were allocated based on their relative fair values at issuance of the Series A Preferred Stock and the Common Stock. The allocation of the net proceeds from the March 2019

Private Placement are set forth below (dollars in thousands):

	Series A Preferred Stock				Common			Convertible
	Shares	Amount			Stock			Notes		Total
Fair value on March 7, 2019:
Series A Preferred Stock	6,500	$	5,313	(1)	$	—		$	—	$	5,313
Common Stock	—	—			722		(2)	—		722
Convertible Notes	—	—			—			—		—
Total	6,500	$	5,313		$	722		$	—	$	6,035
Relative fair value allocation on March 7, 2019:
Aggregate cash proceeds on March 7, 2019	6,500	$	5,093	(3)	$	692	(3)	$	—	$	5,785
Incremental and direct costs	—	(661)		(4)	(90)		(4)	—		(751)
Net carrying value on March 7, 2019	6,500	$	4,432		$	602		$	—	$	5,034

(1)The liquidation preference for each share of Series A Preferred Stock on the closing date for the March 2019 Private Placement was $1,000 per share for an aggregate liquidation preference of $6.5 million. The estimated fair value of the Series A Preferred Stock was approximately $5.3 million on March 7, 2019, which is the basis for allocation of the net proceeds. Please refer to Note 12 for further discussion of the valuation methodology employed.

(2)The fair value of the issuance of approximately 134,483 shares of Common Stock was based on the closing price of $5.37 per share on the date prior to closing of the transaction.

(3)The aggregate cash proceeds of $5.8 million on March 7, 2019 were allocated pro rata based on the fair value of all consideration issued.

(4)Incremental and direct costs related to the March 2019 Private Placement were allocated pro rata based on the fair value of all consideration issued. Such costs included the issuance of 85,000 shares of Common Stock to the Initial Private Placement investors in the Series A Preferred Stock for their consent of approximately $0.5 million and financial advisory and professional fees that were incurred of approximately $0.3 million that were either paid or accrued directly by the Company as of March 31, 2019.

June 2019 Securities Purchase Agreement

On June 20, 2019, the Company entered into a securities purchase agreement (the “June 2019 SPA”) with accredited investors for a private placement (the “June 2019 Private Placement”) of (i) 3,500 shares of Series A Preferred Stock, (ii) 72,414 shares of Common Stock, and (iii) a Convertible Note with no principal balance outstanding. The shares of the Series A Preferred Stock were authorized pursuant to the CoD and are subject to the provisions set forth in an amended Security Agreement, a Convertible Note and a registration rights agreement that is substantially similar in all material respects to the Registration Rights Agreement entered into in connection with the 2018 SPA discussed above. The accredited investors in the June 2019 Private Placement are not affiliated with the accredited investors in the March 2019 Private Placement or the Initial Private Placement.

The aggregate cash proceeds from the June 2019 Private Placement were $3.3 million in cash (after a 5.0% discount or $0.2 million). The net proceeds were approximately $3.0 million after estimated transaction costs payable by the Company of $0.3 million. The transaction costs consisted of 35,000 shares of Common Stock issued to the existing holders of the Series A Preferred Stock for their consent at a cost of approximately $0.2 million and direct transaction costs of approximately $0.2 million related to professional fees of the investors, existing holders of Series A Preferred Stock and the Company. The net proceeds were allocated based on their relative fair values at issuance of the Series A Preferred Stock and the Common Stock.

The allocation of the net proceeds from the June 2019 Private Placement are set forth below (dollars in thousands):

	Series A Preferred Stock				Common			Convertible
	Shares	Amount			Stock			Notes		Total
Fair value on June 20, 2019:
Series A Preferred Stock	3,500	$	2,997	(1)	$	—		$	—	$	2,997
Common Stock	—	—			376		(2)	—		376
Convertible Notes	—	—			—			—		—
Total	3,500	$	2,997		$	376		$	—	$	3,373
Relative fair value allocation on June 20, 2019:
Aggregate cash proceeds on June 20, 2019	3,500	$	2,954	(3)	$	371	(3)	$	—	$	3,325
Incremental and direct costs	—	(301)		(4)	(38)		(4)	—		(339)
Net carrying value on June 20, 2019	3,500	$	2,653		$	333		$	—	$	2,986

(1)The liquidation preference for each share of Series A Preferred Stock on the closing date for the June 2019 Private Placement was $1,000 per share for an aggregate liquidation preference of $3.5 million. The estimated fair value of the Series A Preferred Stock was approximately $3.0 million on June 20, 2019, which is the basis for allocation of the net proceeds. Please refer to Note 12 for further discussion of the valuation methodology employed.

(2)The fair value of the issuance of approximately 72,414 shares of Common Stock was based on the closing price of $5.19 per share on the date prior to closing of the transaction.

(3)The aggregate cash proceeds of $3.3 million on June 20, 2019 were allocated pro rata based on the fair value of all consideration issued.

(4)Incremental and direct costs related to the June 2019 Private Placement were allocated pro rata based on the fair value of all consideration issued. Such costs included the issuance of 35,000 shares of Common Stock to the Initial Private Placement investors in the Series A Preferred Stock for their consent of approximately $0.2 million and financial advisory and professional fees that were incurred of approximately $0.2 million that were either paid or accrued directly by the Company as of June 30, 2019.

On July 20, 2021, the Company redeemed the remaining 87,802 shares of its 13.00% Series A Preferred Stock at an aggregate total redemption price of $88.4 million. The total price consisted of $87.8 million related to the outstanding shares of Series A Preferred Stock with a face value of $1,000 per share and $0.6 million or $6.86 per share of Series A Preferred Stock related to the dividends earned for the period from July 1, 2021 through July 19, 2021. The redeemed shares of the Series A Preferred Stock, along with the dividends, were recorded on the redemption date of July 20, 2021.

The Company funded the July 20, 2021 redemption with borrowings under the Credit Facility. See Note 5 for further information regarding the Company's Credit Facility.

On April 16, 2021, the Company redeemed 60,000 shares of its 13.00% Series A Preferred Stock at an aggregate total redemption price of $62.3 million. The total price consisted of $60.0 million related to the face value of $1,000 per share of Series A Preferred Stock and $2.3 million or $39.05 per share of Series A Preferred Stock related to the dividends to be earned for the period from April 1, 2021 through July 18, 2021. The redeemed shares of Series A Preferred Stock, along with the dividends were recorded when the Series A Preferred Stock became mandatorily redeemable on April 16, 2021.

The Company funded the April 16, 2021 redemption with a portion of the proceeds from the March 2021 Offering and the August 2020 Offering, which raised aggregate net proceeds of approximately $80.7 million.

On January 5, 2021, the Company entered into an agreement with certain of the holders of its Series A Preferred Stock (the “January 2021 Stock Repurchase Agreement”) to repurchase 10,000 shares of Series A Preferred Stock and the associated obligations pursuant to the Company’s Convertible Secured Promissory Notes outstanding in respect thereof (the “Note Obligations”) for an aggregate purchase price of approximately $8.95 million representing a discount to the face value of such shares of Series A Preferred Stock and no make-whole payments were required. The January 2021 Stock Repurchase Agreement contains customary representations, warranties and covenants of the parties and waivers relating to the purchased shares of Series A Preferred Stock.

Upon the closing of the transactions contemplated by the January 2021 Stock Repurchase Agreement, the shares of Series A Preferred Stock purchased by the Company were retired (and the underlying Note Obligations cancelled) and are not eligible for re-issuance by the Company in accordance with the terms of the CoD.

The changes in the net carrying value of Series A Preferred Stock from December 31, 2020 to September 30, 2021 are set forth below (dollars in thousands):

	Series A Preferred Stock
	Shares	Amount
Net carrying value as of December 31, 2020	154,911	$	137,854
Issuance of shares to settle PIK Dividends on January 4, 2021	1,193	1,193
Repurchase of 10,000 shares on January 5, 2021	(10,000)	(8,913)
Accretion of discount for the three months ended March 31, 2021	—	1,473
Net carrying value as of March 31, 2021	146,104	131,607
Issuance of shares to settle PIK Dividends on April 1, 2021	1,051	1,051
Redemption of 60,000 shares on April 16, 2021	(60,000)	(54,327)
Accretion of discount for the three months ended June 30, 2021	—	804
Net carrying value as of June 30, 2021	87,155	79,135
Issuance of shares to settle PIK Dividends on July 1, 2021	647	647
Redemption of 87,802 shares on July 20, 2021	(87,802)	(79,782)
Net carrying value as of September 30, 2021	—	$	—

Certificate of Designations of the Series A Preferred Stock and Dividends

The CoD authorized the issuance of up to 180,000 shares of Series A Preferred Stock. The holders of Series A Preferred Stock were entitled to, from the respective issuance date, a cash dividend of 10.0% per annum (the “Cash Dividends”) and a payment-in-kind dividend of 3.0% per annum (the “PIK Dividends” and, together with the Cash Dividends, the “Dividends”) for the first five years following the initial June 2018 closing and thereafter all dividends accruing on such Series A Preferred Stock would be payable in cash at a rate of 13.0% per annum. The Series A Preferred Stock was classified as mezzanine equity in the Company’s consolidated balance sheet as of December 31, 2020 since the holders had redemption rights beginning on July 19, 2023 (and earlier under certain circumstances).

Presented below is a summary of total and per share dividends declared through September 30, 2021 (dollars in thousands, except per share amounts):

	Dividends Payable in:				Total		Dividends
	Cash		PIK		Dividends		Per Share
Dividends payable as of December 31, 2020	$	3,842	$	1,193	$	5,035	$	32.50
Cash Dividends @ 10% per annum	3,660		—		3,660		23.40
PIK Dividends @ 3% per annum	—		1,098		1,098		7.02
Fractional PIK shares settled for cash	47		(47)		—		—
Less dividends settled January 4, 2021	(4,009)		(1,193)		(5,202)		(33.26)
Dividends payable as of March 31, 2021	3,540		1,051		4,591		32.14
Cash Dividends @ 10% per annum	2,179		—		2,179		25.00
PIK Dividends @ 3% per annum	—		654		654		7.50
Fractional PIK shares settled for cash	7		(7)		—		—
Less dividends settled April 1, 2021	(3,540)		(1,051)		(4,591)		(52.68)
Dividends payable as of June 30, 2021	2,186		647		2,833		32.51
Less dividends settled on July 1, 2021	(2,186)		(647)		(2,833)		(32.27)
Dividends payable as of September 30, 2021	$	—	$	—	$	—	$	—

XML

COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS

9 Months Ended

Sep. 30, 2021

Share-based Payment Arrangement [Abstract]

COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS

COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS 

Common Stock Offerings

On March 11, 2021, the Company completed the March 2021 Offering of 7.8 million shares of its Common Stock at a price of $7.75 per share for total gross proceeds of $57.0 million. Underwriter discounts and commissions were $2.9 million and the underwriter expenses were $0.2 million. The Company also incurred additional professional fees and expenses of $1.3 million as part of the transaction, resulting in net proceeds from the March 2021 Offering of approximately $55.6 million. The Company used the net proceeds from the March 2021 Offering to redeem 60,000 shares of Series A Preferred Stock in April 2021.

On August 18, 2020, the Company completed the August 2020 Offering of 6.1 million shares of its Common Stock at a price of $4.50 per share for total gross proceeds of $27.5 million. Underwriter discounts and commissions were $1.7 million and the underwriter expenses were $0.1 million. The Company also incurred additional professional fees of $0.6 million as part of the transaction, resulting in net proceeds from the August 2020 Offering of approximately $25.1 million. The Company used the net proceeds from the August 2020 Offering to redeem 60,000 shares of Series A Preferred Stock and for working capital and other general corporate purposes.

Acquisition of Common Stock upon Vesting of Restricted Stock Units

On August 6, 2021, the Company reacquired 0.1 million shares of common stock for $1.1 million related to restricted stock units (“RSUs”) that vested on that date.

Stock Plans

The Company’s stock plans consist of the 2007 Stock Plan (the “2007 Plan”) and the 2013 Equity Incentive Plan, as amended and restated in July 2017 (the “2013 Plan”). The 2007 Plan and the 2013 Plan are collectively referred to as the “Stock Plans”. On February 23, 2021, the Board of Directors authorized an increase of approximately 3.1 million shares available for grant under the 2013 Plan. For additional information about the Stock Plans, please refer to Note 8 to the Company’s consolidated financial statements for the year ended December 31, 2020, included in the 2020 Form 10-K/A. The information presented below provides an update for activity under the Stock Plans for both the three and nine months ended September 30, 2021.

Restricted Stock Units

For the nine months ended September 30, 2021, the Board of Directors granted RSUs under the 2013 Plan for an aggregate of approximately 1.4 million shares of Common Stock to employees and to non-employee directors of the Company. RSU grants vest over periods generally ranging from 12 to 36 months from the respective grant dates and the awards are subject to forfeiture upon termination of employment or service on the Board of Directors, as applicable. Based on the weighted average fair market value of the Common Stock on the date of grant of $7.57 per share, the aggregate fair value for the shares underlying the RSUs amounted to $10.6 million as of the grant date that will be recognized as compensation cost over the vesting period. Accordingly, compensation expense related to RSUs of approximately $2.1 million and $1.8 million was recognized for the three months ended September 30, 2021 and 2020, respectively. Compensation expense related to RSUs of approximately $6.2 million and $4.3 million was recognized for the nine months ended September 30, 2021 and 2020, respectively. As of September 30, 2021, the unrecognized expense of $12.2 million net of forfeitures is expected to be charged to expense on a straight-line basis as the RSUs vest over a weighted-average period of approximately 1.8 years.

Stock Options

For the nine months ended September 30, 2021, the Board of Directors granted stock options for the purchase of an aggregate of approximately 0.9 million shares of Common Stock at exercise prices that were equal to the fair market value of the Common Stock on the date of grant. These stock options generally vest annually for one-third of the awards and expire ten years after the grant date.

The following table sets forth a summary of stock option activity under the Stock Plans for the nine months ended September 30, 2021 (shares in

thousands): 

	Shares	Price (1)		Term (2)
Outstanding, December 31, 2020	7,007	$	5.24	5.0
Granted	928	7.77
Forfeited	(170)	6.21
Expired	(113)	6.63
Exercised	(1,184)	4.26
Outstanding, September 30, 2021 (3)(4)	6,468	5.73		5.1
Vested, September 30, 2021 (3)	5,056	5.53		4.0

(1)Represents the weighted average exercise price.

(2)Represents the weighted average remaining contractual term until the stock options expire.

(3)As of September 30, 2021, the aggregate intrinsic value of all stock options outstanding was $25.4 million. As of September 30, 2021, the aggregate intrinsic value of vested stock options was $20.9 million.

(4)The number of outstanding stock options that are not expected to ultimately vest due to forfeiture amounted to 0.2 million shares as of September 30, 2021.

The following table presents activity affecting the total number of shares available for grant under the Stock Plans for the nine months ended September 30, 2021 (in thousands):

 

Available, December 31, 2020	4,037
Newly authorized by Board of Directors	3,056
Stock options granted	(928)
Restricted stock units granted	(1,394)
Expired options under Stock Plans	113
Forfeited options under Stock Plans	170
Forfeited restricted stock units under Stock Plans	348
Shares repurchased	137
Available, September 30, 2021	5,539

The aggregate fair value of approximately 0.9 million stock options granted for the nine months ended September 30, 2021 amounted to $3.0 million, or $3.20 per stock option as of the grant date utilizing the Black-Scholes-Merton (“BSM”) method. The fair valued derived under the BSM method will result in the recognition of compensation cost over the vesting period of the stock options. For the nine months ended September 30, 2021, the fair value of each stock option grant under the Stock Plans was estimated on the date of grant using the BSM option-pricing model, with the following weighted-average assumptions:

 

Expected life (in years)	6.0
Volatility	42%
Dividend yield	0%
Risk-free interest rate	0.87%
Fair value per common share on date of grant	$7.77

As of September 30, 2021 and December 31, 2020, total unrecognized compensation costs related to unvested stock options, net of estimated forfeitures, was $2.4 million and $1.2 million, respectively. As of September 30, 2021, the unrecognized costs are expected to be charged to expense on a straight-line basis over a weighted-average vesting period of approximately 2.1 years.

Stock-Based Compensation Expense

Stock-based compensation expense attributable to RSUs and stock options is classified as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Cost of revenues	$	376	$	303	$	1,067	$	866
Sales and marketing	752		734		2,353		1,994
General and administrative	1,265		1,152		3,684		2,565
Total	$	2,393	$	2,189	$	7,104	$	5,425

Warrants

On April 12, 2021, the SEC issued a Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (the “SEC Staff Statement”). Upon review of the SEC Staff Statement which addressed certain accounting and reporting considerations related to warrants similar to the Company’s GP Sponsor Private Placement Warrants and upon review of ASC 815-40, Contracts in Entity’s Own Equity, the Company determined that its GP Sponsor Private Placement Warrants should have been classified as a liability instead of equity. See Note 2 for further information regarding this revision to the Company’s consolidated financial statements. See Note 12 for information regarding the fair value of the GP Sponsor Private Placement Warrants as of September 30, 2021 and December 31, 2020.

As of September 30, 2021, warrants were outstanding for an aggregate of 18.1 million shares of Common Stock, including 3.4 million shares of Common Stock exercisable at $5.64 per share, and an aggregate of 14.7 million shares of Common Stock exercisable at $11.50 per share. For additional information about these warrants, please refer to Note 8 to the Company’s consolidated financial statements for the year ended December 31, 2020, included in the 2020 Form 10-K/A.

XML

INCOME TAXES

9 Months Ended

Sep. 30, 2021

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was passed into law, amending portions of relevant U.S. tax laws. The CARES Act contains changes to corporate taxation, including among other things, adjusting net operating loss (NOL) limitations and carryback rules, refundable AMT credits, bonus depreciation and interest expense limitations. The CARES Act also provides for an Employee Retention Credit, a fully refundable payroll tax credit for certain eligible employers and the ability for all eligible employers to defer payment of the employer share of payroll taxes owed on wages paid for the period ending December 31, 2020 (such deferred payroll taxes are due in two installments: 50% by December 31, 2021 and 50% by December 31, 2022). The Company has elected to defer payroll tax payments which totaled $3.2 million as of September 30, 2021.

For the three months ended September 30, 2021 and 2020, the Company’s effective tax rate was 47.2% and 26.1%, respectively. For the nine months ended September 30, 2021 and 2020, the Company’s effective tax rate was 45.0% and 26.8%, respectively. The Company’s income tax expense was primarily attributable to earnings in foreign jurisdictions subject to income taxes and foreign withholding taxes. In addition, there was no tax impact associated with the loss on change in fair value of redeemable warrants for three months ended September 30, 2021. The Company did not have any material changes to its conclusions regarding valuation allowances for deferred income tax assets or uncertain tax positions for the three months ended September 30, 2021 and 2020.

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

Retirement Plan

The Company has defined contribution plans for both its U.S. and foreign employees. For certain of these plans, employees may contribute up to the statutory maximum, which is set by law each year. The plans also provide for employer contributions. The Company’s matching contributions to these plans totaled $0.8 million and $0.7 million for the three months ended September 30, 2021 and 2020, respectively. The Company’s matching contributions to these plans totaled $2.5 million and $2.0 million for the nine months ended September 30, 2021 and 2020, respectively.

Rimini I Litigation

In January 2010, certain subsidiaries of Oracle Corporation (together with its subsidiaries individually and collectively, “Oracle”) filed a lawsuit, Oracle USA, Inc. et al. v. Rimini Street, Inc. et al. (United States District Court for the District of Nevada) (the “District Court”) (“Rimini I”), against the Company and its Chief Executive Officer, Seth Ravin, alleging that certain of the Company’s processes (Process 1.0) violated Oracle’s license agreements with its customers and that the Company committed acts of copyright infringement and violated other federal and state laws. The litigation involved the Company’s business processes and the manner in which the Company provided services to its clients.

After completion of a jury trial in 2015 and subsequent appeals, the final outcome of Rimini I was that Mr. Ravin was found not liable for any claims and the Company was found liable for only one claim: “innocent infringement,” a jury finding that the Company did not know and had no reason to know that its former support processes were infringing. The jury also found that the infringement did not cause Oracle to suffer lost profits. The Company was ordered to pay a judgment of $124.4 million in 2016, which the Company promptly paid and then pursued appeals. With interest, attorneys’ fees and costs, the total judgment paid by the Company to Oracle after the completion of all appeals was approximately $89.9 million. A portion of such judgment was paid by the Company’s insurance carriers.

Injunction Proceedings

In October 2016, the District Court entered a permanent injunction prohibiting the Company from using certain processes. In August 2019, the United States Court of Appeals for the Ninth Circuit (the “Court of Appeals”) affirmed the permanent injunction issued by the District Court, while also correcting certain legal errors that narrowed the scope of the injunction. The injunction prohibits the Company from using support processes that had been found in Rimini I to “innocently” infringe certain Oracle copyrights, which the Company ceased using no later than July 31, 2014. The injunction does not prohibit the Company’s provision of support services for any Oracle product lines, but rather defines the manner in which the Company can provide support services for certain Oracle product lines.

On July 10, 2020, Oracle filed a motion to show cause contending that the Company is in violation of the injunction, and the Company opposed this motion, disputing Oracle’s claims. On March 31, 2021, the District Court issued an order resolving many outstanding disputes between the parties relating to the injunction. The District Court found that the Company violated the injunction in four certain narrow instances. The District Court refused to consider Oracle’s claims about certain processes that were not litigated in Rimini I, and that are being litigated in the separately filed Rimini Street Inc. v. Oracle Int’l Corp. litigation (described below under the heading “Rimini II Litigation”). In April 2021, the Company filed a motion for reconsideration for two of the four injunction violations identified by the District Court (since they occurred before the injunction became effective). The District Court granted the Company’s motion for reconsideration on June 10, 2021, striking from its March 31, 2021 order its holding regarding those two violations. During an evidentiary hearing in September 2021, the District Court heard evidence and argument regarding whether the Company (i) violated the injunction for certain accused conduct for which the District Court requested additional information and (ii) should be held in contempt in the two instances where the District Court found a violation of the injunction, and what sanctions, if any, are appropriate. As of the date of filing of this Report, the District Court has not rendered a decision regarding the issues presented in the September 2021 evidentiary hearing.

At this time, the Company does not have sufficient information regarding the likelihood of any possible damages for any violations of the injunction or the contempt claim asserted by Oracle. As a result, an estimate of any range of potential loss cannot be reasonably determined at this time. The Company believes that it has substantially complied with the injunction, that Oracle did not meet the burden to establish contempt of the injunction for the two certain narrow instances for which the District Court found violations, that Oracle was unable to establish additional violations of the injunction at the September 2021 hearing, and that an award for sanctions is not probable. Accordingly, no accrual has been made as of September 30, 2021. If the District Court orders any penalties for violations of the injunction and/or the Company is found to be in contempt of the injunction, Oracle may seek and the District Court may order equitable, punitive, and compensatory relief, the outcome of which could have a material adverse effect on the Company’s business and financial condition. The Company reserves all rights, including appellate rights, with respect to the District Court rulings and findings.

Rimini II Litigation

In October 2014, the Company filed a separate lawsuit, Rimini Street Inc. v. Oracle Int’l Corp., in the District Court against Oracle seeking a declaratory judgment that the Company’s revised “Process 2.0” support practices, in use since at least July 2014, do not infringe certain Oracle copyrights (“Rimini II”). The Company’s operative complaint asserts declaratory

judgment, tort, and statutory claims. Oracle’s operative counterclaim asserts declaratory judgment and copyright infringement claims and Lanham Act, breach of contract, and business tort violations.

On September 15, 2020, the District Court issued an order resolving the parties’ motions for summary judgment. It found infringement of 17 Oracle PeopleSoft copyrights for work the Company performed for a set of “gap customers” that were supported by processes litigated in Rimini I, and that became the Company’s customers after Rimini I was filed. The District Court also found infringement of four Oracle PeopleSoft copyrights involving support of two specific Company clients, described by the District Court as “limited cases” and involving “limited circumstance[s].” There was no finding of infringement on any other Oracle copyrights at issue.

The order also resolved several of the non-copyright claims asserted by the parties: (i) allowing the Company’s claim for injunctive relief against Oracle for unfair competition in violation of the California Business & Professions Code §17200 et seq. to proceed to trial; (ii) granting summary judgment for Oracle on the Company’s affirmative claims for damages under the Nevada and California unfair and deceptive trade practices statutes; and (iii) holding that Oracle had the right to revoke the Company’s access to its websites. The Court also reiterated that the Company has the legal right to provide aftermarket support for Oracle’s enterprise software.

The parties filed their joint pretrial order in Rimini II in December 2020. On September 3, 2021, the District Court granted Oracle’s motion to realign the parties with Oracle now designated as plaintiff and the Company and Mr. Ravin now designated as the defendants in the case caption and at trial. The District Court also granted Oracle’s motion to bifurcate the trial – the jury trial will proceed first and will be followed by a separate bench trial on the parties’ equitable claims for unfair competition and Oracle’s claim for an accounting.

On September 30, 2021, the District Court approved the Pretrial Order and indicated that it had “ordered counsel to meet and confer on possible trial dates in mid-2022 and the potential trial length for a trial.” Presently, there is no specific trial date approved or ordered by the District Court.

As of this date, no damages of any kind have been awarded by the District Court in Rimini II. Damages, if any, will be a decision for the Rimini II jury. The Company reserves all rights, including appellate rights, with respect to the District Court and jury rulings and findings in Rimini II.

At this time, the Company does not have sufficient information regarding possible damages exposure for the counterclaims asserted by Oracle. The Company maintains that zero damages should be awarded in Rimini II. A jury will ultimately determine what amount, if any, of damages to award. Both parties have sought injunctive relief in addition to monetary damages in this matter, and the Company has reserved its rights to appeal regarding the possible recovery of damages by the Company in connection with the Company’s claims against Oracle. As a result, an estimate of the range of loss, if any, cannot be reasonably determined. The Company also believes that an award for damages payable to Oracle is not probable, so no accrual has been made as of September 30, 2021. However, as with any jury trial, the ultimate outcome may be different from our best estimates and could have a material adverse impact on our financial results and our business.

Other Litigation

From time to time, the Company may be a party to litigation and subject to claims incident to the ordinary course of business. Although the results of litigation and claims cannot be predicted with certainty, the Company currently believes that the final outcome of these ordinary course matters will not have a material adverse effect on its business. Regardless of the outcome, litigation can have an adverse impact on the Company because of judgment, defense and settlement costs, diversion of management resources and other factors. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, Contingencies. Legal fees are expensed as incurred.

Liquidated Damages

The Company enters into agreements with clients that contain provisions related to liquidated damages that would be triggered in the event that the Company is no longer able to provide services to these clients. The maximum cash payments related to these liquidated damages is approximately $10.9 million and $13.8 million as of September 30, 2021 and December 31, 2020, respectively. To date, the Company has not incurred any costs as a result of such provisions and has not accrued any liabilities related to such provisions in these unaudited condensed consolidated financial statements.

XML

RELATED PARTY TRANSACTIONS

9 Months Ended

Sep. 30, 2021

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

Rimini Street, Inc. (“RSI”) was incorporated in the state of Nevada in September 2005. RSI provides enterprise software support services. In May 2017, RSI entered into an Agreement and Plan of Merger (the “Merger Agreement”) with GP Investments Acquisition Corp. (“GPIA”), a publicly-held special purpose acquisition company (“SPAC”) incorporated in the Cayman Islands and formed for the purpose of effecting a business combination with one or more businesses. The Merger Agreement was approved by the respective shareholders of RSI and GPIA in October 2017, and closing occurred on October 10, 2017, resulting in (i) the merger of a wholly-owned subsidiary of GPIA with and into RSI, with RSI as the surviving corporation, after which (ii) RSI merged with and into GPIA, with GPIA as the surviving corporation and renamed “Rimini Street, Inc.” (referred to herein as “RMNI”, as distinguished from RSI, which is defined as the predecessor entity with the same legal name) immediately after consummation of the second merger. Prior to the consummation of the mergers, the ultimate parent entity of GPIA was GP Investments, Ltd. (“GP Investments”), a global private equity firm and an affiliate of the Company. An affiliate of GP Investments (Mr. Antonio Bonchristiano) was a member of our Board of Directors until May 5, 2020.

In addition, an affiliate of Adams Street Partners and its affiliates (collectively referred to as “ASP”) is also a member of the Company’s Board of Directors. As of September 30, 2021, ASP owned approximately 27.2% of the Company’s issued and outstanding shares of Common Stock. In July 2018, ASP acquired 19,209 shares of Series A Preferred Stock and approximately 0.4 million shares of Common Stock issued in the Initial Private Placement for total consideration of approximately $19.2 million, which shares of Series A Preferred Stock were all redeemed by the Company in 2021 on the same terms as the redemption applicable to other holders of Series A Preferred Stock.

XML

EARNINGS (LOSS) PER SHARE

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

EARNINGS (LOSS) PER SHARE

EARNINGS (LOSS) PER SHARE

The Company computes earnings per share in accordance with ASC Topic 260, Earnings per Share, which requires earnings per share for each class of stock to be calculated using the two-class method. The holders of Series A Preferred Stock were entitled to participate in Common Stock dividends, if and when declared, on a one-to-one per-share basis. Accordingly, in periods in which the Company has net income, earnings per share will be computed using the two-class method whereby the pro rata dividends on Common Stock that are also distributable to the holders of Series A Preferred Stock would have been deducted from earnings applicable to common stockholders, regardless of whether a dividend is declared for such undistributed earnings. Under the two-class method, earnings for the reporting period were allocated between the holders of the Company’s Common Stock and the Series A Preferred Stock based on their respective participation rights in undistributed earnings.

Basic earnings per share of Common Stock is computed by dividing net income attributable to common stockholders by the weighted average number of shares of basic Common Stock outstanding. Net income allocated to the holders of the Company’s Series A Preferred Stock is calculated based on the shareholders’ proportionate share of the weighted average shares of Common Stock outstanding on an if-converted basis. Diluted earnings per share of Common Stock is calculated by adjusting the basic earnings per share of Common Stock for the effects of potential dilutive Common Stock shares outstanding such as stock options, restricted stock units and warrants.

For the three and nine months ended September 30, 2021 and 2020, basic and diluted net earnings per share of Common Stock were computed by dividing the net income attributable to common stockholders by the weighted average number of common shares outstanding during the respective periods. The following tables set forth the computation of basic and diluted net loss attributable to common stockholders for the three and nine months ended September 30, 2021 and 2020 (in thousands, except per share amounts):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Income attributable to common stockholders:
Net income	$	1,931		$	3,609		$	5,162		$	9,078
Return on repurchase of Series A Preferred Stock shares	—			—			(38)			—
Accretion related to redemption of Series A Preferred Stock	(8,020)			—			(13,693)			—
Make-whole dividends related to redemption of Series A Preferred Stock	(602)			—			(2,945)			—
Dividends and accretion related to Series A Preferred Stock:
Cash dividends declared	—			(3,968)			(5,839)			(11,817)
PIK dividends declared	—			(1,190)			(1,752)			(3,545)
Accretion of discount	—			(1,587)			(2,277)			(4,702)
	(6,691)			(3,136)			(21,382)			(10,986)
Undistributed earnings allocated using the two-class method	—			—			—			—
Net loss attributable to common stockholders	$	(6,691)		$	(3,136)		$	(21,382)		$	(10,986)
	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Weighted average number of shares of Common Stock outstanding	86,189			72,377			83,449			69,521
Additional shares outstanding if Series A Preferred Stock is converted to Common Stock	1,813			15,873			8,698			15,756
Total shares outstanding if Series A Preferred Stock is converted to Common Stock	88,002			88,250			92,147			85,277
Percentage of shares allocable to Series A Preferred Stock	2.1		%	18.0		%	9.4		%	18.5		%
Weighted average number of shares of Common Stock outstanding:
Basic and diluted	86,189			72,377			83,449			69,521
Net loss per share attributable to common stockholders:
Basic and diluted	$	(0.08)		$	(0.04)		$	(0.26)		$	(0.16)

For both the three months and nine months ended September 30, 2021 and 2020, basic and diluted loss per share attributable to common stockholders were the same because all Common Stock equivalents were anti-dilutive. If the Company had recorded net income attributable to common stockholders, the diluted shares would have been as follows (in thousands):

	Three Months Ended September 30,		Nine Months Ended September 30,
	2021	2020	2021	2020
Restricted stock units	1,673	685	1,815	598
Stock options	2,136	1,243	2,964	1,640
Warrants	1,203	—	988	—
Total	5,012	1,928	5,767	2,238

As of September 30, 2021 and December 31, 2020, the following potential Common Stock equivalents were excluded from the computation of diluted net loss per share for the respective periods ending on these dates since the impact of inclusion was anti-dilutive (in thousands): 

	2021	2020
Series A Preferred Stock	—	15,491
Restricted stock units	2,913	3,322
Stock options	6,468	7,007
Warrants	18,128	18,128
Total	27,509	43,948

XML

FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS

9 Months Ended

Sep. 30, 2021

Investments, All Other Investments [Abstract]

FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS

FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS

Fair Value Measurements

Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which it transacts, and considers assumptions that market participants would use when pricing the asset or liability. Additional information on fair value measurements is included in Note 13 to the Company’s consolidated financial statements for the year ended December 31, 2020, included in the 2020 Form 10-K/A. The Company’s policy is to recognize asset or liability transfers among Level 1, Level 2 and Level 3 as of the actual date of the events or change in circumstances that caused the transfer.

As of September 30, 2021 and December 31, 2020, the Company has determined that its GP Sponsor Private Placement Warrants are subject to treatment as a liability. The GP Sponsor Private Placement Warrants may not be redeemed by the Company so long as these warrants are held by the initial purchasers or such purchasers’ permitted transferees. If these warrants are held by someone other than the initial purchasers or such purchasers’ permitted transferees, these warrants are redeemable by the Company and exercisable on the same basis as certain warrants to purchase approximately 8.6 million shares of the Company’s Common Stock, at $11.50 per share (the “Public Warrants”). As a result, the GP Sponsor Private Placement Warrants were reclassified as a liability. The fair value of these instruments as of September 30, 2021 and December 31, 2020 was $5.1 million and $2.1 million, respectively, utilizing the BSM method. The GP Sponsor Private Placement Warrants are classified as Level 2 financial instruments. The key assumptions used to determine the fair value was the term period of the warrants, the risk free rate and volatility. As of September 30, 2021, the term to expiration was 1.03 years, the risk free rate of 0.10% and the implied volatility of 37.9%.

As discussed in Note 6, the fair value for the Company’s Series A Preferred Stock issuances on June 20, 2019, March 7, 2019 and July 19, 2018 was determined to be $3.0 million, $5.3 million and $126.8 million, respectively, which were utilized to determine the basis for allocating the net proceeds. The fair value was determined by utilizing a combination of a discounted cash flow methodology related to funds generated by the Series A Preferred Stock, along with the BSM option-pricing model in relation to the conversion feature. Key assumptions applied for the discounted cash flow and BSM analysis included (i) three different scenarios whereby the Series A Preferred Stock would remain outstanding between 4 and 5 years along with a probability weighting assigned to each scenario, (ii) an implied yield of the Series A Preferred Stock ranging from 20.9% to 22.9% calibrated to the transaction values as of June 20, 2019, March 7, 2019 and July 19, 2018, respectively, (iii) risk-free interest rates of 1.72%, 2.44% and 2.8% and (iv) historical volatility of 30.0%.

The carrying amounts of the Company’s financial instruments including cash and cash equivalents, restricted cash, accounts receivable, accounts payable, and accrued liabilities approximate fair values due to their short-term maturities. Based on borrowing rates currently available to the Company for debt with similar terms, the carrying value of capital lease obligations approximate fair value as of the respective balance sheet dates. The liability for redeemable warrants are also considered financial instruments and valued utilizing the BSM method and assumptions noted above.

Significant Concentrations

The Company attributes revenues to geographic regions based on the location of its clients’ contracting entity. The following table shows revenues by geographic region (in thousands):

 

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
United States of America	$	50,479	$	48,160	$	147,600	$	142,982
International	45,163		34,358		127,551		95,970
Total	$	95,642	$	82,518	$	275,151	$	238,952

No clients represented more than 10% of revenue for both the three months and nine months ended September 30, 2021 or 2020. As of September 30, 2021 and 2020, no clients accounted for more than 10% of total net accounts receivable. The Company tracks its assets by physical location. As of September 30, 2021 and December 31, 2020, the net carrying value of the Company’s property and equipment located outside of the United States amounted to approximately $1.5 million and $1.3 million, respectively. As of September 30, 2021, the Company had operating lease right-of-use assets of $9.5 million, $5.0 million and $0.5 million in the United States, India and the rest of the world, respectively. As of December 31, 2020, the Company had operating lease right-of-use assets of $11.0 million, $5.8 million and $0.8 million in the United States, India and the rest of the world, respectively.

Financial instruments that subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. The Company maintains its cash, cash equivalents and restricted cash at high-quality financial institutions, primarily in the United States. Deposits, including those held in foreign branches of global banks, may exceed the amount of insurance provided on such deposits. As of September 30, 2021 and December 31, 2020, the Company had cash, cash equivalents and restricted cash with a single financial institution for an aggregate of $73.3 million and $50.2 million, respectively. As of September 30, 2021 and December 31, 2020, the Company had restricted cash of $0.4 million and $0.3 million, respectively. The Company has never experienced any losses related to these balances.

Generally, credit risk with respect to accounts receivable is diversified due to the number of entities comprising the Company’s client base and their dispersion across different geographies and industries. The Company performs ongoing credit evaluations on certain clients and generally does not require collateral on accounts receivable. The Company maintains reserves for potential bad debts and historically such losses are generally not significant.

XML

LEASES

9 Months Ended

Sep. 30, 2021

Leases [Abstract]

LEASES

LEASES

Effective at the start of fiscal 2020, the Company adopted the provisions and expanded disclosure requirements described in Accounting Standards Codification (ASC) Topic 842, Leases. The Company adopted the standard using the prospective method. The Company has operating leases for real estate and equipment with an option to renew the leases for up to one month to five years. Some of the leases include the option to terminate the leases upon 30-days notice with a penalty. The Company’s leases have various remaining lease terms ranging from July 2021 to January 2027. The Company’s lease agreements may include renewal or termination options for varying periods that are generally at the Company's discretion. The Company’s lease terms only include those periods related to renewal options the Company believes are reasonably certain to exercise. The Company generally does not include these renewal options as it is not reasonably certain to renew at the lease commencement date. This determination is based on consideration of certain economic, strategic and other factors that the Company evaluates at lease commencement date and reevaluates throughout the lease term. Some leases also include options to terminate the leases and the Company only includes those periods beyond the termination date if it is reasonably certain not to exercise the termination option.

The Company uses a discount rate to calculate the right of use (“ROU”) asset and lease liability. When the implicit rate is known or provided in the lease documents, the Company is required to use this rate. In cases in which the implicit rate is not known, the Company uses an estimated incremental borrowing rate.

Some leasing arrangements require variable payments that are dependent on usage or may vary for other reasons, such as payments for insurance and tax payments. The variable portion of lease payments is not included in the Company’s ROU assets or lease liabilities. Rather, variable payments, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred and are included in lease expenses recorded in selling and administrative expenses on the Consolidated Statements of Operations and Comprehensive Income.

The Company has lease agreements with both lease and non-lease components that are treated as a single lease component for all underlying asset classes. Accordingly, all expenses associated with a lease contract are accounted for as lease expenses.

The Company has elected to apply the short-term lease exception for all underlying asset classes. That is, leases with a term of 12 months or less are not recognized on the balance sheet, but rather expensed on a straight-line basis over the lease term. The Company’s leases do not include significant restrictions or covenants, and residual value guarantees are generally not included within its operating leases. As of September 30, 2021, the Company did not have any material additional operating leases that have not yet commenced.

The components of lease expense and supplemental balance sheet information were as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Operating lease expense related to ROU assets and liabilities	$	1,526	$	1,581	$	4,626	$	4,628
Other lease expense	204		231		496		846
Total lease expense	$	1,730	$	1,812	$	5,122	$	5,474

Other information related to leases was as follows (in thousands):

Supplemental Balance Sheet Information	September 30, 2021		December 31, 2020
Operating lease right-of-use assets, noncurrent	$	15,023	$	17,521
	September 30, 2021		December 31, 2020
Operating lease liabilities, current	$	4,226	$	3,940
Operating lease liabilities, noncurrent	13,574		15,993
Total operating lease liabilities	$	17,800	$	19,933

Weighted Average Remaining Lease Term	Years
Operating leases	4.18
Weighted Average Discount Rate
Operating leases	10.5	%

Maturities of operating lease liabilities as of September 30, 2021 were as follows (in thousands):

Year ending September 30:
2022	$	5,831
2023	5,046
2024	4,409
2025	3,544
2026	2,422
Thereafter	832
Total future undiscounted lease payments	22,084
Less imputed interest	(4,284)
Total	$	17,800

For the three months ended September 30, 2021 and 2020, the Company paid $1.5 million and $1.6 million, respectively, for operating lease liabilities. For both the nine months ended September 30, 2021 and 2020, the Company paid $4.6 million for operating lease liabilities.

XML

LIQUIDITY AND SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Nature of Business

Nature of Business

Rimini Street, Inc. (the “Company”) is a global provider of enterprise software support services. The Company’s subscription-based software support products and services offer enterprise software licensees a choice of solutions that replace or supplement the support products and services offered by enterprise software vendors.

Basis of Presentation and Consolidation

Basis of Presentation and Consolidation

The unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly-owned subsidiaries, are prepared in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”). All significant intercompany balances and transactions have been eliminated. The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, certain information and footnote disclosures required by U.S. GAAP for complete financial statements have been condensed or omitted in accordance with such rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the unaudited condensed consolidated financial statements have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2020, included in the Company’s 2020 Annual Report on Form 10-K as filed with the SEC on March 3, 2021 and as subsequently amended on May 10, 2021 (as amended, the “2020 Form 10-K/A”).

The accompanying condensed consolidated balance sheet and related disclosures as of December 31, 2020 have been derived from the Company’s audited financial statements. The Company’s financial condition as of September 30, 2021, and operating results for the three months ended September 30, 2021, are not necessarily indicative of the financial condition and results of operations that may be expected for any future interim period or for the year ending December 31, 2021.

Use of Estimates

Use of Estimates

The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the amounts reported in its consolidated financial statements and accompanying notes. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes are reasonable under the circumstances to determine the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s significant accounting estimates include, but are not necessarily limited to, accounts receivable, valuation assumptions for stock options and leases, deferred income taxes and the related valuation allowances, and the evaluation and measurement of contingencies. To the extent there are material differences between the Company’s estimates and actual results, the Company’s future consolidated results of operation may be affected.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Recently Adopted Standards. The following accounting standards were adopted during the fiscal year 2021:

In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The guidance removes certain exceptions to the general income tax

accounting principles, and clarifies and amends existing guidance to facilitate consistent application of the accounting principles. The new guidance was effective for the Company as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2020, the FASB issued ASU 2020-1, Investments—Equity Securities (Topic 321), Investments - Equity and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The guidance clarifies interactions between current accounting standards on equity securities, equity method and joint ventures, and derivatives and hedging. The new guidance addresses accounting for the transition into and out of the equity method and measuring certain purchased options and forward contracts to acquire investments. The new guidance was effective for the Company as of January 1, 2021. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.

Earnings Per Share

The Company computes earnings per share in accordance with ASC Topic 260, Earnings per Share, which requires earnings per share for each class of stock to be calculated using the two-class method. The holders of Series A Preferred Stock were entitled to participate in Common Stock dividends, if and when declared, on a one-to-one per-share basis. Accordingly, in periods in which the Company has net income, earnings per share will be computed using the two-class method whereby the pro rata dividends on Common Stock that are also distributable to the holders of Series A Preferred Stock would have been deducted from earnings applicable to common stockholders, regardless of whether a dividend is declared for such undistributed earnings. Under the two-class method, earnings for the reporting period were allocated between the holders of the Company’s Common Stock and the Series A Preferred Stock based on their respective participation rights in undistributed earnings.

Basic earnings per share of Common Stock is computed by dividing net income attributable to common stockholders by the weighted average number of shares of basic Common Stock outstanding. Net income allocated to the holders of the Company’s Series A Preferred Stock is calculated based on the shareholders’ proportionate share of the weighted average shares of Common Stock outstanding on an if-converted basis. Diluted earnings per share of Common Stock is calculated by adjusting the basic earnings per share of Common Stock for the effects of potential dilutive Common Stock shares outstanding such as stock options, restricted stock units and warrants.

XML

DEFERRED CONTRACT COSTS AND DEFERRED REVENUE (Tables)

9 Months Ended

Sep. 30, 2021

Revenue from Contract with Customer [Abstract]

Contract Liabilities

Activity for deferred contract costs for the three and nine months ended September 30, 2021 and 2020 is shown below (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Deferred contract costs, current and noncurrent, as of the beginning of period	$	36,561	$	29,384	$	34,945	$	28,049
Capitalized commissions during the period	4,295		7,123		13,437		15,165
Amortized deferred contract costs during the period	(4,132)		(3,585)		(11,658)		(10,292)
Deferred contract costs, current and noncurrent, as of the end of period	$	36,724	$	32,922	$	36,724	$	32,922

Deferred revenue activity for the three and nine months ended September 30, 2021 and 2020 is shown below (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Deferred revenue, current and noncurrent, as of the beginning of period	$	265,638	$	218,506	$	256,933	$	235,498
Billings, net	73,686		68,309		261,900		207,751
Revenue recognized	(95,642)		(82,518)		(275,151)		(238,952)
Deferred revenue, current and noncurrent, as of the end of period	$	243,682	$	204,297	$	243,682	$	204,297

XML

OTHER FINANCIAL INFORMATION (Tables)

9 Months Ended

Sep. 30, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Other Accrued Liabilities

As of September 30, 2021 and December 31, 2020, other accrued liabilities consist of the following (in thousands): 

	2021		2020
Accrued sales and other taxes	$	4,238	$	5,213
Accrued professional fees	6,997		5,912
Accrued dividends on Redeemable Series A Preferred Stock	—		3,842
Current maturities of capital lease obligations	334		429
Income taxes payable	721		2,245
Other accrued expenses	4,828		3,513
Total other accrued liabilities	$	17,118	$	21,154

XML

DEBT (Tables)

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

Schedule of Carrying Value of Debt

As of September 30, 2021 and December 31, 2020, debt consisted of the following (in thousands):

	2021		2020
Credit Facility	$	84,226	$	—
Less current maturities	3,670		—
Long-term debt, net of current maturities	$	80,556	$	—

Interest Expense Disclosure

The components of interest expense for the three and nine months ended September 30, 2021 and 2020 are presented below (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Credit Facility:
Interest expense	$	435	$	—	$	435	$	—
Accretion expense related to discount and issuance costs	196		—		196		—
Interest on finance leases	22		10		107		35
	$	653	$	10	$	738	$	35

XML

REDEEMABLE SERIES A PREFERRED STOCK (Tables)

9 Months Ended

Sep. 30, 2021

Temporary Equity Disclosure [Abstract]

Allocation Private Placement Proceeds

The allocation of the net proceeds as of the closing date, along with changes in the net carrying value of the Series A Preferred Stock through September 30, 2021, are set forth below (dollars in thousands):

	Series A Preferred Stock				Common			Convertible
	Shares	Amount			Stock			Notes		Total
Fair value on July 19, 2018:
Series A Preferred Stock	140,000	$	126,763	(1)	$	—		$	—	$	126,763
Common Stock	—	—			20,131		(2)	—		20,131
Convertible Notes	—	—			—			—		—
Total	140,000	$	126,763		$	20,131		$	—	$	146,894
Relative fair value allocation on July 19, 2018
Aggregate cash proceeds on July 19, 2018	140,000	$	114,773	(3)	$	18,227	(3)	$	—	$	133,000
Incremental and direct costs	—	(3,994)		(4)	(634)		(4)	—		(4,628)
Net carrying value on July 19, 2018	140,000	$	110,779		$	17,593		$	—	$	128,372

_________________

(1)The liquidation preference for each share of Series A Preferred Stock on the closing date for the Initial Private Placement was $1,000 per share for an aggregate liquidation preference of $140.0 million. The estimated fair value of the Series A Preferred Stock was approximately $126.8 million on July 19, 2018, which is the basis for allocation of the net proceeds. Please refer to Note 12 for further discussion of the valuation methodology employed.

(2)The fair value of the issuance of approximately 2.9 million shares of Common Stock was based on the last closing price of $6.95 per share on the date prior to closing the transaction.

(3)The aggregate cash proceeds of $133.0 million on July 19, 2018 were allocated pro rata based on the fair value of all consideration issued.

(4)Incremental and direct costs of the Initial Private Placement were allocated pro rata based on the fair value of all consideration issued. Such costs include financial advisory and professional fees of $2.7 million that were incurred by the Company, and due diligence and professional fees incurred by the investors of $1.9 million.

The allocation of the net proceeds from the March 2019

Private Placement are set forth below (dollars in thousands):

	Series A Preferred Stock				Common			Convertible
	Shares	Amount			Stock			Notes		Total
Fair value on March 7, 2019:
Series A Preferred Stock	6,500	$	5,313	(1)	$	—		$	—	$	5,313
Common Stock	—	—			722		(2)	—		722
Convertible Notes	—	—			—			—		—
Total	6,500	$	5,313		$	722		$	—	$	6,035
Relative fair value allocation on March 7, 2019:
Aggregate cash proceeds on March 7, 2019	6,500	$	5,093	(3)	$	692	(3)	$	—	$	5,785
Incremental and direct costs	—	(661)		(4)	(90)		(4)	—		(751)
Net carrying value on March 7, 2019	6,500	$	4,432		$	602		$	—	$	5,034

(1)The liquidation preference for each share of Series A Preferred Stock on the closing date for the March 2019 Private Placement was $1,000 per share for an aggregate liquidation preference of $6.5 million. The estimated fair value of the Series A Preferred Stock was approximately $5.3 million on March 7, 2019, which is the basis for allocation of the net proceeds. Please refer to Note 12 for further discussion of the valuation methodology employed.

(2)The fair value of the issuance of approximately 134,483 shares of Common Stock was based on the closing price of $5.37 per share on the date prior to closing of the transaction.

(3)The aggregate cash proceeds of $5.8 million on March 7, 2019 were allocated pro rata based on the fair value of all consideration issued.

(4)Incremental and direct costs related to the March 2019 Private Placement were allocated pro rata based on the fair value of all consideration issued. Such costs included the issuance of 85,000 shares of Common Stock to the Initial Private Placement investors in the Series A Preferred Stock for their consent of approximately $0.5 million and financial advisory and professional fees that were incurred of approximately $0.3 million that were either paid or accrued directly by the Company as of March 31, 2019.

The allocation of the net proceeds from the June 2019 Private Placement are set forth below (dollars in thousands):

	Series A Preferred Stock				Common			Convertible
	Shares	Amount			Stock			Notes		Total
Fair value on June 20, 2019:
Series A Preferred Stock	3,500	$	2,997	(1)	$	—		$	—	$	2,997
Common Stock	—	—			376		(2)	—		376
Convertible Notes	—	—			—			—		—
Total	3,500	$	2,997		$	376		$	—	$	3,373
Relative fair value allocation on June 20, 2019:
Aggregate cash proceeds on June 20, 2019	3,500	$	2,954	(3)	$	371	(3)	$	—	$	3,325
Incremental and direct costs	—	(301)		(4)	(38)		(4)	—		(339)
Net carrying value on June 20, 2019	3,500	$	2,653		$	333		$	—	$	2,986

(1)The liquidation preference for each share of Series A Preferred Stock on the closing date for the June 2019 Private Placement was $1,000 per share for an aggregate liquidation preference of $3.5 million. The estimated fair value of the Series A Preferred Stock was approximately $3.0 million on June 20, 2019, which is the basis for allocation of the net proceeds. Please refer to Note 12 for further discussion of the valuation methodology employed.

(2)The fair value of the issuance of approximately 72,414 shares of Common Stock was based on the closing price of $5.19 per share on the date prior to closing of the transaction.

(3)The aggregate cash proceeds of $3.3 million on June 20, 2019 were allocated pro rata based on the fair value of all consideration issued.

(4)Incremental and direct costs related to the June 2019 Private Placement were allocated pro rata based on the fair value of all consideration issued. Such costs included the issuance of 35,000 shares of Common Stock to the Initial Private Placement investors in the Series A Preferred Stock for their consent of approximately $0.2 million and financial advisory and professional fees that were incurred of approximately $0.2 million that were either paid or accrued directly by the Company as of June 30, 2019.

Temporary Equity

The changes in the net carrying value of Series A Preferred Stock from December 31, 2020 to September 30, 2021 are set forth below (dollars in thousands):

	Series A Preferred Stock
	Shares	Amount
Net carrying value as of December 31, 2020	154,911	$	137,854
Issuance of shares to settle PIK Dividends on January 4, 2021	1,193	1,193
Repurchase of 10,000 shares on January 5, 2021	(10,000)	(8,913)
Accretion of discount for the three months ended March 31, 2021	—	1,473
Net carrying value as of March 31, 2021	146,104	131,607
Issuance of shares to settle PIK Dividends on April 1, 2021	1,051	1,051
Redemption of 60,000 shares on April 16, 2021	(60,000)	(54,327)
Accretion of discount for the three months ended June 30, 2021	—	804
Net carrying value as of June 30, 2021	87,155	79,135
Issuance of shares to settle PIK Dividends on July 1, 2021	647	647
Redemption of 87,802 shares on July 20, 2021	(87,802)	(79,782)
Net carrying value as of September 30, 2021	—	$	—

Dividends Declared

Presented below is a summary of total and per share dividends declared through September 30, 2021 (dollars in thousands, except per share amounts):

	Dividends Payable in:				Total		Dividends
	Cash		PIK		Dividends		Per Share
Dividends payable as of December 31, 2020	$	3,842	$	1,193	$	5,035	$	32.50
Cash Dividends @ 10% per annum	3,660		—		3,660		23.40
PIK Dividends @ 3% per annum	—		1,098		1,098		7.02
Fractional PIK shares settled for cash	47		(47)		—		—
Less dividends settled January 4, 2021	(4,009)		(1,193)		(5,202)		(33.26)
Dividends payable as of March 31, 2021	3,540		1,051		4,591		32.14
Cash Dividends @ 10% per annum	2,179		—		2,179		25.00
PIK Dividends @ 3% per annum	—		654		654		7.50
Fractional PIK shares settled for cash	7		(7)		—		—
Less dividends settled April 1, 2021	(3,540)		(1,051)		(4,591)		(52.68)
Dividends payable as of June 30, 2021	2,186		647		2,833		32.51
Less dividends settled on July 1, 2021	(2,186)		(647)		(2,833)		(32.27)
Dividends payable as of September 30, 2021	$	—	$	—	$	—	$	—

XML

COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS (Tables)

9 Months Ended

Sep. 30, 2021

Share-based Payment Arrangement [Abstract]

Schedule of Stock Option Activity

The following table sets forth a summary of stock option activity under the Stock Plans for the nine months ended September 30, 2021 (shares in

thousands): 

	Shares	Price (1)		Term (2)
Outstanding, December 31, 2020	7,007	$	5.24	5.0
Granted	928	7.77
Forfeited	(170)	6.21
Expired	(113)	6.63
Exercised	(1,184)	4.26
Outstanding, September 30, 2021 (3)(4)	6,468	5.73		5.1
Vested, September 30, 2021 (3)	5,056	5.53		4.0

(1)Represents the weighted average exercise price.

(2)Represents the weighted average remaining contractual term until the stock options expire.

(3)As of September 30, 2021, the aggregate intrinsic value of all stock options outstanding was $25.4 million. As of September 30, 2021, the aggregate intrinsic value of vested stock options was $20.9 million.

(4)The number of outstanding stock options that are not expected to ultimately vest due to forfeiture amounted to 0.2 million shares as of September 30, 2021.

Schedule of Shares Available for Grant Activity

The following table presents activity affecting the total number of shares available for grant under the Stock Plans for the nine months ended September 30, 2021 (in thousands):

 

Available, December 31, 2020	4,037
Newly authorized by Board of Directors	3,056
Stock options granted	(928)
Restricted stock units granted	(1,394)
Expired options under Stock Plans	113
Forfeited options under Stock Plans	170
Forfeited restricted stock units under Stock Plans	348
Shares repurchased	137
Available, September 30, 2021	5,539

Schedule of Assumptions of Fair Value of Stock Option Grants

For the nine months ended September 30, 2021, the fair value of each stock option grant under the Stock Plans was estimated on the date of grant using the BSM option-pricing model, with the following weighted-average assumptions: 

Expected life (in years)	6.0
Volatility	42%
Dividend yield	0%
Risk-free interest rate	0.87%
Fair value per common share on date of grant	$7.77

Schedule of Stock-based Compensation Expense

Stock-based compensation expense attributable to RSUs and stock options is classified as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Cost of revenues	$	376	$	303	$	1,067	$	866
Sales and marketing	752		734		2,353		1,994
General and administrative	1,265		1,152		3,684		2,565
Total	$	2,393	$	2,189	$	7,104	$	5,425

XML

EARNINGS (LOSS) PER SHARE (Tables)

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following tables set forth the computation of basic and diluted net loss attributable to common stockholders for the three and nine months ended September 30, 2021 and 2020 (in thousands, except per share amounts):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Income attributable to common stockholders:
Net income	$	1,931		$	3,609		$	5,162		$	9,078
Return on repurchase of Series A Preferred Stock shares	—			—			(38)			—
Accretion related to redemption of Series A Preferred Stock	(8,020)			—			(13,693)			—
Make-whole dividends related to redemption of Series A Preferred Stock	(602)			—			(2,945)			—
Dividends and accretion related to Series A Preferred Stock:
Cash dividends declared	—			(3,968)			(5,839)			(11,817)
PIK dividends declared	—			(1,190)			(1,752)			(3,545)
Accretion of discount	—			(1,587)			(2,277)			(4,702)
	(6,691)			(3,136)			(21,382)			(10,986)
Undistributed earnings allocated using the two-class method	—			—			—			—
Net loss attributable to common stockholders	$	(6,691)		$	(3,136)		$	(21,382)		$	(10,986)
	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Weighted average number of shares of Common Stock outstanding	86,189			72,377			83,449			69,521
Additional shares outstanding if Series A Preferred Stock is converted to Common Stock	1,813			15,873			8,698			15,756
Total shares outstanding if Series A Preferred Stock is converted to Common Stock	88,002			88,250			92,147			85,277
Percentage of shares allocable to Series A Preferred Stock	2.1		%	18.0		%	9.4		%	18.5		%
Weighted average number of shares of Common Stock outstanding:
Basic and diluted	86,189			72,377			83,449			69,521
Net loss per share attributable to common stockholders:
Basic and diluted	$	(0.08)		$	(0.04)		$	(0.26)		$	(0.16)

Schedule of Weighted Average Number of Shares

If the Company had recorded net income attributable to common stockholders, the diluted shares would have been as follows (in thousands):

	Three Months Ended September 30,		Nine Months Ended September 30,
	2021	2020	2021	2020
Restricted stock units	1,673	685	1,815	598
Stock options	2,136	1,243	2,964	1,640
Warrants	1,203	—	988	—
Total	5,012	1,928	5,767	2,238

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

As of September 30, 2021 and December 31, 2020, the following potential Common Stock equivalents were excluded from the computation of diluted net loss per share for the respective periods ending on these dates since the impact of inclusion was anti-dilutive (in thousands): 

	2021	2020
Series A Preferred Stock	—	15,491
Restricted stock units	2,913	3,322
Stock options	6,468	7,007
Warrants	18,128	18,128
Total	27,509	43,948

XML

FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS (Tables)

9 Months Ended

Sep. 30, 2021

Investments, All Other Investments [Abstract]

Schedule of Revenues by Geographic Regions

The Company attributes revenues to geographic regions based on the location of its clients’ contracting entity. The following table shows revenues by geographic region (in thousands): 

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
United States of America	$	50,479	$	48,160	$	147,600	$	142,982
International	45,163		34,358		127,551		95,970
Total	$	95,642	$	82,518	$	275,151	$	238,952

XML

LEASES (Tables)

9 Months Ended

Sep. 30, 2021

Leases [Abstract]

Components of Lease Expense

The components of lease expense and supplemental balance sheet information were as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Operating lease expense related to ROU assets and liabilities	$	1,526	$	1,581	$	4,626	$	4,628
Other lease expense	204		231		496		846
Total lease expense	$	1,730	$	1,812	$	5,122	$	5,474

Other information related to leases was as follows (in thousands):

Supplemental Balance Sheet Information	September 30, 2021		December 31, 2020
Operating lease right-of-use assets, noncurrent	$	15,023	$	17,521
	September 30, 2021		December 31, 2020
Operating lease liabilities, current	$	4,226	$	3,940
Operating lease liabilities, noncurrent	13,574		15,993
Total operating lease liabilities	$	17,800	$	19,933

Weighted Average Remaining Lease Term	Years
Operating leases	4.18
Weighted Average Discount Rate
Operating leases	10.5	%

Maturities of Operating Lease Liabilities

Maturities of operating lease liabilities as of September 30, 2021 were as follows (in thousands):

Year ending September 30:
2022	$	5,831
2023	5,046
2024	4,409
2025	3,544
2026	2,422
Thereafter	832
Total future undiscounted lease payments	22,084
Less imputed interest	(4,284)
Total	$	17,800

XML

LIQUIDITY AND SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)						3 Months Ended		9 Months Ended
	Jul. 20, 2021	Apr. 16, 2021	Mar. 11, 2021	Aug. 18, 2020	Jul. 19, 2018	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2021	Jan. 05, 2021	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Significant Accounting Policies Disclosure [Line Items]
Working capital deficit								$ 64,200,000
Net loss						$ 1,931,000	$ 3,609,000	5,162,000	$ 9,078,000
Cash, cash equivalents, restricted cash and restricted cash equivalents						103,440,000	83,743,000	103,440,000	83,743,000			$ 87,909,000		$ 38,388,000
Deferred revenue, current						$ 203,800,000		$ 203,800,000
Historical cost of goods and services (as a percent of deferred revenue)						35.00%
Debt instrument, term	5 years
Long-term debt	$ 90,000,000
Annual minimum principal payments year one	5.00%
Annual minimum principal payments year two	5.00%
Annual minimum principal payments year three	7.50%
Annual minimum principal payments year four	7.50%
Annual minimum principal payments year five	10.00%
Common stock, par value (USD per share)						$ 0.0001		$ 0.0001				$ 0.0001
Underwriter discounts and commissions								$ 2,948,000	1,650,000
Underwriter expenses								1,050,000	143,000
Professional fees					$ 200,000
Operating and capital lease payments due within next twelve months						$ 6,300,000		6,300,000
Fair value instruments						5,145,000		5,145,000				$ 2,122,000
Income tax expense (benefit)						1,729,000	1,272,000	4,218,000	3,327,000
Stockholders' equity attributable to parent						$ 160,164,000	202,030,000	$ 160,164,000	202,030,000	$ 156,299,000		$ 203,060,000	$ 227,788,000	223,321,000
GP Sponsor Private Placement Warrants
Significant Accounting Policies Disclosure [Line Items]
Warrants outstanding (shares)												6,100,000
Exercise price of warrants (in USD per share)												$ 11.50
Revision of Prior Period, Adjustment
Significant Accounting Policies Disclosure [Line Items]
Gain impact to the statement of operations							300,000		300,000
Other operating activities, cash flow statement							200,000		200,000
Income tax expense (benefit)							0		0
Stockholders' equity attributable to parent							$ 1,000,000		$ 1,000,000					$ 700,000
Series A Preferred Stock
Significant Accounting Policies Disclosure [Line Items]
Redemption shares issued (in shares)	87,802	60,000
Redemption percentage	13.00%	13.00%
Redemption price	$ 88,400,000	$ 60,000,000
Aggregate redemption price	$ 87,800,000	$ 62,300,000
Preferred stock, dividends per share, declared (usd per share)	$ 1,000	$ 1,000
Redemption of accrued dividends	$ 600,000	$ 2,300,000
Per share amount of accrued dividends (in usd per share)	$ 6.86	$ 39.05
Sale of stock (shares)			60,000	60,000
Dividend rate (as a percent)						13.00%		13.00%
Value of shares authorized to be repurchased											$ 8,950,000
March 2021 Offering
Significant Accounting Policies Disclosure [Line Items]
Sale of stock (shares)			7,800,000
Common stock, par value (USD per share)			$ 0.0001
Price per share (usd per share)			$ 7.75
Gross proceeds			$ 57,000,000
Underwriter discounts and commissions			2,900,000
Underwriter expenses			200,000
Professional fees			1,300,000
Consideration received			$ 55,600,000
August 2020 Offering
Significant Accounting Policies Disclosure [Line Items]
Sale of stock (shares)				6,100,000
Price per share (usd per share)				$ 4.50
Gross proceeds				$ 27,500,000
Underwriter discounts and commissions				1,700,000
Underwriter expenses				100,000
Professional fees				600,000
Consideration received				$ 25,100,000

XML

DEFERRED CONTRACT COSTS AND DEFERRED REVENUE (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Capitalized Contract Cost, Net [Abstract]
Deferred contract costs, current and noncurrent, as of the beginning of period	$ 36,561	$ 29,384	$ 34,945	$ 28,049
Capitalized commissions during the period	4,295	7,123	13,437	15,165
Amortized deferred contract costs during the period	(4,132)	(3,585)	(11,658)	(10,292)
Deferred contract costs, current and noncurrent, as of the end of period	36,724	32,922	36,724	32,922
Change in Contract with Customer, Liability [Abstract]
Deferred revenue, current and noncurrent, as of the beginning of period	265,638	218,506	256,933	235,498
Billings, net	73,686	68,309	261,900	207,751
Revenue recognized	(95,642)	(82,518)	(275,151)	(238,952)
Deferred revenue, current and noncurrent, as of the end of period	243,682	$ 204,297	243,682	$ 204,297
Deferred revenue, current	203,806		203,806		$ 228,967
Deferred revenue, noncurrent	$ 39,876		$ 39,876		$ 27,966

XML

OTHER FINANCIAL INFORMATION - Other Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued sales and other taxes	$ 4,238	$ 5,213
Accrued professional fees	6,997	5,912
Accrued dividends on Redeemable Series A Preferred Stock	0	3,842
Current maturities of capital lease obligations	334	429
Income taxes payable	721	2,245
Other accrued expenses	4,828	3,513
Total other accrued liabilities	$ 17,118	$ 21,154

XML

OTHER FINANCIAL INFORMATION - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Interest expense	$ 653	$ 10	$ 738	$ 35

XML

DEBT - Net of Debt Discounts and Issuance Costs (Details) - USD ($)	Sep. 30, 2021	Jul. 20, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Credit Facility		$ 90,000,000
Less current maturities	$ 3,670,000		$ 0
Long-term debt, net of current maturities	80,556,000		0
Term Loan | Credit Facility
Debt Instrument [Line Items]
Credit Facility	84,226,000		0
Less current maturities	3,670,000		0
Long-term debt, net of current maturities	$ 80,556,000		$ 0

XML

DEBT - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
	Jul. 20, 2021	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2020
Debt Instrument [Line Items]
Net proceeds related			$ 89,313	$ 0
Debt instrument, term	5 years
Annual minimum principal payments year one	5.00%
Annual minimum principal payments year two	5.00%
Annual minimum principal payments year three	7.50%
Annual minimum principal payments year four	7.50%
Annual minimum principal payments year five	10.00%
Term Loan | Credit Facility
Debt Instrument [Line Items]
Net proceeds related	$ 89,300
Issuance costs discount	0.375%
Incurred issuance costs	$ 4,200
Line of credit facility, interest rate		2.40%
Minimum fixed charge ratio	1.25
Total leverage ratio	3.75
Financial covenants, minimum liquidity	$ 20,000
Debt instrument, term	5 years
Annual minimum principal payments year one	5.00%
Annual minimum principal payments year two	5.00%
Annual minimum principal payments year three	7.50%
Annual minimum principal payments year four	7.50%
Annual minimum principal payments year five	10.00%
Principal payment		$ 1,100	$ 1,100
LIBOR | Minimum | Term Loan | Credit Facility
Debt Instrument [Line Items]
Debt instrument, interest rate	1.75%
LIBOR | Maximum | Term Loan | Credit Facility
Debt Instrument [Line Items]
Debt instrument, interest rate	2.50%

XML

DEBT - Components of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Debt Instrument [Line Items]
Interest Expense, Total	$ 653	$ 10	$ 738	$ 35
Credit Facility | Term Loan
Debt Instrument [Line Items]
Interest expense	435	0	435	0
Accretion expense related to discount and issuance costs	196	0	196	0
Interest on finance leases	$ 22	$ 10	$ 107	$ 35

XML

REDEEMABLE SERIES A PREFERRED STOCK - Narrative (Details) - USD ($)										3 Months Ended		9 Months Ended
	Jul. 20, 2021	Apr. 16, 2021	Mar. 11, 2021	Aug. 18, 2020	Jun. 30, 2019	Jun. 20, 2019	Mar. 31, 2019	Mar. 07, 2019	Jul. 19, 2018	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2021	Sep. 30, 2020	Jan. 05, 2021	Dec. 31, 2020
Securities Purchase Agreements
Discount on shares									$ 7,000,000
Line of credit unpaid transaction costs									2,700,000
Repayments of lines of credit												$ 1,125,000	$ 0
Stock issuance costs												1,296,000	253,000
Professional fees									200,000
Net proceeds related to Common Stock issuances in March 2021 and August 2020 Offerings		$ 80,700,000										$ 56,965,000	$ 25,657,000
Certificate of Designations
Redeemable preferred stock, shares authorized (shares)										180,000		180,000			180,000
Number of years dividend will be effective												5 years
Funded Debt
Securities Purchase Agreements
Repayments of lines of credit									132,800,000
Private Placement
Securities Purchase Agreements
Proceeds from issuance of private placement						$ 3,325,000		$ 5,785,000	133,000,000
Discount on shares						200,000		700,000
Incremental and direct transaction costs						339,000		751,000	4,628,000
Stock issuance costs						$ 300,000		$ 800,000	2,700,000
Discount on shares (as a percent)						5.00%		11.00%
Consideration received						$ 2,986,000		$ 5,034,000	$ 128,372,000
Incremental and direct costs, shares issued, cost						$ 200,000		$ 500,000
Series A Preferred Stock
Securities Purchase Agreements
Sale of stock (shares)			60,000	60,000
Redemption shares issued (in shares)	87,802	60,000
Redemption percentage	13.00%	13.00%
Redemption price	$ 88,400,000	$ 60,000,000
Aggregate redemption price	$ 87,800,000	$ 62,300,000
Preferred stock, dividends per share, declared (usd per share)	$ 1,000	$ 1,000
Redemption of accrued dividends	$ 600,000	$ 2,300,000
Per share amount of accrued dividends (in usd per share)	$ 6.86	$ 39.05
Shares authorized to be repurchased (in shares)														10,000
Value of shares authorized to be repurchased														$ 8,950,000
Certificate of Designations
Dividend rate (as a percent)										13.00%		13.00%
Series A Preferred Stock | Private Placement
Securities Purchase Agreements
Sale of stock (shares)						3,500		6,500	140,000
Proceeds from issuance of private placement						$ 2,954,000		$ 5,093,000	$ 114,773,000
Incremental and direct transaction costs						$ 301,000		$ 661,000	$ 3,994,000
Redemption price										$ 79,782,000	$ 54,327,000
Common Stock
Securities Purchase Agreements
New stock issued during period (shares)						72,414		134,483	2,900,000
Common Stock | Private Placement
Securities Purchase Agreements
New stock issued during period (shares)						72,414		134,483
Proceeds from issuance of private placement						$ 371,000		$ 692,000	$ 18,227,000
Incremental and direct transaction costs						$ 38,000		$ 90,000	634,000
Incremental and direct costs (shares)						35,000		85,000
Due Diligence And Professional Fees | Private Placement
Securities Purchase Agreements
Incremental and direct transaction costs					$ 200,000	$ 200,000	$ 300,000	$ 300,000	$ 1,900,000
Cash Dividend
Certificate of Designations
Dividend rate (as a percent)										10.00%		10.00%
Paid-In-Kind Dividend
Certificate of Designations
Dividend rate (as a percent)										3.00%		3.00%

XML

REDEEMABLE SERIES A PREFERRED STOCK - Series A Preferred Stock Summary (Details) - USD ($) $ / shares in Units, $ in Thousands	Jun. 30, 2019	Jun. 20, 2019	Mar. 31, 2019	Mar. 07, 2019	Jul. 19, 2018	Sep. 30, 2021	Dec. 31, 2020
Temporary Equity [Line Items]
Net carrying value						$ 0	$ 137,854
Common stock issued						9	8
Footnotes
Temporary equity, liquidation preference (usd per share)					$ 1,000
Redeemable preferred stock, liquidation preference		$ 3,500		$ 6,500	$ 140,000	$ 0	$ 154,911
Private Placement
Temporary Equity [Line Items]
Temporary stock issued		2,997		5,313	126,763
Issuance of Common Stock in March 2021 and August 2020 Offerings, net		3,373		6,035	146,894
Aggregate cash proceeds		3,325		5,785	133,000
Incremental and direct costs		(339)		(751)	(4,628)
Consideration received		2,986		5,034	128,372
Footnotes
Temporary stock issued		2,997		5,313	126,763
Incremental and direct costs, shares issued, cost		200		500
Incremental and direct transaction costs		$ 339		$ 751	$ 4,628
Private Placement | Series A Preferred Stock
Temporary Equity [Line Items]
Temporary stock issued (shares)		3,500		6,500	140,000
Temporary stock issued		$ 2,997		$ 5,313	$ 126,763
Aggregate cash proceeds		2,954		5,093	114,773
Incremental and direct costs		(301)		(661)	(3,994)
Net carrying value		$ 2,653		$ 4,432	110,779
Footnotes
Temporary equity, liquidation preference (usd per share)		$ 1,000		$ 1,000
Temporary stock issued		$ 2,997		$ 5,313	126,763
Incremental and direct transaction costs		$ 301		$ 661	$ 3,994
Common Stock
Footnotes
New stock issued during period (shares)		72,414		134,483	2,900,000
Shares issued (usd per share)		$ 5.19		$ 5.37	$ 6.95
Common Stock | Private Placement
Temporary Equity [Line Items]
Issuance of Common Stock in March 2021 and August 2020 Offerings, net		$ 376		$ 722	$ 20,131
Aggregate cash proceeds		371		692	18,227
Incremental and direct costs		(38)		(90)	(634)
Common stock issued		$ 333		$ 602	17,593
Footnotes
New stock issued during period (shares)		72,414		134,483
Incremental and direct costs (shares)		35,000		85,000
Incremental and direct transaction costs		$ 38		$ 90	634
Financial Advisor And Professional Fees | Private Placement
Temporary Equity [Line Items]
Incremental and direct costs					(2,700)
Footnotes
Incremental and direct transaction costs					2,700
Due Diligence And Professional Fees | Private Placement
Temporary Equity [Line Items]
Incremental and direct costs	$ (200)	(200)	$ (300)	(300)	(1,900)
Footnotes
Incremental and direct transaction costs	$ 200	$ 200	$ 300	$ 300	$ 1,900

XML

REDEEMABLE SERIES A PREFERRED STOCK - Change in Value of Temporary Equity (Details) - USD ($)				3 Months Ended				9 Months Ended
	Jul. 20, 2021	Apr. 16, 2021	Jan. 05, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Increase (Decrease) in Temporary Equity [Roll Forward]
Net carrying value beginning balance (shares)						155,000		155,000
Net carrying value beginning balance (shares)				0				0
Series A Preferred Stock
Increase (Decrease) in Temporary Equity [Roll Forward]
Aggregate redemption price	$ (88,400,000)	$ (60,000,000)
Accretion related to redemption of Series A Preferred Stock				$ 8,020,000			$ 0	$ 13,693,000	$ 0
Private Placement | Series A Preferred Stock
Increase (Decrease) in Temporary Equity [Roll Forward]
Net carrying value beginning balance (shares)				87,155	146,104	154,911		154,911
Net carrying value beginning balance				$ 79,135,000	$ 131,607,000	$ 137,854,000		$ 137,854,000
Issuance of shares to settle PIK Dividends (shares)				647	1,051	1,193
Issuance of shares to settle PIK Dividends				$ 647,000	$ 1,051,000	$ 1,193,000
Repurchase (shares)			(10,000)			(10,000)
Repurchase						$ (8,913,000)
Stock redeemed or called during period (in shares)	(87,802)	(60,000)		(87,802)	(60,000)
Aggregate redemption price				$ (79,782,000)	$ (54,327,000)
Accretion of discount (shares)					0	0
Accretion related to redemption of Series A Preferred Stock					$ 804,000	$ 1,473,000
Net carrying value beginning balance (shares)				0	87,155	146,104		0
Net carrying value beginning balance				$ 0	$ 79,135,000	$ 131,607,000		$ 0

XML

REDEEMABLE SERIES A PREFERRED STOCK - Dividends (Details) - USD ($) $ / shares in Units, $ in Thousands				3 Months Ended				9 Months Ended
	Jul. 01, 2021	Apr. 01, 2021	Jan. 04, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Dividends Payable [Roll Forward]
Cash dividends declared				$ 0			$ 3,968	$ 5,839	$ 11,817
Dividends, paid-in-kind				$ 0			$ 1,190	1,752	3,545
Payments of cash dividends on Series A Preferred Stock								$ (12,679)	$ (11,750)
Cash Dividend
Dividends Payable [Roll Forward]
Dividend rate (as a percent)				10.00%				10.00%
Paid-In-Kind Dividend
Dividends Payable [Roll Forward]
Dividend rate (as a percent)				3.00%				3.00%
Series A Preferred Stock
Dividends Payable [Roll Forward]
Dividends payable start of period	$ 2,833	$ 4,591		$ 2,833	$ 4,591	$ 5,035		$ 5,035
Dividends payable (usd per share)				$ 0	$ 32.51	$ 32.14		$ 0		$ 32.50
Payments of cash dividends on Series A Preferred Stock	$ (2,833)	$ (4,591)	$ (5,202)
Dividends, cash paid (usd per share)	$ (32.27)	$ (52.68)	$ (33.26)
Dividends payable end of period				$ 0	$ 2,833	$ 4,591		$ 0
Dividend rate (as a percent)				13.00%				13.00%
Series A Preferred Stock | Cash Dividend
Dividends Payable [Roll Forward]
Dividends payable start of period	$ 2,186	$ 3,540		$ 2,186	3,540	3,842		$ 3,842
Cash dividends declared					2,179	3,660
Dividends					$ 2,179	$ 3,660
Dividends payable (usd per share)					$ 25.00	$ 23.40
Payments of cash dividends on Series A Preferred Stock	(2,186)	(3,540)	$ (4,009)
Dividends payable end of period				0	$ 2,186	$ 3,540		0
Series A Preferred Stock | Paid-In-Kind Dividend
Dividends Payable [Roll Forward]
Dividends payable start of period	647	1,051		647	1,051	1,193		1,193
Cash dividends declared					7	47
Dividends, paid-in-kind					654	1,098
Dividends					$ 654	$ 1,098
Dividends payable (usd per share)					$ 7.50	$ 7.02
Payments of cash dividends on Series A Preferred Stock	$ (647)	$ (1,051)	$ (1,193)
Dividends payable end of period				$ 0	$ 647	$ 1,051		$ 0
Series A Preferred Stock | Fractional Shares
Dividends Payable [Roll Forward]
Cash dividends declared					7	47
Dividends					$ 0	$ 0
Dividends payable (usd per share)					$ 0	$ 0

XML

COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands						3 Months Ended		9 Months Ended
	Aug. 06, 2021	Mar. 11, 2021	Feb. 23, 2021	Aug. 18, 2020	Jul. 19, 2018	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Common Stock Offering
Underwriter discounts and commissions								$ 2,948	$ 1,650
Underwriter expenses								$ 1,050	143
Professional fees					$ 200
Stock Plans
Stock available for grant newly authorized by Board of Directors (shares)								3,056,000
Restricted Stock Units
Stock-based compensation expense						$ 2,393	$ 2,189	$ 7,104	5,425
Stock Options
Stock options granted in period (shares)								928,000
Warrants
Warrants outstanding (shares)						18,100,000		18,100,000
Series A Preferred Stock
Common Stock Offering
Sale of stock (shares)		60,000		60,000
Acquisition of Common Stock Upon Vesting of Restricted Stock Units [Abstract]
Stock reacquired						$ 0	0	$ 38	0
March 2021 Offering
Common Stock Offering
Sale of stock (shares)		7,800,000
Price per share (usd per share)		$ 7.75
Gross proceeds		$ 57,000
Underwriter discounts and commissions		2,900
Underwriter expenses		200
Professional fees		1,300
Consideration received		$ 55,600
August 2020 Offering
Common Stock Offering
Sale of stock (shares)				6,100,000
Price per share (usd per share)				$ 4.50
Gross proceeds				$ 27,500
Underwriter discounts and commissions				1,700
Underwriter expenses				100
Professional fees				600
Consideration received				$ 25,100
Exercise Price $5.64
Warrants
Warrants outstanding (shares)						3,400,000		3,400,000
Exercise price of warrants (in USD per share)						$ 5.64		$ 5.64
Exercise Price $11.50
Warrants
Warrants outstanding (shares)						14,700,000		14,700,000
Exercise price of warrants (in USD per share)						$ 11.50		$ 11.50
Stock options
Restricted Stock Units
Period for recognition of compensation costs not yet recognized related to nonvested awards								2 years 1 month 6 days
Stock Options
Stock options granted in period (shares)								900,000
Fair value of stock options granted								$ 3,000
Weighted-average grant date fair value per share of options granted in period (usd per share)								$ 3.20
Unrecognized compensation costs						$ 2,400		$ 2,400		$ 1,200
Period for recognition of compensation costs not yet recognized related to nonvested awards								2 years 1 month 6 days
Restricted stock units
Acquisition of Common Stock Upon Vesting of Restricted Stock Units [Abstract]
Stock repurchased (Shares)	100,000
Stock reacquired	$ 1,100
2013 Plan
Stock Plans
Stock available for grant newly authorized by Board of Directors (shares)			3,100,000
2013 Plan | Stock options
Stock Options
Award vesting rights (percentage)								33.33%
2013 Plan | Restricted stock units
Restricted Stock Units
Restricted stock units granted in period (shares)						1,400,000		1,400,000
Share price of common stock on date of grant of RSUs (USD per share)								$ 7.57
Aggregate fair value of shares underlying RSU's								$ 10,600
Stock-based compensation expense						$ 2,100	$ 1,800	6,200	$ 4,300
Compensation costs not yet recognized of nonvested awards						$ 12,200		$ 12,200
Period for recognition of compensation costs not yet recognized related to nonvested awards								1 year 9 months 18 days
Stock Options
Period for recognition of compensation costs not yet recognized related to nonvested awards								1 year 9 months 18 days
2013 Plan | Restricted stock units | Minimum
Restricted Stock Units
Award vesting period								12 months
2013 Plan | Restricted stock units | Maximum
Restricted Stock Units
Award vesting period								36 months
Stock Plans | Stock options
Stock Options
Term of vested options (years)								10 years

XML

COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS - Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares	Dec. 31, 2020 $ / shares shares
Shares
Outstanding at beginning of period (shares)	7,007
Granted (shares)	928
Forfeited (shares)	(170)
Expired (shares)	(113)
Exercised (shares)	(1,184)
Outstanding at end of period (shares)	6,468	7,007
Vested at end of period (shares)	5,056
Price
Outstanding at beginning of period (USD per share) | $ / shares	$ 5.24
Granted (USD per share) | $ / shares	7.77
Forfeited (USD per share) | $ / shares	6.21
Expired (USD per share) | $ / shares	6.63
Exercised (USD per share) | $ / shares	4.26
Outstanding at end of period (USD per share) | $ / shares	5.73	$ 5.24
Vested (USD per share) | $ / shares	$ 5.53
Term
Term of outstanding options	5 years 1 month 6 days	5 years
Term of vested options (years)	4 years
Aggregate intrinsic value of stock options outstanding | $	$ 25.4
Aggregate intrinsic value of vested stock options | $	$ 20.9
Outstanding stock options not expected to vest due to forfeitures (shares)	200

XML

COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS - Shares Available for Grant (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2021 shares
Shares Available for Grant [Roll Forward]
Available at beginning of period (shares)	4,037
Newly authorized by Board of Directors (shares)	3,056
Stock options granted (shares)	(928)
Restricted stock units granted (shares)	(1,394)
Expired options under Stock Plans (shares)	113
Forfeited options under Stock Plans (shares)	170
Forfeited restricted stock units under Stock Plans (shares)	348
Shares repurchased (shares)	137
Available at end of period (shares)	5,539

XML

COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS - Assumptions of Fair Value of Stock Option Grants (Details)	9 Months Ended
	Sep. 30, 2021 $ / shares
Share-based Payment Arrangement [Abstract]
Expected life (in years)	6 years
Volatility (as a percent)	42.00%
Dividend yield (as a percent)	0.00%
Risk-free interest rate (as a percent)	0.87%
Fair value per common share on date of grant (USD per share)	$ 7.77

XML

COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 2,393	$ 2,189	$ 7,104	$ 5,425
Cost of revenues
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	376	303	1,067	866
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	752	734	2,353	1,994
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 1,265	$ 1,152	$ 3,684	$ 2,565

XML

INCOME TAXES (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Deferred payroll tax payments	$ 3.2		$ 3.2
Federal statutory income tax rate (as a percent)	47.20%	26.10%	45.00%	26.80%

XML

COMMITMENTS AND CONTINGENCIES - Narrative (Details) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021 USD ($) motion	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) motion	Sep. 30, 2020 USD ($)	Dec. 31, 2016 USD ($)	Jun. 10, 2021 motion	Apr. 30, 2021 motion	Mar. 31, 2021 motion	Dec. 31, 2020 USD ($)	Sep. 15, 2020 client copyright
Loss Contingencies [Line Items]
Employer contribution	$ 0.8	$ 0.7	$ 2.5	$ 2.0
Current carrying value of guarantor obligations	$ 10.9		$ 10.9						$ 13.8
Oracle Litigation
Loss Contingencies [Line Items]
Number of violated injunctions asserted | motion								4
Number of injunctions motioned to be reconsidered | motion	2		2			2	2
Damages awarded			$ 89.9		$ 124.4
Oracle Litigation II | Two Specific Company Clients
Loss Contingencies [Line Items]
Copyrights infringed | copyright										4
Number of clients | client										2

XML

RELATED PARTY TRANSACTIONS (Details) - USD ($) $ in Millions	1 Months Ended	9 Months Ended
	Jul. 31, 2018	Sep. 30, 2021
Common Class A Stock
Related Party Transaction [Line Items]
New stock issued during period (shares)	400,000
Adams Street Partners | Common Stock
Related Party Transaction [Line Items]
Ownership of common stock outstanding (as a percent)		27.20%
Adams Street Partners | Series A Preferred Stock
Related Party Transaction [Line Items]
New stock issued during period (shares)	19,209
Private Placements | Affiliated Entity
Related Party Transaction [Line Items]
Total consideration	$ 19.2

XML

EARNINGS (LOSS) PER SHARE - Earnings per share (Details) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Temporary equity, conversion ratio			1
Net income	$ 1,931	$ 3,609	$ 5,162	$ 9,078
Cash dividends declared	0	(3,968)	(5,839)	(11,817)
PIK dividends declared	0	(1,190)	(1,752)	(3,545)
Accretion of discount	0	(1,587)	(2,277)	(4,702)
Net (loss) income after dividends and accretion	(6,691)	(3,136)	(21,382)	(10,986)
Undistributed earnings allocated using the two-class method	0	0	0	0
Net loss attributable to common stockholders	(6,691)	(3,136)	(21,382)	(10,986)
Net loss attributable to common stockholders	$ (6,691)	$ (3,136)	$ (21,382)	$ (10,986)
Weighted average number of shares of Common Stock outstanding (shares) | shares	86,189	72,377	83,449	69,521
Additional shares outstanding if Series A Preferred Stock is converted to Common Stock (shares) | shares	1,813	15,873	8,698	15,756
Total shares outstanding if Series A Preferred Stock is converted to Common Stock (shares) | shares	88,002	88,250	92,147	85,277
Percentage of shares allocable to Series A Preferred Stock (percent)	2.10%	18.00%	9.40%	18.50%
Weighted average number of shares outstanding, basic (shares) | shares	86,189	72,377	83,449	69,521
Weighted average number of shares outstanding, diluted (shares) | shares	86,189	72,377	83,449	69,521
Basic (usd per share) | $ / shares	$ (0.08)	$ (0.04)	$ (0.26)	$ (0.16)
Diluted (usd per share) | $ / shares	$ (0.08)	$ (0.04)	$ (0.26)	$ (0.16)
Series A Preferred Stock
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Return on repurchase of Series A Preferred Stock shares	$ 0	$ 0	$ (38)	$ 0
Accretion related to redemption of Series A Preferred Stock	(8,020)	0	(13,693)	0
Make-whole dividends related to redemption of Series A Preferred Stock	$ (602)	$ 0	$ (2,945)	$ 0

XML

EARNINGS (LOSS) PER SHARE - Summary (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income attributable to common stockholders, the diluted (shares)	5,012	1,928	5,767	2,238
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income attributable to common stockholders, the diluted (shares)	1,673	685	1,815	598
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income attributable to common stockholders, the diluted (shares)	2,136	1,243	2,964	1,640
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income attributable to common stockholders, the diluted (shares)	1,203	0	988	0

XML

EARNINGS (LOSS) PER SHARE - Antidilutive (Details) - shares shares in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings (in shares)	27,509	43,948
Series A Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings (in shares)	0	15,491
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings (in shares)	2,913	3,322
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings (in shares)	6,468	7,007
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings (in shares)	18,128	18,128

XML

FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Narrative (Details) $ / shares in Units, $ in Thousands, shares in Millions	Jun. 20, 2019 USD ($)	Mar. 07, 2019 USD ($)	Jul. 19, 2018 USD ($)	Sep. 30, 2021 USD ($) year $ / shares shares	Dec. 31, 2020 USD ($)
Concentration Risk [Line Items]
Warrants outstanding (shares) | shares				18.1
Liability for redeemable warrants				$ 5,145	$ 2,122
Term to expirations (in years)				1 year 10 days
Property and equipment, net				$ 4,547	4,820
Operating lease right-of-use assets				15,023	17,521
Cash and cash equivalents				$ 103,015	87,575
Public Warrants
Concentration Risk [Line Items]
Warrants outstanding (shares) | shares				8.6
Exercise price of warrants (in USD per share) | $ / shares				$ 11.50
Non-US
Concentration Risk [Line Items]
Property and equipment, net				$ 1,500	1,300
UNITED STATES
Concentration Risk [Line Items]
Operating lease right-of-use assets				9,500	11,000
INDIA
Concentration Risk [Line Items]
Operating lease right-of-use assets				5,000	5,800
Rest of the world
Concentration Risk [Line Items]
Operating lease right-of-use assets				500	800
Single Financial Institution
Concentration Risk [Line Items]
Cash and cash equivalents				73,300	50,200
Current restricted cash				$ 400	$ 300
Private Placement
Concentration Risk [Line Items]
Temporary stock issued	$ 2,997	$ 5,313	$ 126,763
Series A Preferred Stock | Private Placement
Concentration Risk [Line Items]
Temporary stock issued	$ 2,997	$ 5,313	$ 126,763
Measurement Input, Expected Term | Series A Preferred Stock | Minimum
Concentration Risk [Line Items]
Measurement input (as a percent) | year				4
Measurement Input, Expected Term | Series A Preferred Stock | Maximum
Concentration Risk [Line Items]
Measurement input (as a percent) | year				5
Measurement Input, Implied Yield | Series A Preferred Stock | Minimum
Concentration Risk [Line Items]
Measurement input (as a percent)				0.209
Measurement Input, Implied Yield | Series A Preferred Stock | Maximum
Concentration Risk [Line Items]
Measurement input (as a percent)				0.229
Measurement Input, Risk Free Interest Rate
Concentration Risk [Line Items]
Warrants and rights outstanding, measurement input (as a percent)				0.0010
Measurement Input, Risk Free Interest Rate | Series A Preferred Stock
Concentration Risk [Line Items]
Warrants and rights outstanding, measurement input (as a percent)	0.0172	0.0244	0.028
Measurement Input, Price Volatility
Concentration Risk [Line Items]
Warrants and rights outstanding, measurement input (as a percent)				0.379
Measurement Input, Price Volatility | Series A Preferred Stock
Concentration Risk [Line Items]
Measurement input (as a percent)				0.300

XML

FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Summary (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 95,642	$ 82,518	$ 275,151	$ 238,952
United States of America
Disaggregation of Revenue [Line Items]
Revenue	50,479	48,160	147,600	142,982
International
Disaggregation of Revenue [Line Items]
Revenue	$ 45,163	$ 34,358	$ 127,551	$ 95,970

XML

LEASES - Narrative (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021 USD ($) day	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) day
Lessee, Lease, Description [Line Items]
Days notice required to terminate (days) | day	30		30
Operating lease payments | $	$ 1.5	$ 1.6	$ 4.6
Minimum
Lessee, Lease, Description [Line Items]
Operating lease renewal term (years)	1 month		1 month
Maximum
Lessee, Lease, Description [Line Items]
Operating lease renewal term (years)	5 years		5 years

XML

LEASES - Components of lease expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Operating lease expense related to ROU assets and liabilities	$ 1,526	$ 1,581	$ 4,626	$ 4,628
Other lease expense	204	231	496	846
Total lease expense	$ 1,730	$ 1,812	$ 5,122	$ 5,474

XML

LEASES - Supplemental balance sheet information (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Leases [Abstract]
Operating lease right-of-use assets, noncurrent	$ 15,023	$ 17,521
Operating lease liabilities, current	4,226	3,940
Operating lease liabilities, noncurrent	13,574	15,993
Total operating lease liabilities	$ 17,800	$ 19,933
Weighted average remaining lease term, operating leases (years)	4 years 2 months 4 days
Weighted average discount rate, operating leases (as a percent)	10.50%

XML

LEASES - Maturities of lease liability (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Leases [Abstract]
2022	$ 5,831
2023	5,046
2024	4,409
2025	3,544
2026	2,422
Thereafter	832
Total future undiscounted lease payments	22,084
Less imputed interest	(4,284)
Total	$ 17,800	$ 19,933